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CHAPTER I 
 
 
 
INTRODUCTION  
 
 
 
Suicide is a devastating phenomenon, with a reach that extends beyond the individual 
victim. Each year in the United States, approximately 30,000 people take their own lives. The rate 
of suicide in the United States is increasing. In 2007, suicide was the 11th leading cause of death; 
in 2008 and 2009, suicide was the 10th leading cause of death (when adjusted for age). In  2009, 
36,909, suicides were reported, as a rate of 12.0/100,000. This is an increase from 2007, when the 
rate was 11.5 (per 100,000). Suicide was the 3rd leading cause of death in young people, ages 10-
24, after accidents and homicide (first and second leading causes of death for young people in 
2008, respectively). The American Association of Suicidology estimates that for every completed 
suicide, 25 others have attempted suicide (McIntosh, 2012). These acts of self-directed violence 
have lasting emotional and economic effects on individuals, families, and communities.  
 Fatal and non-fatal injuries resulting from self-directed violence incur direct expenditures 
in healthcare and law enforcement systems. Hospitalizations resulting from self-inflicted violence 
lasted an average of four days and cost, in total, approximately $1.1 billion in 2005 (Russo, 
Owens, & Hambrick, 2008). The indirect costs of these injuries arise from lost productivity and 
inability to continue with activities of daily life.  These indirect costs eventually contribute to 
slower economic development and increased socioeconomic inequality. In the United States, the 
estimated cost due to lost income alone was $11.8 billion dollars in 1998 (Goldsmith, Pellmar, 
Kleinman, & Bunney, 2002). Other indirect costs are derived from reduced productivity of loved 
ones’ grieving a suicide, and the lost or reduced productivity of people suffering from suicidality. 
Additionally, the cost of delivering emergency intervention and non-emergency treatment for 
suicidality is ultimately borne by workers and taxpayers.   
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US Veterans and Suicide 
 
Recent studies demonstrate a higher rate of suicide among veterans who are enrolled in 
Veterans Health Administration (VHA) services, than in (1) the general population (Blow, et al., 
2012), and (2) in veterans who do not receive care in VHA (I. R. Katz, McCarthy, Ignacio, & 
Kemp, 2012). Concern about suicide among veterans is magnified by the anticipated increase in 
the numbers of veterans enrolling in VA services (Congressional Budget Office, October 2010), 
especially among younger veterans (I. R. Katz, et al., 2012). These patterns emphasize the crucial 
role of the VHA in managing suicide prevention interventions for veterans receiving care at VHA 
facilities.  
 Costs related to suicide prevention efforts at the VHA include funding for research, 
staffing, and maintenance of the suicide prevention hotline. For Fiscal Year 2008, spending was 
projected to include: $970,000 to establish the suicide prevention hotline; $1.97 million for the 
Center of Excellence in Canandaigua, New York; $2.20 million for the Mental Illness Research, 
Education and Clinical Center in Denver, Colorado; $90,000 for the Serious Mental Illness 
Research, Education and Clinical Center for monitoring of suicide rates and risk factors; and 
$14.32 million for Suicide Prevention Coordinators (Sundararaman, V., & Lister, 2008). 
 
Significance to Healthcare 
 
A non-fatal suicide attempt is one of the strongest clinical predictors of suicide. Observed 
suicide rates for attempters are on average, approximately 40 times greater than expected rates; in 
some cases, suicide risk was more than 100 times greater than expected (Harris, et al., 2007). 
Until recently, healthcare systems have not been able to readily identify patients with a history of 
a prior suicide attempt. Since 2008, the VHA’s enhanced suicide behavior surveillance system 
can better identify VHA patients who have attempted suicide. With this monitoring system in 
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place, the VHA has the ability to target this population for enhanced service delivery of specific 
interventions.  
In addition to the risk imparted by a prior attempt, there is also an association between 
completed suicide and contact with a healthcare system. An unsettling proportion of those who 
commit suicide have had recent contact with a healthcare provider. This pattern is detectable in 
civilian and veteran populations. VHA investigators (Denneson, et al., 2010) examined the health 
care contacts in the year prior of 112 veterans who completed suicide between 2000-2005. 
Findings revealed that 61 (54%) of these Veterans were seen by a VHA health care provider in 
the 30 days prior to death. This association challenges healthcare organizations to enhance their 
efforts in identifying and managing suicide risk in all healthcare settings.  
The transition from inpatient to outpatient care is a particularly vulnerable time for 
civilians and veterans who receive inpatient psychiatric care. High rates of suicide are associated 
with recent hospital discharge, regardless of the reason for admission. One study (Appleby, et al., 
1999) examined survey data from more than 2,000 suicides by patients who had made contact 
with mental health services in the year before their death. Approximately 25% of these deaths 
occurred within three months of discharge from a psychiatric hospital, and almost half of those 
deaths occurred within the first week of discharge. A case-control study found that of the suicides 
that occurred after psychiatric hospital discharge in Hong Kong from 1996-1999 (n = 73), 80% 
occurred within the first year after discharge (Yim, et al., 2004).   
In a retrospective case control study, comparing 238 patients dying by suicide within 
three months of discharge, matched on date of discharge to living controls (Hunt, et al., 2009), 
102 (43%) suicides occurred within the first month of discharge from a psychiatric inpatient unit.  
The first week and the first day after discharge were particularly high-risk periods. These findings 
are consistent in veteran populations; for veterans diagnosed with depression, elevated rates of 
suicide are associated with the 12-week period after psychiatric discharge (Valenstein, et al., 
2009). Considering the compounded suicide risk for patients who experience a suicide attempt 
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and who are recently discharged from psychiatric hospitalization, the study of care delivery 
surrounding psychiatric hospitalization is crucial.  
 
The Role of the Healthcare System 
 
Successes in reducing suicide rates within healthcare agencies can be attributed to system 
wide changes in care delivery. In 2001, the Division of Behavioral Health Services of the Henry 
Ford Health System conducted a complete redesign of their depression care delivery (Coffey, 
2007). The key goal of this initiative was to eliminate suicide. This initiative reported a 75% 
reduction in suicide rates after four years. This was, in part, accomplished by delivering a 
consistent standard of care across a broad population, regardless of prior suicide behavior.   
 In recent years, VHA has recognized the importance of systematically providing an 
enhanced level of care for veterans admitted to inpatient psychiatric care for a suicide attempt. 
The implementation of these enhanced services emphasizes the delivery of a safety planning 
intervention during hospitalization and the arrangement of intensive post-discharge psychiatric 
care (I. Katz, 2012). However, directives regarding these enhanced services do not include 
recommendations for care coordination between inpatient and outpatient settings. Additionally, 
there is little guidance on the content of psychiatric care appointments, the recommended 
expertise of the provider conducting the appointment, or the appropriate setting for the 
appointments.  
 To inform future recommendations for care for this vulnerable population, 
further study was needed to more fully capture the care processes proximal to suicide events. This 
study described aspects of the acute inpatient and outpatient care delivered to veterans 
hospitalized for a suicide attempt. It also described aspects of inpatient and outpatient care 
coordination and the potential impact on the delivery of treatment after hospital discharge. This 
study aimed to (1) describe, for patients who did and did not experience a suicide re-attempt in 
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six months after the index attempt, the setting, provider, type, timing, duration and intensity of 
behavioral health care to veterans recently hospitalized for a suicide attempt and (2) describe 
associations between factors related to patient characteristics, prior health utilization, index 
admission and the timing of post-discharge behavioral health care.  
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CHAPTER II 
 
LITERATURE REVIEW AND THEORETICAL FRAMEWORK 
 
For centuries, many have speculated about the causes of suicide. Theories attempting to 
explain suicide are prevalent in the areas of philosophy, theology, sociology, anthropology, 
psychology and medicine. Many questions have been posed about the cause of suicide, yet 
satisfactory answers remain elusive. To date, there is no robust theory explaining the cause of 
suicide behavior. In the absence of such a theory, it is not possible to reliably predict suicide 
behavior. Without a theory for predicting suicide, it is all the more difficult to prevent suicide.  
Despite absence of a predictive theory of suicide behavior, models exist that describe 
concepts associated with suicide and prevention. Several psychological models describe 
associations between individual-level cognitive (Johnson, Gooding, & Wood, 2010; Wenzel & 
Beck, 2008), psychodynamic (Huprich, 2004; Rudd, 2004) or interpersonal (Van Orden, et al., 
2010) processes and the potential for suicide behavior. Epidemiological models describe 
associations between population demographic variables and suicide behavior (Eve K. Moscicki, 
1997; E. K. Moscicki, 2001).  Observational studies have retrospectively and prospectively 
described associations among demographics, modifiable risk factors, and suicide behavior 
(Haney, et al., 2012; NICE & National Institute for Health and Clinical Excellence, 2011). From 
this knowledge, demographic (fixed) and modifiable risk factors for suicide have been identified, 
as discussed in greater detail in later sections of this chapter.  
Conceptual models for suicide prevention combine existing public health prevention 
models with variables associated with suicide (Maris, Berman, & Silverman, 2000; Silverman & 
Felner, 1995). Such concepts describe prevention efforts targeting individuals, selected 
populations defined by common risk factors, or broad populations defined by geography. These 
concepts inform the delivery of prevention interventions to populations, based on observable risk 
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factors (i.e. demographics, military experience, substance use disorder, psychiatric illness, 
psychiatric hospitalization). However, a history of a prior attempt (arguably the strongest 
predictor of suicide) might only be observed within a specific time window and in select settings 
(e.g. a suicide attempt might only be observed by the healthcare system treating the suicide 
behavior, therefore the delivery of prevention interventions for this segment of the population is 
sensitive to the timing of delivery). Therefore, the participation of healthcare systems in detecting 
suicide behaviors is vital to targeting this population for further prevention interventions.  
 Prior investigations have independently demonstrated that a history of recent discharge 
from a psychiatric hospital or a history of prior suicide behaviors are associated with increased 
likelihood of future suicide behavior. About one in five people who receive treatment for self-
harm in an emergency department will harm themselves again in the following year. Following 
an act of self-harm, the rate of suicide increases between 50-100 times the rate of suicide in the 
general population (NICE & National Institute for Health and Clinical Excellence, 2011). The 
proportion of patients who will fatally repeat self-harm behavior ranges from 1.6% in the first 
year, to 3.4% in nine years (D. Owens, Horrocks, & House, 2002). Any suicide prevention model 
describing the delivery of treatments should consider the compounded risk associated with 
discharge from psychiatric hospitalization for those who were admitted for a suicide behavior.  
 The development of a suicide prevention model should incorporate concepts related to 
healthcare service delivery. Such concepts impart the relationship among outcomes (e.g. future 
suicide behavior) and aspects of treatment that go beyond the typical dichotomy of treatment 
delivery. Kane’s conceptualization of treatment incorporates variables related to the dosing of 
treatment, the provider delivering the treatment, and the organizational characteristics of the 
treatment setting (Kane, 2006). However, concepts related to the coordination of treatment 
delivery are not included in Kane’s model. The importance of these concepts, which are 
potentially related to the delivery of treatment for suicide behavior, will be discussed in later 
sections.  
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Investigations of protective treatments for suicide behavior suggest that delivering such 
treatments reduces the risk of future suicide behavior (Hawton, et al., 1998; Mann, et al., 2005; 
O'Neil, et al., 2012). These treatments have targeted groups with suicide risk factors, including 
prior suicide behavior. Although this evidence base has its limitations (e.g. small sample sizes, 
selection bias), it is the only area of suicide research that has applied rigorous methods, including 
randomized controlled trials, to determine causality.  
 
Definitions 
 
This section describes the concepts underpinning the present study. Where possible, these 
definitions are selected from sources associated with the Veterans Health Administration, or 
relevant to the care of veteran populations.  Because the outcome of interest in the present inquiry 
is the repetition of a suicide attempt, evidence for risks associated with repetition of suicide 
behavior is discussed in considerable detail. In instances where evidence associated with 
repetition of suicide behavior is lacking, I will describe evidence for risks associated with fatal 
suicide behavior. The following concepts and evidence that shape the proposed inquiry include:   
1. Suicide Behavior 
2. Prevention  
3. Conceptualizations of risk factors for suicidal SDV 
a. Patient-level risk factors 
b. Organizational risk factors 
4. Preventive Treatments 
a. Medications 
b. Procedures 
c. Education/Counseling  
d. Coordination 
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5. Treatment Factors: organizational concepts that contribute to variation in outcomes 
a. Provider Characteristics 
b. Setting Characteristics 
c. Dose of treatment: Timing, intensity and duration 
d. Continuity Measures 
The following pages describe each.  
Suicide Behavior 
The field of Suicidology has long struggled with the lack of universally recognized 
definitions for suicide (Goldsmith, et al., 2002).  The use of consistent nomenclature for suicide is 
necessary to support accurate epidemiological analysis, research methodology and evidence-
based suicide assessment and treatment. The VHA has recently adopted a Self-Directed Violence 
Classification System in order to standardize the language uses to describe suicide, suicide 
attempts, and other forms of self-directed violence (Brenner, Breshears, et al., 2011; Silverman, 
Berman, Sanddal, O'Carroll P, & Joiner, 2007a, 2007b). Suicidal Self-Directed Violence (SDV) 
is “behavior that is self-directed and deliberately results in injury or the potential for injury to 
oneself. There is evidence, whether implicit or explicit, of suicidal intent” (Brenner, Breshears, et 
al., 2011). Modifiers of the term “self-directed violence” convey fatality, the presence or absence 
of an injury, and whether the behavior was interrupted by self or other. The term self-directed 
violence does not include cognitions related to suicide, such as suicidal ideations or formulations 
of suicide plans.  
Limitations associated with the use of SDV as an outcome variable are associated with 
reliability of data sources that provide SDV information. Self-report of past SDV can contribute 
to bias for estimates of the frequency and severity of past behavior (NICE & National Institute for 
Health and Clinical Excellence, 2011; Silverman, et al., 2007a). The accuracy of objective 
measures of SDV relies upon provider assessment and documentation, which is variable (Haney, 
2012). The implementation of the VHA Suicide Prevention program and the standardization of 
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nomenclature within the VHA, have the potential to reduce variation in determinations of SDV. 
Selected methods for establishing the intent of self-directed violence will be discussed in Chapter 
Three.  
Prevention Frameworks 
 One intrinsic challenge in preventing suicide is the limited understanding of what causes 
suicide. As discussed in the previous section, the myriad factors and interactions that contribute to 
the risk for suicide build a complex case for the potential causes of suicide. Debate continues 
about whether suicide is a symptom of an underlying disease process, such as major depressive 
disorder, or is a discreet behavior independent of a detectable disorder. In spite of this lack of 
clarity, there appears to be a consensus that there are warning signs that, if observed, predict an 
imminent suicide threat. Additionally, there is evidence that individuals who die by suicide have 
had recent contact with a healthcare professional. Therefore, the healthcare system is an ideal 
venue for initiating suicide prevention interventions, upon detection of warning signs and/or 
suicide risk factors.  
The following pages will describe concepts and models related to prevention. 
Traditionally, prevention models have described the delivery of interventions to the point of 
disease onset. After disease onset, further interventions are referred to as “treatment”. In 
discussing suicide prevention, the onset of suicide is terminal. Therefore, many activities aimed at 
decreasing the risk of suicide fall under the term “prevention”. The concept of “treatment”, and 
its implications for suicide prevention efforts in healthcare systems, will be described in later 
sections.   
 Public Health Model of Prevention. The Public Health Model is comprised of Primary, 
Secondary, and Tertiary levels prevention. Primary prevention focuses on entire populations to 
reduce the incidence of new cases of a disorder. Secondary prevention targets persons showing 
early signs of a disorder, with the goal of reducing the intensity, severity, and duration of these 
problems. Tertiary prevention focuses on individuals who are already displaying a serious 
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disorder. The Public Health Model conceptualize the trajectory of disease as a linear process, 
where disorders move sequentially from onset through clinical syndrome (Silverman & Felner, 
1995).  
When discussing “prevention”, the public health model is the framework that has been 
traditionally employed. Recently, there has been a shift away from this language when discussing 
prevention in mental health.  As it pertains to the prevention of mental disorders, the conceptual 
shift away from the Public Health Model was noted in the IOM report on a program of research in 
this area (Mrazek & Haggerty, 1994). Henceforth, prevention efforts in mental health have been 
described according to the operational model of prevention.  
 Operational Model. The US National Strategy for Suicide Prevention (US Department 
of Health and Human Services, 2001) employs an Operational Model for Prevention to guide 
recommendations for interventions. This Operational Model for Prevention (Gordon, 1983), shifts 
from the “primary, secondary, & tertiary” language of the traditional public health model, and 
instead describes the level of intervention as “universal, selected and targeted/indicated”.  
1. Universal: Most generally applicable type of intervention, designed to affect everyone in 
a defined population.   
2. Selective: recommended for subgroups of the population distinguished by obvious 
characteristics (e.g. demographics), which impart an increased risk for the condition  
3. Indicated: these measures or interventions encompass activities that are only advisable 
for persons who, upon examination, are found to possess a risk factor, condition or 
abnormality that identifies them at sufficiently high risk to warrant the preventive 
intervention.  
Table 2.1 outlines Universal, Selected, and Indicated interventions, and was adapted from the US 
National Strategy for Suicide Prevention (US Department of Health and Human Services, 2001).  
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Table 2.1 
Universal, Selective, and Indicated Interventions for Suicide Prevention 
 Biopsychosocial Environmental Sociocultural 
Universal 
Depression screening in 
primary care practice 
Safe storage of firearms 
and ammunition 
 
Package drugs in blister 
packs 
Teach conflict resolution 
skills to elementary school 
children 
 
Promote programs that 
improve early parent-child 
relationships 
 
Selective 
Improve screening and 
treatment for depression of 
the elderly in primary care 
Reduce access to the 
means for self-harm in 
jails and prisons 
Develop programs to reduce 
despair and provide 
opportunities for high risk 
populations, such as Native 
American Youth 
 
Indicated 
Implement Cognitive 
Behavioral Therapy (CBT) 
immediately after patients 
have been evaluated in an 
emergency department after 
a suicide attempt 
Teach caregivers to 
remove firearms and old 
medicines from the 
home before hospitalized 
patients are discharged 
Develop and promote 
honorable pathways for 
military personnel to receive 
treatment for mental and 
substance use disorders and 
return to full duty without 
prejudice 
 
 
 Antecedent Conditions Model. A third model, the Antecedent Conditions Model 
(ACM) was developed to address the lack of an adequate prevention model to account for the 
complexity of suicidal behavior (Silverman & Maris, 1995). While this model is less developed 
than the Public Health Model or the Operational Model, it will be mentioned briefly, since the 
ACM is specific to suicidal behavior.  
 In the ACM, the focus of prevention efforts is on the mechanisms and processes that lead 
to the expression of the disorder, not the disorder itself. This focus departs from the classic 
medical-public health paradigm, which approaches prevention by targeting specific conditions 
that interact with specifiable individual vulnerabilities. The ACM assumes that there are two 
distinct sets of conditions that are antecedent to the expression of suicidal behaviors—
predisposing conditions and precipitating conditions. Predisposing conditions are distal to the 
suicidal behavior but are necessary to place an individual at higher risk. Precipitating conditions 
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are more proximal to the suicidal behavior, but will not lead to the expression of suicidal behavior 
in the absence of the predisposing condition.  
 This model asserts that there are two loci for intervention:  a societal, community 
approach that diminished predisposing conditions for the entire population, and targeted 
interventions for those who have already been identified as having experienced predisposing 
conditions. Targeted interventions would attempt to eliminate or ameliorate those precipitating 
conditions that are proximally or temporally related to the manifestation of the behavior.  
 The ACM is not well represented in the suicide prevention health policy literature. Due to 
the divergence from traditional language and definitions typically used in prevention frameworks, 
a novel framework incorporating this model for prevention would likely face challenges in 
widespread adoption. The Operational model of prevention is generally well accepted in the field 
of Suicidology, and is consistent with the language used in the US National Strategy for Suicide 
Prevention (US Department of Health and Human Services, 2001). Therefore, the Operational 
model will be incorporated into the proposed conceptual model that guided this study.  
Conceptualizations of Suicide Risk 
Risk and protective factors are typically categorized as biopsychosocial, environmental, 
and sociocultural in nature (Goldsmith, et al., 2002; Ramchand, Acosta, Burns, Jaycox, & Pernin, 
2011; US Department of Health and Human Services, 2001). Although these categories are 
somewhat arbitrary, they serve to guide discussion of appropriate prevention interventions. In the 
following paragraphs, I emphasize risk factors that are most frequently encountered on the 
individual level, and will focus on those that are most amenable to modification from within the 
healthcare system.  
Conceptual models describing suicide risk present various dichotomies to describe 
stratification of risk factors: the stress-diathesis model, an epidemiological model, and a model 
describing risk as fixed or modifiable. The stress-diathesis model of suicide risk proposes two 
types of risk factors: a predisposition (diathesis) for suicide (e.g. impulsive-aggressive lifetime 
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traits), and the future onset of an event, experience, or psychological state (stress), including the 
development of psychiatric disorders (Mann, 1998; Mann, Waternaux, Haas, & Malone, 1999). 
An epidemiological model of risk temporally stratifies risk factors as “distal” or “proximal”, 
relative to the suicide behavior. Distal risk factors, similar to diathesis, represent an underlying 
vulnerability towards suicide, which may occur on the individual and environmental levels. 
Proximal risk factors are more immediately antecedent to the suicide behavior, and can act as 
precipitants (E. K. Moscicki, 2001). On their own, proximal (stress) and distal (diathesis) risk 
factors are necessary but not sufficient to result in suicide behavior. However, it is the cumulative 
effect of both factors that creates the sufficient conditions for suicide.  
 For the healthcare provider who is treating the patient who recently attempted suicide, it 
may be more meaningful to determine which contributing risk factors are the most amenable to 
treatment. Therefore, dichotomizing risk according to “fixed” and “modifiable” factors is likely to 
be more useful for informing the development of individual treatment plans. Fixed risk factors for 
suicide behavior are characterized by historical or genetic attributes and include demographics, 
personal historical events, and prior patterns of healthcare utilization. These factors are not 
amenable to change, however their identification through screening procedures may inform future 
interventions to mitigate suicide risk. Other fixed risk factors are not as obvious, but may be 
useful in screening processes to establish risk for suicide. These risk factors are informed by past 
behaviors, such as a history of self-harm, or by healthcare utilization patterns, such as a history of 
psychiatric admissions or prior outpatient mental health treatment.  
In contrast to fixed risk factors, modifiable risk factors are characterized by a state of 
illness or circumstance that is potentially amenable to intervention. These factors include 
psychiatric illness, physical illness, substance use, geography, dysfunctional family environment, 
psychological characteristics such as hopelessness, impulsivity, aggression, or perceived 
burdensomeness, and stressful life events such as loss of employment, financial crisis, relational 
loss, or suicide of a known other. Unfortunately, the scope of resources provided by most 
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healthcare facilities limits the ability to modify many of these risk factors. For example, a 
healthcare provider may be aware of a patient’s recent job loss, but the provider has limited or no 
ability to directly affect this circumstance. Risk factors characterized by medical illness, 
psychiatric conditions, substance use, and psychological states are amenable to modification 
through interventions typically delivered in healthcare settings. Potential interventions will be 
discussed in later sections.  
In the following paragraphs, I present a review of selected suicide risk factors, especially 
those associated with recurring suicidal SDV. Additionally, risk factors that relate specifically to 
veteran populations are reviewed.  
Patient Characteristics 
The patient-level variables of interest are the biopsychosocial characteristics most 
commonly associated with suicide behavior. Many studies have been conducted in determining 
the risk factors associated with fatal and non-fatal suicide behavior in civilian, military and 
veteran populations (Haney, et al., 2012). Fewer studies distinguish factors associated with a first 
episode of non-fatal suicide behavior from those factors associated with repetition of non-fatal 
suicide behavior. The following sections will describe these patient characteristics and their 
associations with fatal and non-fatal repetition of a suicide attempt.   
 Age. Age is an important factor in establishing risk for fatal and non-fatal SDV. In 2009, 
United States suicide rates for ages 15-24 were slightly lower than the national rate (10.1 vs. 12.0 
per 100,000). However, suicide was the third leading cause of death for ages 15-24, and the 10th 
leading cause of death in the US the general population. Additionally, those aged 15-24 
demonstrated a higher attempt to completion ratio compared to the general population. For every 
suicide death for those aged 15-24, an estimated 100-200 suicide attempts were reported. 
Conversely, for every suicide death in the general population, there are an estimated 25 attempts 
(McIntosh, 2012).  
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Studies examining rates of suicide in veteran and non-veteran populations have found age 
differences in fatal suicide behavior when comparing veterans to the general population, and 
when comparing non-VHA utilizing veterans to those who use VHA healthcare services. In the 
sixteen states that participate in the National Violent Death Reporting System, veterans 
demonstrated varying rates of fatal suicide behavior and VHA utilization patterns according to 
age. The proportion of male veterans (under the age of 30) who utilized VHA healthcare 
increased significantly from 2005-2008. This growth is not observed in older veteran populations 
(30 years and older). Male veterans under the age of 30, who utilized VHA services, 
demonstrated decreasing rates of suicide over time (between 2005-2008) compared to non-
utilizers. This trend is not noted in any other age group among male veterans. In fact, for male 
veterans aged 30-64 and >65, suicide rates are higher for utilizers, compared to non-utilizer male 
veterans in corresponding age groups (I. R. Katz, et al., 2012). In a preliminary report of suicide 
attempts in veteran populations, repeated suicide attempts occur most frequently, at a rate of 
approximately 16%, in groups aged 50-59 years (Kemp & Bossarte, 2012).  
The evidence supporting the association between age and risk for repeated suicide 
behavior is mixed.  Several studies report “youth” as a risk factor for repetition. However, 
variation in age categorization precludes comparison across these studies. Some studies did not 
find differences in risk for suicide behavior repetition among age groups in adjusted (for lengths 
of follow up time) (Chen, et al., 2010) and unadjusted  analyses (Wang & Mortensen, 2006).  
Differences in age among males were detected in a study examining the number of suicide 
behavior repetitions. Males with four or more repetitions of suicide behavior were more likely to 
be aged 25-34 and less likely to be aged 55 or older. There were no significant differences in age 
for females, among suicide behavior repetition groups (Haw, Bergen, Casey, & Hawton, 2007). 
In a study examining self-poisoning re-admissions within two years of an initial self-poisoning 
attempt, older patients (> 65 years) were less likely to be re-admitted for self-poisoning compared 
to patients aged 15-24 years (Payne, Oliver, Bain, Elders, & Bateman, 2009).  
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Gender. In the United States, there are differences in suicidal behavior between men and 
women. Rates of suicide for men are consistently three to four times higher compared to suicide 
rates for women; this gender difference was also observed within white, nonwhite, and black 
racial groups. In 2009 there were 3.7 male deaths by suicide for each female death by suicide 
(McIntosh, 2012). In veteran populations that utilize VHA services, the overall suicide rate is 
higher compared to the general population, but the gender differences are comparable. Suicide 
rates among male VHA users the annual rates of suicide ranged from 36.4 to 43.1 suicides per 
100,000 person years (from 2000-2007). In females these rates, over the same time period, ranged 
from 9.8-13.7 per 100,000 person-years (Blow, et al., 2012).  
In a study evaluating the risk of suicide related to a history of repeated suicide behavior 
(N = 11,583), both males and females demonstrated an increased risk for suicide, when compared 
to non-repeaters (Zahl & Hawton, 2004). This association appears stronger for females, RR = 3.5, 
CI = 2.3-5.3, compared to males, RR = 1.8, CI = 1.3-2.4.  When comparing multiple repeaters 
(more than two suicide behavior episodes after the index episode) and single repeaters (one 
episode after the index episode), differences in risk for suicide were found for females, χ2 = 5.98, 
p = .015, but not for males, χ2 = 0.56, p = .456. There were no significant differences between 
males and females in the proportion of patients with prior suicide behavior (n =1043, 23% males; 
n = 1661, 24% females) or in the proportion that repeated SDV during the follow-up period (n = 
1073, 23% males; n = 1593, 23% females). 
Two studies (Chen, et al., 2010; Scoliers, Portzky, van Heeringen, & Audenaert, 2009) 
reported females were at a higher risk for repetition. They were pooled, resulting in an adjusted 
relative risk of 1.96, CI = 1.22-3.15 (NICE & National Institute for Health and Clinical 
Excellence, 2011). Adjusted factors included age (both studies) method of suicide behavior 
(Chen, et al., 2010), depression, anxiety, and education (Scoliers, et al., 2009). Contrary to this 
finding, another study evaluating the risk of suicide behavior repetition found that females were 
less likely to repeat suicide behavior compared to males, HR = 0.80, CI = not reported, p < .050 
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(Christiansen & Jensen, 2007). In contrast, a pooled unadjusted odds ratio of four studies 
(Chandrasekaran & Gnanaselane, 2008; Johnsson, Öjehagen, & Träskman-Bendz, 1996; Krarup, 
Nielsen, Rask, & Petersen, 1991; D Owens, Dennis, Read, & Davis, 1994), revealed inconclusive 
findings related to gender and the likelihood of suicide behavior repetition, unadjusted OR =1.01, 
CI = 0.50-2.04 (NICE & National Institute for Health and Clinical Excellence, 2011).   
 There is consistent evidence for gender differences in suicide rates in the US general and 
veteran populations. The evidence for gender differences when considering suicide behavior 
repetition is less conclusive. A preliminary report of twelve-month repeat suicide attempt among 
veterans describes the rate of repetition among males is approximately 14%, while females 
experienced a repetition rates of approximately 15% (Kemp & Bossarte, 2012).  
Race and ethnicity. Reported statistics on suicide rates in the United States indicate 
differences among racial and ethnic groups and suicide deaths. Whites and Native-Americans 
demonstrated the highest rates (13.5 and 12.3 per 100,000, respectively), compared to 
Asian/Pacific Islanders (6.3), Hispanics (5.3), Non-whites (5.8) and Blacks (5.1/100,000) 
(McIntosh, 2012). 
Studies have reported a relationship between race and fatal suicide behavior in veterans. 
Two studies investigated the incidence of suicides in patients registered in the VA’s National 
Registry for Depression. Caucasian race was consistently associated with a higher risk for 
suicide, compared to other groups (Ilgen, et al., 2009; Zivin, et al., 2007). Non-Hispanic ethnicity 
was also associated with a higher risk of suicide (rate per 100,000 person years = 86.80 vs. 
Hispanic = 46.28) (Zivin, et al., 2007). Race appears to affect the impact of other risk factors for 
suicide. For example, Iglen, et al., (2009) found that the impact of prior psychiatric 
hospitalization increased suicide risk only for non-African American men with a substance use 
disorder. In the same study, African-American men with a substance use disorder, no other 
variables distinguished those who died by suicide and those who did not.  
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The association between race/ethnicity and repetition of suicide behavior has not been 
evaluated in veteran populations. Given the differences observed in fatal suicide behavior, 
consideration of race and ethnicity is imperative to the study of suicide behavior repetition.  
Marital status. Marital status is a reflection of availability of support to an individual. 
Higher rates of suicide have consistently been observed in divorced people, while the relationship 
between single status, widowhood, and suicide yields mixed findings (Roskar, et al., 2011). A 
change in marital status reflects a disruptive and stressful life event. The stress related to the 
transition into marriage is arguably comparable to the stress of transitioning out of marriage, be it 
through separation, divorce, or widowhood. This transition, and its relationship to suicide risk 
was examined in a recent study (Roskar, et al., 2011). A marital status change in the past five 
years was noted in 11% of the suicide victims (172/1614) compared to 6% of controls 
(257/4617), a statistically significant difference, χ2 (1) = 47.55, p < .001. Becoming widowed, χ2 
(1) = 31.14, p < .001, or divorced, χ2(1) = 14.03, p < .001, was more common in the suicide 
group, compared to controls. There were no differences in the incidence of getting married 
between groups, χ2(1) = 2.34, p = .126, however, within the married group, the risk for suicide 
increased as age increased. A similar trend was seen in the divorced group, suggesting that these 
transitions later in life impart a greater risk for suicide. This study did not investigate the 
relationship between marital transitions and the risk of suicide behavior repetition.  
Pooled unadjusted odds ratios of four studies (Bille-Brahe & Jessen, 1994; 
Chandrasekaran & Gnanaselane, 2008; Johnsson, et al., 1996; D Owens, et al., 1994) were not 
conclusive in determining the association between single/unmarried status and risk for repetition 
of suicide behavior. Among approximately 1700 participants, the unadjusted odds ratio was not 
statistically significant, OR = 1.36, CI = 0.85-2.16 (NICE & National Institute for Health and 
Clinical Excellence, 2011). In two individual studies, the risk of repeated suicide behavior was 
reported to be higher among unmarried participants, however these findings were unadjusted, 
limiting conclusiveness of these associations (Dieserud, Roysamb, Braverman, Dalgard, & 
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Ekeberg, 2003; Kapur, et al., 2006). Another suggests that living alone on day of index suicide 
behavior increases the risk for repetition, HR = 1.4, p < .001) in an unadjusted analysis 
(Christiansen & Jensen, 2007).  In a separate study, investigators adjusted for prior self-harm 
history, psychiatric treatment, employment status and ethnicity and reported an odds ratio of 1.39, 
CI = 1.09-1.76, indicating a higher risk of repeated suicide behavior for unmarried individuals 
(Johnston, Cooper, Webb, & Kapur, 2006). It is unclear whether these studies differentiated 
between “unmarried”,  “divorced” and “separated”.  It remains unclear whether the association 
between unmarried status and suicide behavior repetition is due to the protective effects of 
marriage, or the risks associated with interpersonal difficulties that preclude a sustained marriage.  
The association between marital status and any kind of suicide behavior has not been 
widely studied in veteran populations. Due to findings related to the association between 
unmarried status and the likelihood of suicide behavior repetition, this association should be 
explored in veteran populations. Differentiating between “never married”, “divorced” and 
“separated” may elucidate independent risks associated with each of these relational states.  
Geographic distance from VHA facility. Distance from a VHA facility has not been 
evaluated as a risk factor for suicide behavior repetition, but has been investigated in relation to 
fatal suicides. For veterans who utilize VHA services, suicide rates are higher in those with a 
rural residence (38.8 vs. 31.4/100,000). Firearm deaths are more common in rural suicides: 77% 
of rural suicide deaths occur via firearm, compared to 62% of urban suicide deaths (McCarthy, et 
al., 2012). Greater geographical distance between one’s residence and VHA facility is associated 
with higher suicide rates, even after adjusting for socio-demographic characteristics, including 
diagnosis (Desai, Dausey, & Rosenheck, 2005). These investigations suggest that rurality and 
distance from VHA facilities potentially affect access to resources that are protective against 
suicide. The association between suicide behavior repetition and geographic distance from VHA 
service should be more fully investigated in veteran populations.  
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Service-connected disability rating. Service-connected disabilities are injuries or 
illnesses that were incurred or aggravated during military service. Eligibility is determined 
through an examination process, during which a rating from 10-100%, in increments of 10%, is 
applied to the disability. This rating describes the extent to which the injury or illness is 
attributable to military service. Veterans with service-connected disabilities receive monthly 
monetary compensation, and enjoy enhanced access to healthcare services. Veterans who are 50% 
or more disabled from service-connected conditions (i.e. 50% or more “service connected”) 
receive priority in scheduling of hospital or outpatient medical appointments. Service-connected 
veterans are exempt from copay requirements for inpatient and outpatient primary and specialty 
services, including treatment for non-service connected conditions. Veterans who are 50% or 
more service connected, or who receive treatment for service-connected conditions do not pay 
copays on medications. Veterans who are 30% or more service-connected or receive treatment for 
service-connected conditions are eligible to receive reimbursement for travel costs (41.5 cents per 
mile) when traveling to receive VA-approved medical care (Department of Veterans Affairs, 
2011).  
Service connected veterans who receive treatment at VHA facilities receive incentives to 
participate in healthcare. Many of these incentives start at or above the 50% rating. Therefore, 
any investigation involving veterans’ healthcare utilization should examine differences between 
veterans with no service connection, with 10% to 40% service connection, and with 50% to 100% 
service connection. Studies that have investigated suicide in the veteran population have 
examined the effect of service connection ratings. Desai et al. (2005) found that veterans with 
service-connected disabilities demonstrated lower rates of suicide (< 50% = 39.51; > 50% = 
31.58/10,000 person years) compared to veterans without service-connected disabilities 
(45.34/10,000 person years) χ2(2) = 10.96, p < .005). Similarly, in a study of depressed veterans 
and suicide mortality, veterans with a service-connected disability were less likely to die by 
 22 
suicide, compared to those without a service-connected disability, adjusted for age and PTSD 
diagnosis, HR = 0.87, CI = 0.78-0.97 (Zivin, et al., 2007).   
Psychiatric conditions. There is compelling information that persons with a variety of 
psychiatric symptoms are more likely to demonstrate suicide behavior than those without these 
symptoms. However, this does not confirm that any person demonstrating suicide behavior has a 
mental disorder. In fact, the largest majority of persons with psychiatric disorders, even 
depression, will never demonstrate suicidal ideations or behavior in their lifetimes (Maris, et al., 
2000). Most persons who are at risk for suicide behavior do not choose suicide actively, but 
instead are under the influence of disturbances of thought, feelings, and behavior. It is these 
influences that are amenable to intervention. The following sections will describe several 
psychiatric conditions, which are amenable to treatment, and are thus considered “modifiable” 
risk factors for suicide behavior.   
Depressive symptoms. Depressive symptoms are associated with an increased risk for 
repetition of suicide behavior. These symptoms are defined by the Diagnostic and Statistical 
Manual of Mental Disorders, 4th edition, Text-Revision (DSM-IV-TR) and include: depressed 
mood, diminished interest, weight loss, sleep disturbance, psychomotor agitation or retardation, 
fatigue, inappropriate guilt/worthlessness, impaired concentration, recurrent thoughts of death. 
When five or more of these symptoms are present, and they persist for longer than two weeks and 
cause significant distress and impairment in functioning, a Major Depressive Episode may be 
diagnosed by a healthcare provider (American Psychiatric Association, 2000). In the absence of a 
clinical diagnosis, these symptoms can be ascertained by psychometric tests, such as the Beck 
Depression Inventory (BDI) mentioned below. The BDI has been validated in psychiatric (α = 
0.86) and non-psychiatric populations (α = 0.81) to discriminate among subtypes of depression, 
and to differentiate depressive symptoms from anxiety symptoms (Beck, Steer, & Carbin, 1988).  
In a pooled analysis (NICE & National Institute for Health and Clinical Excellence, 
2011) of two studies examining repetition of non-fatal suicide behavior (Colman, Newman, 
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Schopflocher, Bland, & Dyck, 2004; Dieserud, et al., 2003) the likelihood of repetition for 
patients with depressive symptoms, adjusted for history of prior self-harm, age, and gender, was 
double that of patients without depressive symptoms, OR = 2.19; CI = 1.25-3.81. Depressive 
symptoms were ascertained by the BDI (Dieserud, et al., 2003) or by self-reports of a lifetime 
diagnosis of depression (Colman, et al., 2004). In each of these studies, the repetition rate during 
the follow up was 25% after one to two years (Colman, et al., 2004) and 16% after 18 months 
(Dieserud, et al., 2003).  
In a study of patients experiencing first time suicide behavior and predictors of repetition 
(Chandrasekaran & Gnanaselane, 2008), a diagnosis of major depressive disorder was associated 
with repetition in the two years following the initial suicide behavior, OR = 3.41, CI = 1.76-6.26.  
Diagnoses were ascertained using the Mini International Neuropsychiatric Interview, using DSM-
IV criteria. In the first year after the initial attempt, 14% of the sample had repeated the SDV; 
another 9% of the sample demonstrated repetition in the second year of observation.  
Personality disorder. Disordered personality is defined as “an enduring pattern of inner 
experience and behavior that deviates markedly from expectations of the individual’s culture” 
(American Psychiatric Association, 2000). This pattern is manifested in the ways of perceiving 
and interpreting self, other people, and events; the range, intensity, lability and appropriateness of 
emotional response; interpersonal functioning, or impulse control. The pattern is stable, and of 
long duration, traceable to adolescence or young adulthood. Subjective distress and/or socio-
occupational functional impairment are key characteristics of personality disorders. Diagnosis of 
personality disorders falls within ten different subtypes, however most studies group the subtypes 
together under one diagnostic category.  
In a study of suicide behavior repetition, personality disorder was more common in both 
males and females who repeated suicide behavior during the study period. In a multivariate 
model, personality disorder increased likelihood of repetition in females with one to three 
repetitions during the observation period, OR = 1.90, CI = 1.24-2.91, and with four or more 
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repetitions, OR = 2.90, CI = 1.44-5.87 after adjusting for prior suicide behavior, current 
psychiatric treatment, alcohol misuse, and being a victim of violence (Haw, et al., 2007).  
Psychosis. Psychosis is vaguely and broadly conceptualized, without a widely accepted 
definition. The DSM-IV-TR cites multiple definitions: “hallucinations and delusions, with or 
without insight; a mental impairment that grossly interferes with the capacity to meet ordinary 
demands in life; a gross impairment in reality testing; or, as cited in the diagnostic criteria for 
schizophrenia: hallucinations, delusions, disorganized speech, grossly disorganized behavior, or 
catatonic behavior (American Psychiatric Association, 2000; Sadock & Sadock, 2005). 
Symptoms of psychosis, in combination with other symptom clusters, may result in a diagnosis of 
schizophrenia. Psychosis may also accompany other disorders, such as mood disorders. The 
presence of psychosis in mood disorders imparts a more severe case of the underlying disorder. 
 In two separate studies, a lifetime history of schizophrenia, and symptoms of psychosis 
were associated with an increased risk of repetition of suicide behavior. Coleman, et al., (2004) 
reported that a lifetime history of schizophrenia had an unadjusted odds ratio of 4.24, CI = 2.3-
.79) for repetition of suicide behavior. After adjusting for prior history of self-harm, depression, 
age, gender and physical health problems, the adjusted odds ratio became 3.43, CI = 1.77-6.66. 
Symptoms of psychosis, namely hallucinations, were associated with an increased risk for 
repetition of suicide behavior, unadjusted HR = 1.82, CI = 1.56-2.14 (Kapur, et al., 2006). 
Posttraumatic stress disorder and other anxiety disorders. The development of post-
traumatic stress disorder (PTSD), one type of anxiety disorder, occurs within three symptom 
domains: re-experiencing a traumatic event (characterized by threat of death, or actual or 
threatened harm to physical integrity); avoiding stimuli associated with the trauma, and 
experiencing symptoms of increased autonomic arousal, such as enhanced startle response 
(American Psychiatric Association, 2000). PTSD is of particular interest in veteran populations, 
due to the potential exposure to trauma during combat operations. 
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 There are no studies examining the association between PTSD and repetition of suicide 
behavior in veteran populations. However, in a study of suicide attempters (N = 874) treated at 
the University Hospital of Ghent, 29% of these patients repeated suicide behavior within five 
years. Repetition was associated with anxiety symptoms (as well as depression, more psychiatric 
symptoms, and young age), though did not specify any anxiety-related diagnosis (Scoliers, et al., 
2009).  
PTSD is the most frequently diagnosed mental disorder among Operation Enduring 
Freedom/Operation Iraqi Freedom, OIF/OEF veterans seeking healthcare at VA facilities 
(Jakupcak, et al., 2009). PTSD has been identified as a risk factor, when compared to veterans 
without PTSD, for suicide attempts, adjusted OR = 2.8, CI = 1.5-5.1) (Brenner, Betthauser, et al., 
2011), and suicidal ideations among OIF/OEF veterans, adjusted OR = 4.45, CI = 2.58-7.67 
(Jakupcak, et al., 2009). PTSD is a risk factor for suicide among Vietnam veterans compared to 
the general population, SMR = 6.74, CI = 4.40-9.87 (Kang & Bullman, 2009). Contradictory 
findings were reported by Desai, et al., (2005); this study, which was comprised solely of 
veterans who had received VHA psychiatric inpatient care from 1994 to 1998 (N = 121,933), 
found that suicide rates were lower among patients with PTSD, when compared to patients 
without PTSD (suicide rate per 10,000 person years= 29.20 vs. 44.54 respectively). Another 
contradictory finding was reported by investigators studying depressed veterans (N = 807,694) 
and the association between suicide rates and psychiatric comorbidities with depression. In this 
study, a diagnosis of depression and PTSD was associated with lower rate of suicide, especially 
in older veterans, compared to depressed veterans without PTSD, aged 18-44 years: HR = 0.80, 
CI = 0.58-1.01; aged 45-64 years: HR = 0.66, CI = 0.44-0.99 (Zivin, et al., 2007).  
Substance use. The term “substance use” includes the states of substance dependence 
and substance abuse. Substance abuse is characterized by “a maladaptive pattern of substance use 
manifested by the recurrent and significant adverse consequences related to the repeated use of 
substances” (American Psychiatric Association, 2000). Substance dependence is characterized by 
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“a cluster of cognitive, behavioral, and physiological symptoms indicating that the individual 
continues substance use despite significant substance related problems” (American Psychiatric 
Association, 2000).  According to the DSM-IV-TR, there are eleven designated classes of 
pharmacological agents that comprise “substances”: alcohol; amphetamines or similarly acting 
agents; caffeine; cannabis; cocaine; hallucinogens; inhalants; nicotine; opioids; phencyclidine 
(PCP) or similar agents; and a group that includes sedatives, hypnotics and anxiolytics.  
Many studies do not differentiate between substance abuse and substance dependence. 
The terms “substance use”, “substance use disorder”, or “substance misuse” are used to refer to 
syndromes of abuse and dependence. At times, alcohol use was analyzed separately from other 
substance use. Arguably, in compressing all types of substance use, one loses the independent 
effects of one substance on the risk of suicidal SDV, compared to other substances.  
For veterans with depression, the suicide rate for those with substance use disorders is 
higher compared to veterans without substance use (128.27 vs. 76.48 per 100,000 person years) 
(Ilgen, et al., 2009). One study investigated the incidence of self-reported suicide attempts during 
a follow up interview after receiving VA treatment for a substance use disorder (N = 8,807). Of 
these veterans, four percent (n = 314) reported a suicide attempt within 30 days of the follow-up 
interview. Veterans’ reports of a suicide attempt were associated with more days of alcohol 
problems, or more years of lifetime cocaine use; they were less likely to report a suicide attempt 
if they had participated in more days of a substance use treatment program. For these patients, a 
measure of psychiatric treatment received during the observation period was not associated with a 
suicide attempt (Ilgen, Harris, Moos, & Tiet, 2007).   
Few studies have examined the impact of substance use on the repetition of suicide 
behavior. In a multi-center cohort study, investigators reported both unadjusted, HR = 1.49, CI = 
1.34-1.66, and adjusted HR = 1.3, CI = 1.16-1.45, hazard ratios in describing the association 
between alcohol misuse and repetition of suicide behavior. Slight attenuation was observed after 
adjusting for history of prior self-harm, suicide intent, methods of self-harm, hallucinations, 
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current psychiatric treatment and unemployment. In this study, alcohol misuse was defined as 
“harmful use or consumed more than seven units daily” (Kapur, et al., 2006).  
Illness severity and comorbidity. Objective measures of severity of psychiatric diagnoses 
have not proven effective in distinguishing between those at risk for fatal/non-fatal suicide 
behavior, and those who are not (Mann, 1998; Mann, et al., 1999).  Objective measures of traits, 
such as impulsivity and aggression, and subjective measures of depression, are more reliable 
predictors (Mann, et al., 1999). However, the presence of impulsive and aggressive traits is not 
typically available from large administrative data sources.  
Variation in illness severity and co-morbidity potentially contributes to variation in 
outcomes, independent of the associations under investigation. Therefore, adjustment for case 
mix is an essential component of any observational study, where random allocation may not be 
indicated or possible (Kane, 2006). The assessment of comorbidity and severity is essential to 
make comparisons among practitioners, practice settings, or hospital units. Many tools have been 
designed for accounting for variation in patient characteristics, especially variation attributable to 
diagnoses or disease severity. Selected indices of disease-related variables are designed for use 
with large administrative data sets, and will be discussed in the following paragraphs.  
The Charlson and Elixhauser comorbidity indices are frequently used in studies with 
large administrative databases. Both of these methods use ICD-9-CM codes to determine the 
presence of selected comorbid medical and psychiatric conditions. The Charlson index (Charlson, 
Pompei, Ales, & MacKenzie, 1987) is a weighted index designed to classify comorbid conditions 
to identify risk of mortality in longitudinal studies. It was initially developed to determine relative 
risk of one-year mortality on a sample of patients diagnosed with breast cancer (N = 559). This 
tool has been applied to other clinical populations. The Elixhauser comorbidity index was 
validated with a broader clinical population, (all adult, nonmaternal inpatients from 438 acute 
care hospitals, N = 1,779,167) and explores multiple prognostic endpoints: mortality, hospital 
charges, and hospital length of stay (Elixhauser, Steiner, Harris, & Coffey, 1998). It is not clear 
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whether the Elixhauser index included psychiatric admissions in its validation.  
There are limitations to the use of the Charlson and Elixhauser indices, which may 
preclude their use in an inquiry related to psychiatric populations. First, neither index was 
validated in a psychiatric population. The frame of reference for the comorbidity is the treatment 
of a primary medical condition. This approach would not capture the impact of medical 
comorbidities for patients whose primary diagnosis is psychiatric in nature. Compared to the 
Charlson index, which includes one psychiatric comorbidity (depression), the Elixhauser index 
broadens the scope of psychiatric co-morbidities to include depression, psychoses, alcohol and 
drug abuse.  
Second, the prognostic endpoint for the Charlson index, one-year mortality, is not 
applicable to the proposed inquiry, or any inquiry related to suicide behavior. The methods used 
to identify the conditions listed in the Charlson index have not been applied to predict suicide 
mortality. The Elixhauser index demonstrates predictive validity for three prognostic endpoints: 
in-hospital mortality, hospital length of stay, and hospital charges. These endpoints are relevant to 
many models investigating hospital utilization outcomes. However, the validity of these 
endpoints remains questionable in a model related to psychiatric utilization.   
In spite of these limitations, the association between physical illness and suicide behavior 
should be acknowledged. Certain physical illnesses are associated with an increased risk for self-
directed violence. The impact of traumatic brain injury (TBI) is associated with an increased risk 
of suicidal SDV in civilian and military populations (Brenner, Betthauser, et al., 2011; Brenner, 
Ignacio, & Blow, 2011; Simpson & Tate, 2007). The presence of other medical conditions, such 
as multiple sclerosis, epilepsy, cancer, spinal cord injury, HIV/AIDS, peptic ulcer disease, 
autoimmune disorders, diabetes mellitus, kidney disease, and terminal illness confer an increased 
risk of suicide (Goldblatt, M. J. in (Maris, et al., 2000).  
 Only one study related to the risk associated with suicide behavior utilized the Charlson 
to adjust for comorbidities (Zivin, et al., 2007). In this study, the Charlson score was 
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dichotomized as zero or greater than/equal to one. There was no difference in suicide rates 
between these two groups. The sample was comprised of individuals receiving treatment for 
depression in the VHA system. The authors did not explain if they included the depression 
diagnosis in the Charlson index.  
Although many investigations have sought to establish a risk model for fatal suicide 
behavior, our ability to predict this cause of mortality is poor (Haney, et al., 2012). On the other 
hand, it is feasible to anticipate healthcare utilization patterns in psychiatric populations. A 
psychiatric “case-mix” system (Psy-CMS) was developed to (1) characterize the disease burden 
of patients with mental health and substance use disorders and (2) predict healthcare utilization 
and costs (Sloan, et al., 2006).  Predictive validity was established in VA patients with mental 
health and/or substance use diagnoses, with the aim of predicting three outcomes: cost, outpatient 
mental health and substance abuse encounters, and inpatient/residential mental health or 
substance use bed days of care. This model does not predict mortality. However, the methods for 
describing case mix are applicable to study of healthcare utilization of veterans with psychiatric 
conditions. This method is essential in any model describing potential associations between 
utilization of protective treatments and the delivery of treatment essentials for this population.  
Prior suicide behavior. The strongest predictor of fatal and non-fatal suicide behavior, 
after a psychiatric hospitalization, is a history of recurrent suicide behavior (D. Owens, et al., 
2002). This association may have an impact on the timing of fatal post-discharge suicide. One 
study found that among patients with a recent psychiatric discharge, patients with a history of 
suicide behavior were 13 times more likely to be associated with a fatal suicide outcome (vs. no 
suicide) in the first three months after discharge, OR = 13.8, CI = 3.6-52.8. Among those who 
completed suicide after discharge, those with a history of SDV were five times more likely to be 
associated with an early suicide outcome compared to late suicides (between three months up to 
12 years), OR = 5.1, CI = 1.3-19.9 (McKenzie & Wurr, 2001). This suggests that patients with a 
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history of recurrent suicide behavior would benefit most from immediate and intense psychiatric 
aftercare.  
The extent of historical suicide behavior should be considered when anticipating 
treatment for this population. Some evidence demonstrates that patients with a history of non-
fatal suicide behavior respond differently to interventions compared to those who engaged in 
suicide behavior for the first time. Investigators found that patients with a history of recurrent 
suicide behavior were almost twice as likely to repeat self harm, compared to repeaters who did 
not receive the a crisis telephone consultation intervention, OR = 1.85, CI = 1.14-3.03. In the 
same study, a non-significant protective effect was noted in the “first timer” group, compared to 
other “first timers” who did not receive the intervention, OR = 0.64, CI = 0.34-1.22 (Evans, 
Morgan, Hayward, & Gunnell, 1999).   This suggests that recurrent suicide behavior was not 
amenable to improvement, but that nascent suicide behavior had more potential to respond to the 
intervention.  
In a pooled analysis of three studies (NICE & National Institute for Health and Clinical 
Excellence, 2011), with approximately 5000 participants, a history of previous self-harm was 
associated with a higher risk of repetition, OR = 2.7, CI = 2.13-3.42 (Colman, et al., 2004; 
Johnston, et al., 2006; McAuliffe, Corcoran, Hickey, & McLeavey, 2008). Attenuation of the 
association between prior suicide behavior and future repetition was found in two of these studies 
(Colman, et al., 2004; McAuliffe, et al., 2008). The pooled unadjusted odds ratio was 5.86, CI = 
3.23-10.65. After adjusting for depression, age and gender, the adjusted odds ratio decreased to 
3.81, CI = 1.98-7.35. 
The repetition rate for self-harm during follow-up was as follows; 25% over one to two 
years, (Colman, et al., 2004), 11% in six months (Johnston, et al., 2006) and 30% in 12 months 
(McAuliffe, et al., 2008). The majority of participants in these studies had a prior history of self-
harm: 66% (N = 507) (Colman, et al., 2004), 55% (N = 4743) (Johnston, et al., 2006), and 59% 
(N = 152) (McAuliffe, et al., 2008). 
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A multi-center cohort study (N = 9213) reports that prior SDV was associated with a two-
fold risk in repetition for suicide behavior in the following 12 months (HR = 2.11, CI = 1.87-2.40; 
the multivariate model also contained employment status, suicidal intent, method of self harm, 
current psychiatric treatment, alcohol misuse and the presence of hallucinations. Fifty-one percent 
of the sample experienced a prior history of suicide behavior (Kapur, et al., 2006).  
Utilization of Healthcare Services  
Veterans who use VHA services demonstrate a higher suicide rate (suicide SMR ranged 
from 1.42-1.66 for VHA users) compared to the general US population (Blow, et al., 2012).  
Utilization of VHA services and risk for suicide vary by age. Among male veterans aged 30 years 
and older, an increased risk for suicide is associated with utilization of VHA services. Veterans 
under the age of 30 demonstrate a different pattern: suicide rates are lower among male VHA 
utilizers than among non-utilizers in this age group (I. R. Katz, et al., 2012).  
The association between recent psychiatric hospitalization and fatal suicide behavior has 
been studied extensively. Several retrospective observational studies have identified cohorts of 
discharged psychiatric patients and used vital statistics records to identify their causes of death. 
These inquires demonstrate that that highest rates of suicide deaths occur immediately after 
psychiatric discharge (Appleby, et al., 1999; Hunt, et al., 2009). These findings have been 
replicated in studies of VA psychiatric discharges (Desai, et al., 2005; Valenstein, et al., 2009).  
 Fewer studies have investigated the risk of post-discharge suicide for patients admitted 
for non-fatal suicide behavior. Identification of fatal suicide behavior is challenged by limitations 
in reliable vital statistics information (i.e. confirmation of suicide as the cause of death). 
Detection of non-fatal suicide behavior is further complicated by the unknown proportion of 
people who repeat suicide behavior and do not present to the hospital. For those that do, there can 
be inadequate data collection in the hospital setting. In a meta-analysis of studies investigating 
fatal and non-fatal repetition of suicide behavior, estimates of fatal repetition of suicide behavior 
range from 1.6% in the first year, to 3.4% by nine years, and 6.7% beyond nine years. Estimates 
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of non-fatal repetition range from 15-16% in the first year following hospitalization for suicide 
behavior, rising to 20-25% over the following years (D. Owens, et al., 2002). These estimates are 
derived from studies conducted primarily in Europe, Australia and New Zealand; therefore, these 
estimates may not be generalizable to the US population. A history of utilizing psychiatric 
services increases the risk of repetition of suicide behavior. In a pooled unadjusted analysis of 
two studies (Johnsson, et al., 1996; D Owens, et al., 1994), the experience of prior inpatient and 
outpatient psychiatric care more than tripled the likelihood of repetition of non-fatal suicide 
behavior, OR = 3.46, CI = 2.26-5.3. These studies did not adjust for confounders, and treatment 
for any one psychiatric diagnosis was not specified. History of psychiatric treatment was 
ascertained from local psychiatric services’ case register (D Owens, et al., 1994) and from 
psychiatric records of psychiatric hospital (Johnsson, et al., 1996).  
In females, current psychiatric treatment increased the likelihood of suicide behavior 
repetition for those with one to three repetitions during the observation period, adjusted OR = 
1.67, CI = 1.14-2.44; this association was stronger in females with more than four repetitions, 
adjusted OR = 3.05, CI = 1.56-5.95 (Haw, et al., 2007). A separate study reports similar findings 
after adjusting for confounding variables; current psychiatric treatment increased the risk for 
repetition for male and female patients, HR = 1.42, CI = 1.27-1.59 (Kapur, et al., 2006).   
Limitations surrounding the study of fatal and non-fatal suicide behaviors relate to 
population sample characteristics, unadjusted analysis of risk factors (precluding ability to detect 
confounding effects of other risk factors), and the use of suicide attempts as an outcome (Haney, 
et al., 2012). In the study of veteran populations, samples were derived from registries defined by 
a particular diagnosis such as depression (Valenstein, et al., 2009) or utilization of inpatient 
psychiatric services (Desai, et al., 2005). The heterogeneity of these samples precludes adequate 
comparison across studies, even within veteran populations. There are weaknesses associated 
with the use of suicide attempts as an outcome variable.  Self-reports of past suicide behaviors are 
unreliable, as patients can distort the frequency and severity of past attempts (Silverman, et al., 
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2007a). Objective determinations of suicide attempts rely upon the accuracy of provider 
assessment and documentation, which can be variable.   
Organizational Factors and Suicide Behavior 
There is a paucity of literature regarding healthcare organizational level factors 
associated with suicide risk. This is surprising since many organizational factors related to other 
causes of patient mortality have been investigated. Programs that have demonstrated statistically 
significant reductions in their suicide rates attribute much of their success to widespread 
organizational and cultural changes (Coffey, 2007; Knox, Litts, Talcott, Feig, & Caine, 2003). 
One study considered VHA facility-level characteristics and delivery-of-care variables among 
risks for fatal suicide behavior in veterans (Desai, et al., 2005). Although facility level 
characteristics were not associated with risk for fatal suicide behavior (i.e. facility size, funding 
allocation, or academic affiliation), a measure of continuity of post-discharge care indicated an 
increased risk of fatal suicide behavior with “poorer continuity”. These findings suggest that there 
are intermediate organizational risk factors for suicide, such as poor continuity of care or reduced 
access to mental health services, where the locus of control for modification lies with the 
healthcare organization and not the patient.   
Another clue regarding the potential impact of healthcare systems on suicide risk is found 
with patient-level utilization patterns. Many suicides occur after recent contact with a healthcare 
system, indicating there may be opportunities for intervention by the healthcare system to reduce 
suicide risk (Denneson, et al., 2010). As noted above, individuals who complete suicide 
demonstrate various patterns of healthcare utilization. These patterns may provide some insight 
into the healthcare needs of individuals at high risk for suicide.  
Preventive Treatment 
 The distinction between prevention and treatment is dependent upon one’s point of 
reference along the trajectory of illness, and the ultimate goal of prevention efforts. If the goal is 
to prevent any suicide behavior, the point of reference of the healthcare system is usually situated 
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after the opportunity for prevention has passed. However, if the goal were to prevent mortality 
from suicide, all interventions would be considered preventive. For example, once a patient has 
presented to the Emergency Department after a suicide attempt, the goal is to treat the immediate 
sequelae of the suicide attempt. However, many interventions, delivered after that time, are 
designed to prevent further injury or death from future suicide behavior. To accommodate the 
preventive nature of these treatments, they will heretofore be referred to as “preventive 
treatments”.  
I have conceptualized preventive treatment modalities according to Kane’s model for 
treatments and outcomes (Kane, 2006). Three treatment modalities are described: medications, 
procedures, and education/counseling. I will present these treatments in the following paragraphs, 
as they relate to evidence for mitigating the risk for suicide behavior.  
Medications. Medications “include everything that a patient physically takes into his or 
her system that has some causal, nontrivial relationship to health status” (Kane, 2006). 
Medication classes investigated for reducing risk of suicidal SDV include antidepressants, 
antipsychotic medications, and mood-stabilizers. Pharmacotherapy results are based on few 
studies with limited sample sizes, some methodological quality concerns, and short-term follow-
up assessment periods. In many studies, suicide rates were too low to detect differences between 
treatment groups (O'Neil, et al., 2012). Despite low strength evidence for pharmacotherapy in 
reducing the risk for fatal suicide behavior, assertive treatment of an underlying psychiatric 
condition, especially depression and schizophrenia, is recommended as a suicide prevention 
strategy.  
Procedures. Procedures include anything physically done to the patient. There are few 
“procedures” used to directly treat psychiatric conditions. The only procedure routinely 
performed in psychiatry is electroconvulsive therapy (ECT). ECT has shown no demonstrable 
effect on suicide behavior (Read & Bentall, 2010) , and will not be discussed in this review.  
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Counseling and education. The counseling and education of patients refer to “an 
information exchange between the patient and clinician for a therapeutic purpose…this category 
also includes psychological or psychiatric counseling in which the information exchange itself is 
therapeutic” (Kane, 2006). In this category, preventive treatments include psychotherapeutic 
interventions. A systematic review of suicide prevention interventions reports overall insufficient 
to low strength of evidence for the effectiveness of psychotherapy. Studies were characterized by 
small sample sizes, short-term follow-assessment periods, and methodological flaws (such as lack 
of blinding procedures, non-randomization, selection bias and differing drop-out rates among 
groups). Again, low rates of suicide precluded sufficient power to detect differences between 
treatment groups (O'Neil, et al., 2012).  
Previously published reviews on psychotherapeutic interventions for the prevention of 
suicide behavior present mixed findings related to cognitive therapies, positive findings related to 
Dialectical Behavior Therapy for people with Borderline Personality Disorder, positive findings 
for interpersonal psychotherapy, null findings for outpatient day hospitalization, positive findings 
for problem-solving therapy, positive findings for psychoanalytically oriented partial day 
hospitalization for people with Borderline Personality Disorder, and positive findings for 
transference-focused psychotherapy. Investigations of Attachment-Based Family Therapy vs. 
Enhanced Usual Care, Collaborative Assessment and Management of Suicidality vs. Enhanced 
Care as Usual, and skills based intervention vs. a supportive therapy control condition did not use 
sufficient methodological rigor to support conclusions about their effectiveness (O'Neil, et al., 
2012).  
Care Continuity. Kane’s conceptualization of treatment does not adequately capture 
activities that could be described as “care continuity”. This additional conceptualization of 
treatment captures activities that would not be classified as psychological or psychiatric 
counseling. Rather, activities that support care continuity may enhance referral and follow-up 
services designed to reduce the risk of suicide behavior. These activities may not directly involve 
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the patient, and therefore do not fit Kane’s conceptualization of treatment with education and 
counseling.  
The concept of care continuity is often discussed in the context of broader concepts of 
care coordination and care transitions. There are many definitions for care continuity, and 
consensus on any one definition remains elusive. One systematic review organizes continuity of 
care into three dimensions: informational continuity, or the “use of information on past events 
and personal circumstances to make current care appropriate for each individual;” interpersonal 
continuity, defined as an “ongoing therapeutic relationship between a patient and one or more 
clinicians;” and management continuity, defined as a “consistent and coherent approach to 
management of a health condition that is responsive to patient's changing needs.” Continuity of 
care represents an individual patient's experience of coordination over time with either a single 
clinician or with multiple clinicians (i.e., the extent to which the appropriate care is perceived to 
occur at the right time and in the right order) (Reid, Haggerty, & McKendry, 2002).  
Patients who receive psychiatric care are more likely to receive complex care and 
services across different areas, increasing the risk for fragmented care. This is especially relevant 
to the continuity of care surrounding the transition between levels of care, such as from inpatient 
to outpatient care. Psychiatric patients who do not complete an outpatient appointment after 
discharge are more than twice as likely to experience a one-year readmission, compared to 
patients who complete a post-discharge outpatient appointment (Nelson, Maruish, & Axler, 
2000).  The likelihood of completing the first post-discharge appointment increases when 
patients’ discharge plans are successfully communicated between inpatient and outpatient 
providers (Boyer, McAlpine, Pottick, & Olfson, 2000; Steffen, Kosters, Becker, & Puschner, 
2009).  
A systematic review of suicide prevention referral/follow-up services reports insufficient 
to low-strength evidence for the effectiveness of any referral and follow-up services in the 
prevention of suicide behavior (O'Neil, et al., 2012).  Specifically, the reviewed studies yielded 
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positive results from studies on case management/care coordination and 24-hour contact with a 
mental health professional. Mixed findings came from studies on emergency room contact cards 
and postal contact. Null findings were associated with intensive psychosocial follow-up, 
telephone follow-up, and video education plus family therapy. Limitations included small sample 
sizes, methodological flaws, and short follow-up periods.  
The VHA suicide prevention program has not been formally assessed for its effect on 
prevention of suicide behavior. This program is characterized by a bundle of activities, few of 
which would be considered “treatment” according to Kane’s nosology. The primary function of 
the suicide prevention program is to connect veterans, who demonstrate a high risk for suicide, 
with indicated treatments with the goal of attenuating the suicide risk. In and of itself, the Suicide 
Prevention program is not a treatment, however variation in the implementation of the suicide 
prevention program, and its activities related to informational and management continuity, may 
have an impact on aspects of the received treatment, and potentially affect outcomes of that 
treatment. Other examples of care continuity include referral to specialty services (to address 
underlying risk factors for suicide), arranging aftercare appointments according to the patient’s 
preferences, and strategies for ensuring referral follow-through or attendance to these services.  
Arguably, variation in care continuity activities likely affects the likelihood of exposure to the 
indicated treatments. 
Treatment Essentials 
Treatment Essentials refer to aspects of treatment that contribute to variability in patient 
outcomes. These essentials are derived from Kane conceptualization of treatment variation, which 
are ideal for comparing the effectiveness of treatments on patient outcomes. These include 
provider characteristics, setting, and the timing, duration, and intensity of treatment.  I have added 
“implementation” to this conceptualization, since variation in fidelity to the implementation of 
the intervention will contribute to variation in patient outcomes (Bellg, et al., 2004).  
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Provider Characteristics. There is some evidence on the association between provider 
characteristics and outcomes related to suicide. Associations between psychiatric outcomes and 
provider gender, for example, are inconsistent, however some differences in outcomes that are 
attributable to gender could be related to differences in prescribing habits (Abe, Moriya, Ikeda, 
Kuroda, & Hagihara, 2011). Age (as a proxy for clinical experience) and its association with 
patient outcomes have been investigated in psychiatry and other branches of medicine. Two 
studies demonstrate that inpatient treatment by younger psychiatrists was associated with 
improvements in patient outcomes, such as a reduced risk of post-discharge suicide (Lee & Lin, 
2009) or improved functional status (Abe, et al., 2011).  One explanation is that older providers 
may rely more on their experience than current advances in knowledge, compared to younger 
providers. Another explanation is that older providers, perceived to be more experienced and 
knowledgeable, receive more difficult cases, characterized by more severe symptomatology and 
poorer baseline functioning.  
 Based on these findings related to age and patient outcomes, it is reasonable to consider 
provider characteristics as variable of interest in any study examining care delivery to patients 
with a high risk of suicide.  Time since formal training may be a more accurate proxy of 
experience, compared to age, to impart variation in experience of individual providers. Frequent 
turnover of residents in inpatient and outpatient settings may translate to unfamiliarity with non-
clinical procedures (entering a referral or scheduling an appointment) and capital inputs (no 
access to voicemail, email), which impede direct communication with the outpatient provider.   
Setting. Variation in the setting of care delivery has a potential impact on health-related 
outcomes (Kane, 2006). Inpatient and outpatient care settings are characterized by size, staffing, 
teaching status, and proximity to the patient’s residence. Investigators have determined an 
association between geographic characteristics, proximity to VHA facilities and the risk for fatal 
suicide behavior (Desai, et al., 2005; McCarthy, et al., 2012). In one study, academic affiliation 
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and facility size were not associated with an increased risk of suicide for recently discharge 
psychiatric VHA patients (Desai, et al., 2005).  
Intensity, timing, & duration. Differences in intensity, timing and duration of a 
treatment, contribute to variation in outcomes. Intensity refers to the amount of treatment per unit. 
For example, in the case of the patient who recently attempted suicide, an inquiry related to 
treatment intensity might ask whether several encounters in a short period of time, results in 
comparable outcomes to the same number of encounters spread out over a longer time period. 
Timing, in this case refers to when the preventive treatment is delivered, relative to the discharge. 
Duration refers to the amount of time over which a preventive treatment is consistently delivered. 
Questions related to duration relate to how long an intervention has to be delivered to achieve the 
desired effect. For example, a postcard study delivered the intervention in varying intervals over 
five years (Motto & Bostrom, 2001); further comparison might examine whether the same 
intervention delivered over a shorter period of time results in similar efficacy.  Conversely, the 
inverse of duration, or the observation of gaps/interruptions in treatment, would also affect the 
outcome of the treatment under study.  
Due to the high rates of suicide that occur immediately after discharge, it is hypothesized 
that the timing of service delivery is important to prevent repetition of suicide behavior. 
Recommendations for the timing of psychiatric aftercare for patients who were recently 
hospitalized for a suicide attempt have not been rigorously evaluated. There is an assumption, 
based on the disproportionate rates of suicide in the days and weeks after discharge that an 
intervention delivered during this time could potentially thwart future suicide behavior. The 
timing of post-discharge psychiatric aftercare is important to preventing thirty-day psychiatric re-
admissions, especially if that care was delivered within five days of discharge; one study 
empirically supported this hypothesis by demonstrating that recently discharged patients who 
received aftercare within five days of discharge were less likely to experience a psychiatric re-
admission within thirty days, OR = 0.71, CI = 0.56-0.79. Additionally, exposure to increasing 
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numbers of unique providers (a measure of discontinuity) doubled the risk of thirty-day 
readmission, OR=2.18, CI = 1.62-2.81 (Huff, 2000).  
The unexpected association between aftercare appointment frequency and completed 
suicide precludes the development of sound recommendations for follow-up care after discharge 
from psychiatric hospitalization. The risk for re-admission (Huff, 2000) or suicide (Large, 
Sharma, Cannon, Ryan, & Nielssen, 2011) after psychiatric hospitalization is reduced as the 
number of post-discharge appointment decreases. Huff risk adjusted for severity (psychosis vs. 
no psychosis) but did not control for diagnosis. 
Few studies have been attempted to examine the effect of provider exposure on the risk 
for repeat suicide behavior. The studies that have been conducted provide mixed results. Tohorst 
(1987) randomized recently discharged psychiatric patients to receive aftercare from the same 
clinician (experimental) who assessed them in the hospital, or to a new clinician (control). 
Surprisingly, the group who did not change clinicians, (i.e. those who experienced enhanced 
continuity of care) experienced a statistically significantly higher rate of repeat suicide behavior 
compared to the group that had a change in clinician, OR = 3.70, CI = 1.13-12.09. However, 
those in the continuity group were almost three times more likely to attend at least one outpatient 
treatment session, compared to the group who changed clinicians, OR = 2.75, CI = 1.37-5.52 
(Torhorst, et al., 1987).  
 
Conceptual Model and Analytical Framework 
 
The concepts described in the previous sections do not currently exist in a single 
conceptual model. Therefore, I developed a nascent model (Figure 1) and have described it in the 
following paragraphs. This model includes the aforementioned concepts, and describes the 
directionality of potential associations among these concepts. From this model, I derived an 
analytical framework for the proposed inquiry, which highlights the concepts relevant to the 
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prevention of suicide behavior from the perspective of a healthcare setting (Figure 2). This is 
described in later paragraphs.  
The conceptual model in Figure 1 depicts the various points of intervention for the person 
who engages in non-fatal suicide behavior (termed “non-fatal self-directed violence” in this 
model). It starts with the act of non-fatal suicidal self-directed violence. This act is driven by the 
presence of modifiable and fixed risk factors, as demonstrated by unidirectional arrows from the 
boxes labeled “Fixed Risk Factors” and “Modifiable Risk Factors” to the box labeled “Non-Fatal 
Suicidal Self-Directed Violence”. This represents the association between risk factors and the 
incidence of non-fatal suicidal self-directed violence.  
 
 
Figure 1. Conceptual Model for the Treatment and Prevention of Recurrent Suicide Behavior 
 
Once an act of non-fatal suicidal self-directed violence (SDV) behavior occurs, one of 
three outcomes is possible: the behavior is 1) unrecognized and untreated, 2) recognized and 
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untreated, 3) recognized and treated. Each of these outcomes is met with a specified level of 
prevention intervention. Non-fatal suicidal SDV that is “un-recognized and untreated” does not 
reach the healthcare system and is not exposed to targeted prevention efforts. Non-fatal suicidal 
SDV that follows this trajectory, represented by a unidirectional arrow, is exposed to universal 
prevention interventions for suicidal SDV. These interventions include policies that affect means 
restriction (such as gun control policies), public education about suicidal SDV, and media 
strategies that guide the reporting of fatal suicidal SDV in the community.  
Suicidal SDV that is “recognized and untreated” is exposed to selective prevention 
interventions. These suicidal SDV behaviors may be recognized by a crisis line worker, a 
“gatekeeper” (a community member trained to recognize warning signs for suicidal SDV) or as a 
result of screening process (such as the screening provided when a service member is returning 
home from a combat zone). These selective interventions are not designed to treat acute suicidal 
SDV, but to provide resources to address underlying risk factors for suicidal SDV. Recognized 
and untreated suicidal SDV does not come into contact with the healthcare system for treatment.  
The third potential outcome of non-fatal suicidal SDV is recognition and treatment of the 
behavior via “targeted prevention” interventions. The provision and ongoing management of 
these interventions are the domain of the healthcare organization. Within the area of targeted 
prevention exist the concepts of “preventive treatments” and “treatment essentials”, which were 
described in earlier sections.  
From each of the prevention areas, an arrow follows a unidirectional trajectory back to 
“modifiable risk factors”. This represents the potential impact of these prevention interventions 
on risk factors for future non-fatal suicidal SDV. There is an intentional absence of indication 
related to whether these interventions increase or decrease the risk of future non-fatal suicidal 
SDV. This is due to paucity of consistent evidence in this area, which is marked by mixed 
findings especially related to the impact of hospitalization on future non-fatal suicidal SDV.  
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The variables of interest for this study are organized according to Andersen’s model of 
health behavior (Andersen, 1995). This framework was selected to correspond with the 
conceptual model described in Figure 1, which depicts the various opportunities of intervention 
for the patient who has demonstrated non-fatal suicidal SDV. Andersen’s framework describes a 
multi-directional relationship among three concepts: determinants of health behavior, the 
demonstration of health behavior, and health outcomes (Figure 2).  
 
Figure 2. Andersen’s Model of Health Behavior, Adapted for the Management of Suicide Behavior. 
Note. Adapted from  “Societal and Individual Determinants of Medical Care Utilization in the United 
States” by R. Andersen and J. F. Newman, 2005, The Milbank Quarterly, 83(4). Preventive treatments and 
treatment essentials adapted from “Understanding Health Care Outcomes Research” by R. L. Kane, 2006.  
 
This relationship begins with determinants of health behavior, which exist within 
populations, and within organizations. In populations, these determinants include predisposing 
factors with low mutability (e.g. demographic characteristics), enabling factors with high 
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mutability such as availability of health insurance or benefits, and factors describing need, or the 
immediate reason for care to take place. The construct of “need” is characterized, in part, by the 
presence of illnesses, which require treatment. “Need” may also be informed by experiences prior 
health behavior. For example, for the patient experiences multiple hospitalizations in a psychiatric 
crisis, this patient may perceive that he or she “needs” to be hospitalized in order to address the 
crisis, and may not be open to seeking less restrictive alternatives for care.  Therefore, the patient 
engages in health behavior that corresponds with the perceived need.  
This framework allows for the inclusion of concepts related to patient level risk factors 
for suicide (in population characteristics) and characteristics of treatment, as described by Kane 
(2006): timing, duration, intensity, provider and setting. For this adaptation of Andersen’s 
framework, concepts related to information continuity (activation of a Category II Patient Record 
Flag: High Risk of Suicide) and management plan continuity (initiation of specialty behavioral 
health consults) are included in organizational determinants of health behavior.  
The second concept in this framework describes the health behavior. Health behavior 
refers to the patient’s engagement in personal health practices, and the use of health care services. 
The proposed study will focus on the use of behavioral health services: Mental Health, Suicide 
Prevention, Substance Use, Psychology, PTSD, Homeless Care and Vocational. Here, the 
inclusion of Kane’s factors of treatment: timing, duration and intensity, is appropriate, since these 
factors are theorized to affect patient outcomes. Andersen’s framework depicts the multi-
directional impact of health behavior. Here, the effect of health behavior impacts health 
outcomes, but also impacts determinants of health. For example, if the use of healthcare services, 
such as group therapy, targets suicidal ideations, then the ideal health outcome of this service is a 
reduction in suicidal ideations. However, if the content of the group therapy related skills in 
building a support system, this treatment may have an impact on the enabling factors (such as 
family support) that precede the health behavior.  
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The third concept in Andersen’s framework describes health outcomes. The health 
outcome of the proposed study is the repetition of a suicide attempt. A suicide attempt is not only 
a health outcome, but also a predisposing patient characteristic, which contributes to the patients 
overall risk of suicide. This is represented in Anderson’s framework, with an arrow originating at 
the health outcome, and feeding back into the population determinants of health behavior.   
The adapted framework corresponds to the aims of this study. These aims will determine 
(1) associations among population characteristics, health service utilization, and the outcome of 
interest: suicide attempt repetition, and (2) associations between organization factors of continuity 
and the utilization of healthcare services.  
 This framework proposes a multi-directional relationship, depicted by the arrow leading 
from “delivered preventive treatments” and “outcome” of suicide attempt or suicide completion. 
This framework also considers the possibility that variation in treatment essentials can contribute 
to variation in the outcome of suicide behavior, independent of the delivery of the preventive 
treatments. Investigation of these relationships has the potential to uncover previously 
unmeasured effects of care delivery on suicidal self-directed violence in veteran populations.  
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CHAPTER III 
 
METHODS 
 
The objectives of this study were twofold. First, I sought to describe associations between 
characteristics of the delivery of mental health care to veterans who were recently hospitalized for 
a suicide attempt and the likelihood of a repeat suicide attempt. These characteristics included the 
timing, duration, intensity, provider, and setting of treatment. Second, the investigator determined 
whether there were factors—during or proximal to the initial hospital admission—that increased 
the likelihood of linkage to specialty mental health treatment.  
In the following sections, I will describe the aims, methods and analytical strategy 
employed in this study. I will also discuss my strategy of managing the rare occurrence of my 
outcome of interest: reattempt of suicide within six months of an index suicide attempt.  
 
Research Aims and Design 
 
This study has the following specific aims: 
Aim One: for patients who did and did not experience a suicide re-attempt in six months 
after the index attempt, describe the setting, provider, type, timing, duration and intensity of 
behavioral health care to veterans recently hospitalized for a suicide attempt. 
Aim Two: describe associations between factors related to patient characteristics, prior 
health utilization, index admission and the timing of post-discharge behavioral health care.  
A retrospective cohort design was employed to examine patient groups who experienced 
the outcome of interest and those who did not. This cohort was selected based on the shared 
experience of hospitalization for a suicide attempt. This cohort was retrospectively observed for 
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six months after discharge from the index hospitalization. During the six-month observation 
period there were two outcomes of interest. The outcome of interest for Aim One is the repetition 
of a suicide attempt, and the exposure is the delivery of a specialty mental health treatment. The 
outcome of interest for Aim Two was the completion of an initial behavioral health specialty 
appointment; the exposures of interest were the characteristics of the index admission: High Risk 
Flag activation, length of stay, consult initiation, and site transfer.  
A retrospective single cohort design, with six months of longitudinal observation, was 
determined to be the best fit for this type of inquiry, due to the efficiency and relatively low cost, 
compared to a prospective study design. A single cohort design was selected instead of a design 
that includes a comparison cohort. The patients included in the cohort were similar in that they 
were hospitalized for a suicide attempt, and as a result, exposed to similar recommendations for 
behavioral health treatment after discharge. These recommendations did not apply to other 
cohorts hospitalized for other reasons.  
 
Description of Research Setting 
 
The research setting was all VA facilities, Outpatient Clinics, and Community Based 
Outpatient Clinics (CBOCs) in the Veterans Integrated Service Network (VISN) 9, where patients 
received behavioral health care after hospitalization for a suicide attempt. This network 
encompasses six VA medical centers and approximately sixty CBOCs. Five of the six medical 
center facilities offered psychiatric inpatient services and all six offered outpatient behavioral 
health services. The availability of these services in CBOCS was variable. Some facilities offered 
more intensive mental health services, such as residential treatment programs for Post Traumatic 
Stress Disorder (PTSD) and Substance Use Disorders (SUD).  
 The study of suicide re-attempts in a VA setting offered several opportunities for 
description that were not available in other healthcare settings. The VA is a nationally integrated 
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healthcare system with access to both inpatient and outpatient administrative data. The VA 
National Suicide Prevention program operates a registry of veteran suicide behavior, which can 
be drilled down to the VISN and facility levels. VISN 9 was targeted for study due to 
convenience to the investigator, who was employed by a VISN 9 facility.  
 
Sample 
 
The study sample was comprised of VISN 9 VA patients for whom a known suicide 
attempt occurred after 1/1/2009 and before 3/31/2012, and the suicide attempt resulted in a VA 
hospital admission. These patients were identified in the VA’s registry of suicide behaviors: the 
Suicide Prevention Application Network (SPAN). All known suicide attempts and completions 
by VA patients were recorded in this registry. This data source is described in later sections of 
this chapter.  
Nature and size of sample 
The sample consisted of VA patients who were identified in SPAN as a “suicide attempt” 
between 1/1/2009 and 3/31/2012. The observation period for each veteran was six months after 
index discharge or until the next suicide event, whichever occurred sooner.  
Only veterans, who were hospitalized for a suicide attempt, were included in the study. 
This strategy presumes that the severity of all attempts was high enough to warrant admission to 
an inpatient unit. In contrast, suicide attempts with other outcomes, such as outpatient treatment, 
indicated the possibility that the attempt was either not severe enough to require hospitalization, 
or represented a retroactive report of a prior attempt, from which the informant has fully 
recovered, and was not in acute crisis. Patients who were hospitalized for a suicide attempt were 
exposed to unique processes that were specific to the transition from the inpatient to outpatient 
setting.  
 
 49 
Criteria for sample selection 
Patients who are identified in SPAN to have demonstrated a suicide attempt between 
1/1/2009 and 3/31/2012 were selected for screening. This surveillance process did not start in the 
VA until late 2008, so it was not possible to identify cases in this manner prior to 2009.  
Cases were excluded if:  
1. The index event was not identified as a suicide attempt 
2. The index event did not result in hospital admission 
3. The Veteran is under 18 years of age (this is highly unlikely since the required age 
for military service is 18 or older). 
There were no exclusions based on sex, race, ethnicity, marital status, service connection, 
or diagnosis.  
Methods for subject recruitment 
Because cases were retrospectively selected from administrative data, subjects were not 
recruited for participation. The consent process was waived since this study involved no more 
than minimal risk to subjects. This study could not have been practicably carried out without a 
waiver of informed consent. Obtaining informed consent would have required locating each 
Veteran through phone or mail, which would not have been possible if the veteran had been 
deceased, institutionalized, homeless (and therefore not reachable by traditional means), or 
residing at an address that is not listed in the administrative data.  
Strategies to ensure human subjects protection 
This study did not involve direct patient contact, and was non-interventional. The primary 
risk to subjects in this retrospective study was a breach of data security, potentially compromising 
patient privacy and confidentiality. The consequences of a security breach, in an investigation of 
suicide behavior, had the potential for undue suffering of the patient, due to the stigma 
surrounding suicide behavior.   
Investigators and associated personnel in the proposed study adhered to VA directives 
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regarding data security and privacy. They attended all required trainings and enacted 
precautionary measures to protect patient information. Data was stored on a VA research server, 
located in computer room D-03 at the VA Tennessee Valley Healthcare System (TVHS) facility 
in Nashville, TN. Data was not transmitted outside of the VA; only committee members with VA 
employee status or Without Compensation (WOC) status viewed the data. Upon study 
completion, the data was archived on this VA server, for a time period consistent with VA 
mandates. 
A VISN 9 Data Agreement was completed to allow access to VA National and Local 
databases, and to ensure extra security for these data. This study was approved by the Institutional 
Review Board (IRB) at the VA TVHS (Nashville, TN) and at Vanderbilt University (Nashville, 
TN).  
 
Description of Data Sources 
 
This study used three data sources: the Suicide Prevention Application Network (SPAN), 
VA national databases and VA local databases. In the following paragraphs, I have described 
each data source and discuss their known limitations.  
Suicide Prevention Application Network (SPAN) 
SPAN is a national VA registry that was created by the VA Suicide Prevention Program 
in 2008. It is a surveillance tool that records veteran suicides and suicide behaviors in real time. 
Presently, there is no published literature describing the use of SPAN data for suicide research, or 
testing the reliability of data entry, or the validity of entries. Preliminary research is currently 
underway at the VA Suicide Prevention Center of Excellence in Canandaigua, NY, using SPAN 
as one data source to describe suicide behaviors in VA populations. However, due to a dearth of 
published literature on this resource, current knowledge about the SPAN registry is primarily 
anecdotal.   
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SPAN entries are routinely populated by each VA facility’s Suicide Prevention 
Coordinator (SPC). SPAN data are entered monthly by SPCs and reflect local knowledge of three 
types of suicide behaviors: suicidal ideations, suicide attempts and suicides.  
Reliability of SPAN Data. There are some threats to reliability to consider when using 
the SPAN registry for research. The most critical is unmeasured variation in data entry practices 
by the hundreds of suicide prevention personnel in the VA system.  Completion of the SPAN 
items requires extensive chart abstraction, and variation in these practices potentially impacts the 
reliability of data entry practices.  
Reliability of data entry practices was enhanced through the design of the SPAN web-
based application, and through standardized training for Suicide Prevention personnel. These 
enhancements improved the likelihood that all SPCs are using replicable procedures to enter data, 
thus reducing variation in data entry practices. The SPAN web application guides data entry with 
drop-down menus, radio buttons and fixed item responses. Most item responses are limited to the 
items built into the web application, however there are a few opportunities for free text entry. To 
improve the reliability of suicide event reporting, the SPAN web-based data entry tool introduced 
items to guide the respondent to use approved nomenclature to classify the self-directed violence 
behavior (Brenner, Breshears, et al., 2011). Although this method ensures that all respondents are 
classifying these events according to the same criteria, it was implemented after the initial 
creation of the SPAN registry, and was not available for all cases in the sample.   
There have been anecdotal reports that suicide prevention personnel receive standardized 
training for SPAN data entry practices, however training materials have neither been published 
nor been made available for viewing on centrally located VA Suicide Prevention information 
repositories. Without guidance on which chart elements should inform data entry, each SPC has 
created his or her unique method for conducting a chart review.  
Validity of SPAN data. A critical threat to the validity of SPAN data, relates to the 
verification of suicide events. SPAN captures three types of suicide events: suicides, suicide 
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attempts, and suicidal ideations. If a suicide event cannot be verified, the respondent may choose 
“Undetermined” as an option. The validity of entered data is affected by varying interpretations 
of clinical information or may be informed by the use of different primary information sources 
during chart abstraction. One example is the occurrence of a thwarted attempt, which is called 
“interrupted by self or other” in the suicide behavior nomenclature. Sometimes this is 
documented as a suicide attempt, and other times this is documented as “undetermined”. The 
verification of past suicide attempts encounters similar challenges. This can be verified by patient 
self-report or from past documentation. When relying on past documentation, suicide prevention 
personnel use varying strategies to obtain this information from the electronic health record, 
which is further confounded by variation in provider documentation of past suicide events.  
Many of the data elements in SPAN are duplicated by other VA data sources, and have 
been described in later sections.  Therefore, there is no need to rely on SPAN for most of this 
information. However, there are some data elements that are not available from other VA data 
sources. Specifically, these are:  
• Suicide Event Type: the ability to differentiate between completed suicide, suicide 
attempts and suicidal ideation  
• Number of suicide attempts prior to the recorded suicide behavior  
• Outcome of the Event: the ability to differentiate between suicide attempts resulting in 
hospitalization and other outcomes, such as “outpatient care” or “no treatment sought”.  
• Repeat entries into SPAN after the index event will be used to determine the primary 
outcome of interest: the repetition of suicide behavior.  
The method to identify repetition of suicide behavior was briefly presented at the VA-
DoD Annual Suicide Prevention Conference, June 20-22, 2012, in Washington, D.C. by Robert 
Bossarte, PhD. Dr. Bossarte conducts research at the VA Suicide Prevention Center of 
Excellence. However, at this time, there are no published works describing the use of SPAN to 
capture the repetition of suicide behavior.  
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Considering the aforementioned limitations of the SPAN data, other VA data sources are 
needed to inform the variables under study. The next two sections will describe the other VA data 
sources: VA National Databases, and VA local databases.   
VA National Databases: Patient Treatment Files and Outpatient Care Files 
The following paragraphs will describe VA data sources, specifically those that provide 
data on patient demographics, inpatient treatment, and outpatient healthcare delivery at VA 
facilities. These national data are housed at a central data repository and made available to 
researchers in the form of Statistical Analysis System® (SAS) datasets. General limitations 
surrounding the use of these data in research are addressed in this section. Issues related to the 
validity of data informing specific variables are discussed in the section describing “Data 
Elements”.   
VA health care facility staff members across the United States and Puerto Rico enter 
patient care information into Veterans Health Information Systems and Technology Architecture 
(VistA), the main information collection and data management system in the Veterans Health 
Administration (VHA). A select set of data collected during patient health care encounters are 
entered in local health care facilities VistA systems are then electronically transferred from each 
local VistA system to a centralized data warehouse, the National Patient Care Database (NPCD), 
housed at the Austin Information Technology Center (AITC; formerly the Corporate Franchise 
Data Center) in Austin, Texas.  From the NPCD, two national databases are created: the Patient 
Treatment Files (PTF) and the Outpatient Care Files (OPC). AITC staff members construct 
Medical SAS® Datasets from NPCD data extracts. National Data Systems (NDS) oversees the 
construction of extracts from the NPCD and makes the extracts available in the form of SAS® 
Datasets to authorized users. NDS monitors and provides oversight for the information systems at 
AITC and is responsible for program and project coordination between VHA program offices and 
AITC (VA Information Resource Center, April, 2011).  
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The PTF files are analogous to hospital discharge abstracts and include basic 
demographic data as well as principal, primary, and nine secondary ICD-9-CM codes. In the VA, 
the primary diagnosis code refers to the condition that accounted for the majority of the hospital 
stay. For hospital admissions secondary to a suicide attempt, the primary diagnosis code may 
refer to the injury sustained as a result of the suicide attempt, or may reflect an underlying 
psychiatric condition.  
The OPC files contain information on all patients who are seen in VA outpatient clinics. 
These files contain information on patient demographics, clinic location and stop code, 
ambulatory procedures (in the form of CPT codes), one primary and up to nine secondary 
diagnosis codes.  
A major limitation of these VA databases is that they lack important clinical detail that 
cannot be determined from ICD-9-CM codes, or CPT codes. For example, it is not possible to 
determine if specific suicide prevention activities, such as risk assessment or safety planning, 
occurred during an inpatient or outpatient contact. This information would only be available via 
chart abstraction. Information related to the repetition of suicide behavior would not be readily 
available, without abstracting admission information for all admissions. The availability of SPAN 
data remedies this limitation.  
Another shortcoming specific to VA databases is that they only capture data on veterans 
who seek care at the VA, precluding generalizability of findings to veteran populations who do 
not seek VA healthcare services. Furthermore, many veterans who seek VA healthcare services 
also receive services in the private sector. This can be resolved, in part, by merging VA and 
Medicare data to determine where veterans aged 65 and older receive their care. This strategy was 
not employed in the current study.  
 In spite of these limitations, there are many advantages to using VA national databases. 
As it pertains to this study, which investigated the inpatient and outpatient utilization of a specific 
cohort of patients, it was possible to upload a file of social security numbers to the mainframe and 
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merge these data with the files of interest to determine utilization. In this study, the social security 
numbers of veterans identified in the SPAN registry were uploaded. It was also possible to follow 
a cohort of patients over time to capture outcomes of interest to the investigator, such as the 
delivery of specialty healthcare services.   
VA Local Databases 
 The VistA data source contains extensive clinical information not available in the PTF or 
OPC files. Of interest to this investigation, VistA provided information about patient scheduling 
and bed utilization, in addition to fiscal operations, file transfers to national databases, and 
eligibility queries. These data allowed for differentiation between completed (scheduled and 
unscheduled), cancelled or “no-show” patient encounters. This is especially relevant to the study 
of suicide prevention, since many of the clinical outreach encounters that occur, as part of suicide 
prevention efforts, are not scheduled and occur within non-traditional modalities, such as 
telephone contact.  
Decision Support System 
 The Decision Support System (DSS) is a national database of particular importance to 
epidemiologists and health services researchers. The DSS is a longitudinal database that 
combines selected elements of cost and clinical data from the aforementioned PTF, OPC and 
VistA files. Each VA facility has a DSS site team and manager who are responsible for running 
reports requested by facility administrators, clinic managers and others. While the DSS was 
designed to support local administrative decision making, it is of potential value to VA 
researchers (Maynard & Chapko, 2004). The VA data used in this study was requested via DSS 
support staff at TVHS.  
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Data Elements 
 
This section describes the data elements used in this study. Pertinent methodological 
issues and limitations for each data element are discussed. Please refer to Appendix B for a list of 
all variables. The following sections will be organized by conceptual elements:  
• Identification of index suicide event and hospitalization 
• Patient characteristics and prior health behavior  
• Characteristics of treatment delivery: Timing, Duration, Intensity, Provider and Setting 
• Clinical Outcome: Repetition of suicide attempt 
Identification of index suicide event and hospitalization  
The suicide event was identified through a query to the SPAN registry. The query 
specified: VISN 9, all facilities, attempts only, according to date of event. In the SPAN registry, 
each event entry had a corresponding “outcome” designation. The events with an outcome of 
“hospital admission” were reviewed for eligibility in the study. This designation did not indicate 
whether the hospitalization occurred at a community hospital or at a VA facility. A VA admission 
was verified if a hospital admission date was identified in the VA administrative data within 14 
days of the suicide attempt “event date”. This two-week grace period allowed for any non-VA 
admissions that may have resulted from the index suicide event with patient transfer to a VA 
facility. Cases where a VA admission could not be verified were marked as “non-VA admission”.  
Index Event Date. The index event date was defined as the month, day and year that the 
veteran first demonstrated a suicidal behavior, such as a suicide attempt. This date was derived 
from the SPAN registry, labeled as “event date”. This date was included in the DSS data request, 
to retrieve inpatient admission data surrounding the event date.  
Index Discharge Date. The index discharge date is the month, day, and year marking the 
day of discharge from the inpatient hospitalization that occurred as a result of the suicide attempt. 
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This date was used to generate the number of days from the discharge to other events, such as the 
first outpatient encounter after discharge, or if applicable, a suicide reattempt.  
Patient Characteristics 
Study Identification (ID) Number. The study ID number, a randomly generated 
number, replaced confidential identifying information, such as name and social security number, 
in the analytic data set. The random number function in SPSS was used to create a 4-digit study 
ID for each patient. A crosswalk file, stored on the secure server, pairs each case ID with the 
name, social security number, and date of birth of the corresponding case. To protect personal 
privacy and confidentiality, access to the crosswalk file was limited to authorized personnel.  
Sex. The patient’s sex is categorized as male or female. In the VA, those who identify 
themselves as transsexual are not recorded as anything other than male or female, according to 
the preference of the patient.  
Date of Birth. The patient’s date of birth—the calendar date on which the person was 
born—was used to calculate the person’s age, in years, on the index event date The date format is 
mm/dd/yyyy. This was one data element used to identify the patient in the DSS data request.   
Age.  The age of the person at the time of the suicide event was the difference, in years, 
between the date of birth and the index event date.  
Race and Ethnicity. The race and ethnicity of the veteran were derived from the PTF as 
the race and ethnicity that were available in the PTF during the index hospitalization. Race and 
ethnicity are important demographic characteristics, which inform one’s risk for suicide and 
suicide behavior. However, there are some challenges in securing valid race and ethnicity data, of 
which, the VA is not exempt. These challenges, and methods for resolving them, are described in 
the following paragraphs.  
Managing missing data on race and ethnicity is a reality of working with large 
administrative databases. The Department of Veterans Affairs Information Resource Center 
(VIReC) conducted an analysis of the completeness of race and ethnicity information in VA 
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administrative data. The primary findings were (1) that a “usable” race value (i.e. not missing or 
categorized as “unknown”) was found for 56% of individuals in the sample and that this 
proportion increased to 88% when looking at patients who had an inpatient hospitalization, (2) 
those without a usable race value were younger (mean age 59 vs. 65) and less likely to be male 
(82% vs. 94%) or have non-VA healthcare coverage (34% vs. 51%), (3) adding information from 
more than one fiscal year, from Medicare data, or from the Department of Defense (DoD) data 
increased the proportion of usable race and ethnicity values, and (4) that levels of concordance 
between VA and Medicare data or DoD data, were higher for Whites and African-Americans 
compared to those identified as American Indian/Alaskan Native or Asian/Pacific Islander 
(Stroupe, et al., 2010).  
Excluding all data on patients whose race is not known from sample analysis changes 
important sample characteristics and could bias study results. In the event that these data are 
missing, the report recommends creating an “unknown” category for the study’s race and 
ethnicity variable and to analyze data separately on patients whose race or ethnicity is not known 
(VA Information Resource Center, Sept 2011). VIReC continues to investigate those instances 
where a race variable has the value “Unknown – Unknown by Patient”. This accounts for less 
than 1% of all responses (VA Information Resource Center, April, 2011).  
The Office of Management and Budget (OMB) recommends that self-identification of 
race and ethnicity be used whenever possible, and that respondents have the option to select 
multiple race categories if applicable (Office of Management and Budget (OMB) & Office of 
Information and Regulatory Affairs, 1995). The VA collects the reporting method for race and 
ethnicity (i.e. reported by self, proxy, or observer), however a published report of race data 
quality reveals that there is known systematic misreporting of the race and ethnicity data 
collection method and recommends against using this label in research (VA Information Resource 
Center, Sept 2011).  
In light of these limitations, efforts were not made to determine the source of race and 
 59 
ethnicity data. These data were derived from information available at the index hospital 
admission, increasing the reliability of this information.  
Marital Status. Data regarding marital status reflects the veteran’s status at the time of 
the data request (February, 2013) and may not reflect the veteran’ marital status at the time of the 
index event.  
Residence or Address. Components of the veteran’s address were used to determine 
proximity to healthcare services, as a proxy for access to healthcare services (Andersen, 1995). 
There are several methods for measuring proximity to healthcare services, which will be 
discussed in the following paragraphs.  
 Proximity to VA services as measured by determining the presence of a VA facility in the 
county of residence, has demonstrated predictive power for mental health service utilization, even 
when controlling for distance to the nearest VA facility (Weissman, Rosenheck, & Essock, 2002). 
Using county of residence data is a more efficient method for determining access to VA mental 
health services, since time-consuming geocoding procedures are not required. Therefore, the 
presence of a VA facility in the county of residence was used as a proxy for geographical access 
to care.  
Data regarding the veteran’s county of residence reflects the veteran’s residence 
information available at the time of the data request (February, 2013) and may not reflect the 
veteran’s county of residence at the time of the index event.  
Service Connected Disability Rating.  This rating is reported in 10% increments from 
0-100. Data regarding the veteran’s serviced connected disability rating reflects the veteran’s 
status at the time of the data request (February, 2013) and may not reflect the veteran’s rating at 
the time of the index event.  
Military Service Era and Combat Status. The assigned military service era reflects the 
time period during which the veteran served, and imparts potential exposure to specific conflicts. 
Combat veterans discharged from active duty on or after January 28th 2003 are eligible for 
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enhanced enrollment placement in Priority Group 6 or “Combat Status” for 5 years post 
discharge. Combat Status confers enhanced benefits for veterans receiving care at VA. Veterans 
in this group enjoy waived medication copays, and reduced or waived inpatient hospitalization 
copays, even in the absence of a service-connected condition.  
Psychiatric Diagnosis. This study identified the primary psychiatric diagnosis, i.e. the 
primary psychiatric condition treated during the index hospitalization, and secondary diagnoses of 
a substance use disorder or post-traumatic stress disorder. These diagnoses were reported as 
International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) 
codes.  
The ICD nosology is the most widely used classification of diseases, and has been 
applied to healthcare reimbursement, administration, epidemiology, and health services research 
(O'Malley, et al., 2005). Currently, the ICD is in its ninth iteration, and has been modified to be 
more precise in clinical use; the modified version is called the International Classification of 
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM).  In the proposed study, ICD-9-CM 
classification was used to describe the cohort under study.  
By virtue of the ICD-9-CM nosology, the PTF contains more detailed diagnostic 
information than the SPAN registry. The SPAN registry reports the presence or absence of certain 
psychiatric diagnostic categories at the time of the index event, and lacks the detail available in 
ICD-9-CM coding.  When a diagnosis is entered into SPAN, the diagnostic information is derived 
from chart review, which introduces variability in which chart documents are utilized to make 
these determinations. Additionally, it is possible to select more than one diagnosis, which 
precludes valid and reliable determination of a primary psychiatric disorder. Therefore, data from 
the inpatient SAS dataset were used to determine primary and secondary diagnoses, instead of 
SPAN data.  
ICD-9-CM data in the PTF allowed this investigator to identify the psychiatric illness that 
was the focus of treatment during the index hospital admission. It was assumed that this ICD-9-
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CM code corresponds with the psychiatric illness that contributed most to the suicide behavior 
that led to the hospital admission. The presence of secondary psychiatric condition, such as a 
Substance Use disorder (SUD) or Post Traumatic Stress Disorder (PTSD), may further contribute 
to the risk for suicide behavior.  
 ICD-9-CM code accuracy is the extent to which the assigned code reflects the underlying 
patient’s disease. When a patient is admitted for suicide behavior, the primary diagnosis may 
reflect the injury sustained by the suicide behavior, or may reflect the underlying psychiatric 
condition that contributed to the event, and was the focus of psychiatric treatment. This presents a 
challenge when attempting to discern the primary psychiatric condition, independent of the 
suicide behavior.  
In most cases, the primary psychiatric diagnosis was reflected as the first ICD-9-CM code 
listed among discharge diagnoses in the SAS Inpatient Data Set, and corresponds with a numeric 
ranking variable of “1”).  In cases where the suicide behavior resulted in a significant injury that 
required treatment, the primary diagnosis reflected injury or poisoning, and the second or third 
listed diagnosis was considered to be underlying psychiatric condition that was present at the time 
of hospital admission. In these cases, the first listed psychiatric condition was considered the 
primary psychiatric diagnosis.  
Risk Adjustment. Risk adjustment is the process by which the health status of a 
population is taken into account when evaluating patterns or outcomes of care. Methods for risk 
adjustment considered both psychiatric and medical co-morbidities. Both diagnostic groups have 
implications for utilization of inpatient and outpatient services.  
Psychiatric ICD-9-CM codes were grouped according to a predetermined list of codes 
reflecting psychiatric disorders according to the VA-MH12. This was selected instead of the 
PSY-CMS (described in Chapter 2). Both the VA-MH12 and the PSY-CMS have been used to 
adjust for case mix of psychiatric populations. PSY-CMS case mix is better at predicting 
utilization (Sloan, et al., 2006), however the relatively small sample size for this study precluded 
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the use of 46 diagnostic categories. The VA-MH12 is currently in use at VA. The VA-MH12, 
found in Table 3.1, includes twelve categories of psychiatric diagnoses. 
Table 3.1  
 
VA-MH12 Psychiatric Diagnostic Categories and Corresponding ICD-9-CM Codes 
 
Diagnostic Category ICD-9-CM Codes 
Dementia/Alzheimer disease  290–290.9, 293–294.9, 310.xx 
Alcohol disorder  303.xx, 305.00 
Drug disorder  292-292.9, 304.xx, 305.2–305.93 
Schizophrenia 295.xx 
Other psychoses  297–299.9 
Bipolar disorder  296.0–296.16, 296.4–296.89 
Major depression  296.2–296.36 
Other depression  300.4x, 296.9x, 311, 301.1 
PTSD 309.81 
Anxiety disorder  300.xx excluding 300.4 
Adjustment disorder  309.xx excluding 309.81 
Personality disorder  301.0x, 301.2–301.9 
Note. Adapted from “Development and validation of a psychiatric case-mix system” by K. L. Sloan, M. E. 
Montez-Rath, A. Spiro, C. L. Christiansen, S. Loveland, P. Shokeen, L. Herz, S. Eisen, J. N. Breckenridge, 
and A. K. Rosen, 2006, Medical Care, 44, p. 178.  
 
Possible tools for risk adjustment for medical co-morbidities include the Charlson 
Comorbidity Index and the Elixhauser Comorbidity index (Charlson, et al., 1987; Elixhauser, et 
al., 1998). Both can be used to predict mortality, however the Elixhauser index is also used to 
predict length of stay and hospital charges. The proposed study considered utilization patterns, 
including length of stay, and did not consider the prognostic endpoint of mortality. Therefore, the 
Elixhauser index was one method used in this study to adjust for medical comorbidities.  
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Table 3.2 
 
Elixhauser Risk Adjustment Categories and ICD-9-CM Codes for Medical Comorbidities 
 
Elixhauser Comorbidity Index 
Diagnostic Category  ICD-9-CM Codes 
Congestive heart failure  398.91, 402.11, 402.91, 404.11, 404.13, 404.91, 
404.93, 428.x 
Cardiac arrhythmias  426.10, 426.11, 426.13, 426.2–426.53, 426.6–
426.8, 427.0, 427.2, 427.31, 427.60, 427.9, 785.0, 
V45.0, V53.3 
Valvular disease  093.2, 394.0–397.1, 424.0–424.91, 746.3– 746.6, 
V42.2, V43.3 
Pulmonary circulation disorders  416.x, 417.9 
Peripheral vascular disorders  440.x, 441.2, 441.4, 441.7, 441.9, 443.1– 443.9, 
447.1, 557.1, 557.9, V43.4 
Hypertension, uncomplicated  401.1, 401.9 
Hypertension, complicated  402.10, 402.90, 404.10, 404.90, 405.1, 405.9 
Paralysis  342.0, 342.1, 342.9–344.x 
Other neurological disorders 
 
Huntington’s Disease: (Farrer, 1986; Fiedorowicz, 
Mills, Ruggle, Langbehn, & Paulsen, 2011; 
Schoenfeld, et al., 1984) 
Multiple Sclerosis: (Bronnum-Hansen, Stenager, 
Nylev Stenager, & Koch-Henriksen, 2005; 
Giannini, et al., 2010) 
Epilepsy: (Hesdorffer, et al., 2012) 
 
 331.9, 332.0, 333.4 a, 333.5, 334.x, 335.x, 340.x 
a, 341.1–341.9, 345.0 a, 345.1 a, 345.4 a, 345.5 a, 
345.8 a, 345.9 a, 348.1, 348.3, 780.3, 784.3 
Chronic pulmonary disease  490–492.8, 493.00–493.91, 494.x-505.x, 506.4 
Diabetes, uncomplicated a (Ilgen, et al., 2010)  250.0–250.3 
Diabetes, complicated a (Ilgen, et al., 2010)  250.4–250.7, 250.9 
Hypothyroidism  243–244.2, 244.8, 244.9 
Renal failure a 
(Maris, et al., 2000) 
 403.11, 403.91, 404.12, 404.92, 585.x, 586.x, 
V42.0, V45.1, V56.0, V56.8 
Liver disease  070.32, 070.33, 070.54, 456.0, 456.1, 456.2, 
571.0, 571.2–571.9, 572.3, 572.8, V42.7 
Peptic ulcer disease excluding bleeding a 
(Maris, et al., 2000) 
 531.70, 531.90, 532.70, 532.90, 533.70, 533.90, 
534.70, 534.90, V12.71 
AIDS/HIV a  042.x–044.x 
Lymphoma  200.x–202.3x, 202.5–203.0, 203.8, 238.6, 273.3, 
V10.71, V10.72, V10.79 
Metastatic cancer a 
(Fang, et al., 2012) 
 196.x–199.x 
Solid tumors without metastasis a 
(Fang, et al., 2012) 
 140.x–172.x, 174.x, 175.x, 179.x–195.x, V10.x 
Rheumatoid arthritis/collagen vascular diseases  701.0, 710.x, 714.x, 720.x, 725.x 
Coagulopathy  286.x, 287.1, 287.3–287.5 
Obesity  278.0 
Weight loss  260.x–263.x 
Fluid and electrolyte disorders  276.x 
Blood loss anemia  280.0 
Deficiency anemia  280.1–281.9, 285.9 
Note. Embedded citations indicate literature that reports association between diagnosis and suicide risk.  
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a Diagnosis is associated with an increased risk of suicide.  
Table 3.3  
 
Risk Adjustment Categories and ICD-9-CM Codes for Medical Comorbidities Associated with an 
Increased Risk of Suicide 
 
Conditions Associated with Suicide Risk 
Diagnostic Category  ICD-9-CM Codes 
Migraine 
(Breslau, Schultz, Lipton, Peterson, & Welch, 2012) 
 346.xx 
Traumatic Brain Injury 
(Brenner, Ignacio, et al., 2011) 
 850, 800, 801, 803, 851-854.  
Spinal Cord Injury  
(Giannini, et al., 2010; Hartkopp, Bronnum-Hansen, 
Seidenschnur, & Biering-Sorensen, 1998) 
 952, 806 
Cerebrovascular Disease (Ilgen, et al., 2010)  430-438 
Chronic Obstructive Pulmonary Disease (Ilgen, et al., 
2010) 
 430-438 
Note. Embedded citations indicate literature that reports association between diagnosis and suicide risk.  
 
Table 3.2 describes the comorbidities, and corresponding ICD-9-CM codes, included in 
the Elixhauser index. I have excluded diagnoses that are already captured by the VA-MH12: 
alcohol abuse, drug abuse, psychoses, and depression. Starred items in Table 3.2 indicate 
disorders that have also been associated with an elevated risk for completed suicide. In 
combination with the starred items in the Elixhauser, these conditions, with accompanying ICD-
9-CM codes, was used to create an index of conditions known to increase suicide risk. Conditions 
associated with elevated suicide risk that are not included in the Elixhauser index are described in 
Table 3.3. These conditions were included in the analysis if they were listed as a discharge 
diagnosis from the index hospitalization or one hospitalization in the past two years.  
Healthcare Utilization 
Episode of care prior to index suicide attempt. The outpatient SAS dataset was queried 
to report all encounters in the two years prior to the index suicide attempt. Information pertaining 
to the date, location, provider, and clinic type of the most recent clinical encounter was obtained 
from these data. These data were used to inform variables related to past utilization of outpatient 
behavioral health and primary care services, as well as prior psychiatric and medical 
hospitalizations.  
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Episode of care during the index hospitalization. The index hospitalization was 
identified by matching the index suicide event date (+/- 14 days) with a corresponding hospital 
admission in the PTF. Data were collected on aspects of care delivery during inpatient treatment 
for the index suicide attempt. These data were used to elucidate the potential for handoffs during 
the inpatient stay.  
Activation of Category II Patient Record Flag: High Risk of Suicide. Data elements 
related to patient record flags were available via query to VistA data sources. If an active 
“Category II Patient Record Flag: High Risk of Suicide” was identified within three days of 
discharge, a dichotomous variable indicated that the patient had an active High Risk Flag upon 
discharge. The activation of the High Risk Flag is the responsibility of the facility’s Suicide 
Prevention Coordinator. Its activation communicates recommendations for patient monitoring and 
is considered a form of information continuity. There are no published studies regarding the 
validity and reliability of flag activation and informational continuity.  
Site transfer. SPAN data reflect the site where the suicide attempt was identified. This 
was compared to the facility where the veteran experienced the index hospitalization. This was 
reported as a dichotomous variable reflecting whether the identification of the suicide attempt 
occurred at the same facility where the veteran received the inpatient care. At this time, there are 
no published studies on the extent to which veterans travel between facilities to receive acute 
inpatient treatment for a suicide attempt, and whether this transition has an effect on post-
discharge care. An association between this movement and the delivery of indicated outpatient 
treatments for a suicide attempt has implications for organization of the transition of care from 
inpatient to outpatient settings.  
Hospital admission type. A categorical variable was created to reflect the type of hospital 
admission experienced by the patient. The type of inpatient unit is determined by the bed section 
code. The admitting bed section and discharging bed section were available in the SAS dataset. If 
these bed sections were different, a unit transition was noted during the index admission. Prior 
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investigations of the reliability of VA bed section data have reported that some bed section data is 
more reliable than others. Bedsections where the Patient Treatment File (PTF) and the Medical 
Record agreed best were Orthopedic, k = 0.852, Medical ICU, k = 0.846, and Neurology, k = 
0.820. Bedsections with the worst rates of agreement were Hematology/Oncology, k = 0.009, 
Intermediate Medicine, k = 0.248, Substance Abuse, k = 0.259, and Ear, Nose, Throat, k = 0.290. 
Agreement between the PTF and Medical Record was not evaluated for psychiatry bedsections 
(Kashner, 1998).  
Inpatient length of stay. The inpatient length of stay was calculated from the admission 
date and discharge date of the index hospitalization. This variable reflects the duration of 
inpatient care. Shorter inpatient stays have been associated with an elevated risk of suicide after 
discharge from a VA psychiatric unit (Desai, et al., 2005).  Investigations of the reliability of 
length of stay calculations in VA administrative data have found 98% agreement between the 
PTF and the medical record (Kashner, 1998).  
 Episode of care after hospital discharge. Aim One of this study described two aspects 
of treatment delivery: the type of treatment (Mental Health, Suicide Prevention, Substance Use 
Disorder Treatment, Psychology, Homeless Care, Vocational) and factors that potentially affect 
variation in treatment outcomes, as defined by Kane (2006): timing, duration, intensity, provider, 
and setting. Outpatient encounters were analyzed in temporal increments so that the delivery of 
care could be compared between different time periods. These increments—the seven and the 
thirty days after discharge—reflect VA recommendations for clinical care that should be 
delivered during these intervals.  
Type of treatment. The ideal method for determining the type of behavioral health 
treatment is described in a study that validated the use of specific VA administrative data 
elements to describe outpatient clinical encounters for substance use treatment (Harris, Reeder, 
Ellerbe, & Bowe, 2010). The three key data elements are: diagnosis, current procedural 
terminology (CPT) codes, and “DSS Identifiers”, also known as “clinic stop codes”. VHA uses 
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DSS Identifiers to collect workload data in order to indicate the work group responsible for 
providing the specific set of clinic products, and to serve as a stable identification method that can 
be used to compare costs between facilities. The investigators described a relatively reliable 
method for operationalizing specialized care delivery for substance use disorders (SUD). This 
process involves specifying, a DSS Identifier for any SUD clinic, a SUD diagnosis, and a mental 
health CPT code. When these criteria were applied, investigators found 92% agreement in SUD 
care between the administrative data and the patient record. Conversely, when only the SUD DSS 
Identifier (or SUD bed section, for inpatient SUD treatment) was used, agreement was 
determined on only 55% of the records. A separate investigation further supports the claim that 
bed section and clinic stop code data alone are inadequate for reliably determining where clinical 
care was delivered (kappa approximately 0.5), and recommends that these data are combined with 
other information, such as diagnosis, to more accurately capture the location of care (Kashner, 
1998).  
This study used only stop codes to identify the type of treatment delivered during the 
observation period, and to differentiate behavioral health treatment from other types of outpatient 
clinical care. Outpatient ICD-9-CM codes and CPT codes were not made available to this 
investigator, therefore only stop codes were used to infer the type of treatment that was delivered.  
The stop codes used to create these data elements are listed in Appendix C 
 Identification of providers. Provider information accompanies every encounter recorded 
in the PTF and OPC, including the provider’s name and discipline. Each provider is also assigned 
a unique “provider ID”. However, these codes are assigned at the local level, and it is possible for 
one provider to have multiple provider IDs depending on the number of stations with which 
he/she may be associated. Therefore, it is difficult to associate a unique provider with a provider 
ID beyond the facility level.  For this study, the provider name served as the provider’s unique 
identifier.  
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 There is no provider related data that describes the specialty role of the provider; this 
must be extrapolated from other contextual clues, such as the clinic stop code. For example, a 
provider who works in the PTSD clinic will use a clinic stop code that is specific to the PTSD 
clinic. This provides the basis for distinguishing providers who work in specialty areas, such as 
SUD and PTSD, from mental health providers who work, for example, in the general mental 
health clinic. Unfortunately, there are no such contextual clues for providers who function as part 
of the suicide prevention team. For example, a psychiatrist who provides care in the mental health 
clinic may be indistinguishable from a psychiatrist on the suicide prevention team, who provides 
a treatment to a patient. At TVHS, the clinic stop codes would be identical and would not 
differentiate between provider “roles”.  
 To accommodate for this limitation, it was necessary to devise a method for identifying 
providers who function within a suicide prevention team. In the present study, I used the provider 
name to cross-reference information requested from VISN 9 Suicide Prevention leadership. This 
request included the names and dates of service for those working in the suicide prevention 
program since 2008.  
 Setting and Modality of Care. The setting of behavioral health care delivery was 
categorized into “Medical Center”, “Community-Based Outpatient Clinic” (CBOC), and 
“Residential” treatment. These were determined through examination of the clinic stop code and 
clinic location. The modality of care was also ascertained through the examination of clinic stop 
code title and description. Modality was categorized as “Individual”, “Group”, and “Telephone”. 
Individual clinic stop codes and category assignment can be viewed in Appendix C 
Measuring Continuity of Care. Continuity of care is an intangible aspect of health care 
delivery that is not easy to measure. There are many aspects to continuity of care, requiring 
multiple measures to capture the complexity of the whole concept. Two core elements—patient 
experience with provider, and continuation of care over time (i.e. chronology), and three types of 
continuity—informational, relational, and management continuity—are germane to healthcare 
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settings, in varying degrees (Reid, et al., 2002). Transitions between healthcare settings are a 
potential source of disruption in care continuity. In this scenario, the types of continuity that are 
impacted are (1) informational continuity (due to barriers in communicating the discharge plan 
between facilities) and (2) management plan continuity (due to potential delays in establishing 
aftercare appointments, secondary to the disruption in informational continuity). Describing the 
continuity of mental health care presents challenges, primarily because mental health treatments 
are traditionally delivered by multiple providers, representing a variety of health professions and 
disciplines. The extent to which these providers function as a team is difficult to measure.  
The components of many continuity measures are consistent with Kane’s constructs of 
treatment variation, i.e. timing, intensity, duration, provider, and setting (Kane, 2006). Therefore, 
the measures included in the present study were limited to those that incorporated at least one of 
Kane’s constructs. Table 3.4 lists Kane’s treatment concepts on the left, and the corresponding 
continuity constructs on the right.  
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Table 3.4  
 
Kane’s Treatment Constructs, Continuity of Care Measures, and Resulting Data Elements 
 
Kane 
Construct a 
Type of Care 
Continuity b 
Corresponding 
Measure b Description Data Element 
Timing, 
Duration 
Management “Evidence of 
Longitudinal 
Follow-up” 
Evidence of indicated 
follow-up of care for 
particular problems; often 
used during transition of 
care between providers, 
facilities or levels of care 
(inpatient to outpatient).  
 
Days until first post-
discharge appointment is 
completed 
 
Intensity, 
Duration 
Chronology “Intensity of 
Patient/Provider 
Affiliation” 
Examines the number 
and/or total duration of 
visits with provider over a 
defined interval 
 
 
The number of 
appointments attended 
during defined time 
intervals 
 
 
 
Provider Chronology 
 
“Concentration 
of Care” 
Number of providers with 
whom the patient had 
contact during an episode of 
care or in a defined time 
interval 
 
The number of providers 
who conducted 
appointments during 
defined time intervals.   
Timing Informational “Information 
Transfer” 
Evidence a mechanism for 
information transfer exists 
or that information has 
successfully transferred 
(from one visit to next, or 
between facilities) 
 
The activation of the 
Category II PRF: High 
Risk of Suicide during 
inpatient stay or within 3 
days of discharge.  
 
 
a Adapted from “Understanding Health Care Outcomes Research” by R. L. Kane, 2006.  
b Adapted from “Defusing the Confusion: Concepts and Measures of Continuity of Healthcare” by R. Reid, 
J. Haggerty, and R. McKendry, 2002, Canadian Health Services Research Foundation, p. 4.  
 
Patient Record Flag activation. Because of its relevance to the continuity construct of 
“information transfer” the following paragraphs will explain the purpose of the Category II 
Patient Record Flag (PRF): High Risk of Suicide.  
Identification as a “High Risk of Suicide” is determined by a VA healthcare provider, 
upon face-to-face assessment of the veteran in a VHA facility. This assessment may be guided by 
a VA-endorsed suicide risk assessment tool, and is usually made in collaboration between the 
treating provider and the facility’s Suicide Prevention Coordinator (SPC). When a veteran is 
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identified as a high risk of suicide, the assigned SPC activates a “Category II Patient Record Flag 
(PRF): High Risk of Suicide” on the veteran’s electronic medical record.  
When the PRF is active, it automatically appears in a pop-up window each time the 
patient’s record is accessed by a healthcare provider. This only occurs in the assigned VA facility 
(i.e. if the veteran is flagged at the Louisville VA, it can only be viewed by providers in the 
Louisville VA medical center and its affiliated outpatient clinics). The text of the PRF contains 
recommendations for an increased level of monitoring. The basic language of the PRF, which can 
be read by anyone accessing the medical record, is standardized, but can be modified to 
incorporate information specific to the individual veteran. This action is intended to communicate 
recommendations for care of the veteran identified as a high risk of suicide. An example of the 
full language of the PRF used at VA Tennessee Valley Healthcare System can be found in 
Appendix A. 
 
Analysis Strategy 
 
In the following paragraphs, I describe methods for data cleaning and preparation of the 
analytic dataset, and the analysis strategies for Aim One and Aim Two.  
Preparation 
Data preparation involved the identification of unique episodes of care, as well treatment 
types, settings, modalities and providers of care. This was accomplished by using the Aggregate 
function in SPSS. Appendix B describes the data elements used to inform these variables.  
Variables with more than 10% missing data were excluded from analysis. The only variable with 
more than 10% missing data was Combat Status. Missing data in less than 10% of cases were 
categorized as “missing” in the creation of the variable. The only variable containing a “missing” 
category was “Race”.  Missing encounter data attributable to death was verified by cross-
referencing the death file in the VA’s Beneficiary Identification Record Locator System (BIRLS). 
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Data reduction activities included the grouping of diagnoses according to psychiatric and medical 
comorbidity indices.  Stop codes were categorized to treatment types according to the title of the 
stop code or the description of the stop code (Appendix C).  
Descriptive statistics were generated to provide univariate frequencies and distributions and 
to determine variation among the data elements. The process allowed for the rate of reattempt 
within six months to be determined, and therefore, an appropriate analysis strategy to be 
developed.  
Analysis by Aims 
Aim One. This aim described, for patients who did and did not experience a suicide re-
attempt in six months after the index attempt, the setting, provider, type, timing, duration and 
intensity of behavioral health care to veterans recently hospitalized for a suicide attempt.   
First, descriptive statistics for the variables of interest were organized according to 
outcome group: those who re-attempted suicide during the observation period, and those who did 
not. These were reported on the VISN level. To determine differences between the outcome 
groups, single-sample chi-square test were used for ordinal and nominal variables reported as 
percentages. Continuous variables presented as interval/ratio data were evaluated between the no-
reattempt group and the reattempt group using non-parametric tests, since the distributions of 
these variables were skewed.  
For the purpose of describing the post-discharge treatment delivered to patients 
hospitalized for a suicide attempt, I divided patients who received post-discharge treatment into 
three groups: those who did not reattempt suicide in the 6 months after discharge (“no-reattempt 
group”, n = 467), those who reattempted between 8 and 30 days after discharge (“8-30 day 
reattempt group”, n = 7) and those who reattempted between 31 and 180 days after discharge 
(“31-180 day reattempt group”, n = 20).  
In order to conduct accurate comparisons between patients who did not reattempt suicide, 
and patients who reattempted suicide in the 6 months after discharge, analysis was limited to the 
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behavioral health treatments delivered during two time intervals: 7 days post-discharge and 30 
days post discharge. This adjustment accommodated the varying observation periods experienced 
by the patients who reattempted suicide after discharge and allowed for comparison during the 
interval that all patients had an equal opportunity to attend appointments. In light of this 
adjustment, patients who reattempted between 0-7 days after discharge (n = 3) were not included 
in the description of post-discharge treatment. 
The three patient groups described in Aim One experienced equal opportunities to participate 
in treatment during the first seven days of the observation period. Therefore, descriptions related 
to the first seven days of the observation period were conducted between the no-reattempt group 
and the 8-30 day reattempt group, as well as the no-reattempt group and the 31-180 day reattempt 
group. Statistical comparisons related to the first thirty days of treatment will be limited to the no-
reattempt group and the 31-180 day reattempt group. The 8-30 day reattempt group will not be 
included in the thirty-day comparisons, since the observation period for this group is truncated 
when the reattempt occurs. As a result, patients in this group experienced unequal opportunity for 
participation in care and cannot be accurately compared to the no-reattempt group. Due to the 
relatively small size of the 8-30 day reattempt group (n = 7), no statistical comparisons with this 
group were generated as part of this analysis.  
Aim Two. This aim described the association between factors related to patient 
characteristics, prior health utilization, index admission and the timing of post-discharge 
behavioral health care. The timing of the first specialty mental health appointment was measured 
in days, from the date of discharge, to the date of the first completed behavioral health 
appointment.  
The analysis strategy for this aim described whether differences in the number of days to 
appointment differ, according to patient characteristics, prior health behavior, and factors 
associated with hospital stay. The number of days to the first behavioral health appointment was 
not evenly distributed. Therefore, a Mann-Whitney test was used to determine differences 
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between dichotomous groups: gender, history of prior suicide attempts, living in same county as 
VA facility, PRF activation, change in VA facility and specialty mental health consult initiation. 
In comparing categorical variables, a Kruskal-Wallis test was used to determine if there 
are differences in days to appointment among categories in the variable: race, marital status, 
service connection, and primary psychiatric diagnosis.  
Finally, to compare continuous variables—length of stay, age, number of medical 
comorbidities, days since last mental health appointment, days since last medical appointment, 
days since last psychiatric admission, and days since last medical admission—to the number of 
days until the first appointment, a Spearman’s rank correlation was used.  
Analyses were conducted using IBM SPSS Version 20.   
Determining the Sample for Analysis  
The cohort was identified through a query to the SPAN registry. The query specified: 
VISN 9, all facilities, attempts only, according to date of event.  The report returned 975 unique 
patients representing 1110 events. Of these 975 patients, five were excluded because the 
corresponding suicide attempts were the only events reported between 2009 and 2010.  
Cases with index events occurring after March 31, 2012 were excluded (n = 149). This 
allowed for six months of observational data to be assembled at the time of the data request in 
November 2012. March 31, 2012 is also the last day of the second quarter of FY12, allowing for 
description of events by fiscal year and quarter, if needed.   
In the SPAN registry, each event entry had a corresponding “outcome” designation. The 
events that resulted in hospital admission (as reported in SPAN) were included in the sample for 
analysis. This designation does not indicate whether the hospitalization occurred at a community 
hospital or at a VA facility. Cases with outcomes of “No Treatment Sought” (n = 60), “Outpatient 
Treatment” (n = 40), “Referred to Outside VA” (n = 9), or “Other” (n = 22) were excluded. The 
resulting cohort, with the event outcome labeled “Hospital Admission”, contained 690 cases.  
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To determine factors related to the inpatient admission and the discharge date to inform 
time-based variables, only events with corresponding VA admissions were included in the 
analysis. A VA admission was verified if a hospital admission date was identified in the VA 
administrative data within 14 days of the suicide attempt “event date”. This two-week grace 
period allowed for any non-VA admissions that may have resulted from the index suicide event 
with patient transfer to a VA facility. As a result, 184 cases were excluded from the final analytic 
sample. The number of those patients who attempted suicide between January 1, 2010 and March 
31, 2012, and were hospitalized at a VA facility included 506 cases. Figure 3 depicts a flow map 
describing the patients included in and excluded from the final analytic sample. In Chapter Four, I 
will compare the patients who attempted suicide and were admitted to a VA facility, with those 
patients who attempted suicide, but were not admitted to a VA facility as a result of their attempt.  
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Figure 3. Description of cases included in and excluded from the final analytic sample. 
Cohort meeting criteria for analysis = 504 
Index event between 1/1/10 and 3/31/12 resulting in VA inpatient 
admission. 
 
 
Figure 3: Description of cases included and excluded in final analytic sample.  
Cases with index attempts resulting in hospital 
admission = 690 
Cases identified in SPAN Registry = 975 
Date Range: January 1, 2009-September 30, 2012 (to capture index and 
repeat event) 
All six facilities in VISN 9 
Event Type: Attempt 
 
No verified VA inpatient admission within 14 
days of event date = 184 
 
Patient Death during observation period = 2 
Exclusions due to outcome of index event 
No treatment sought = 60 
Outpatient Treatment = 40 
Referred to Outside VA = 9 
Other = 22 
 
Cases with index events between 
 Jan 1, 2010 through March 31, 2012 = 821 
Cases with events prior to 2009 were excluded =5 
Cases with index event after March 31, 2012 = 149 
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CHAPTER IV 
 
RESULTS 
 
In this chapter, I will first describe the data reduction strategy, including the process by 
which missing data were identified and managed. Second, I will describe the demographic, 
clinical, and utilization characteristics of the patient sample, as well as patient level factors related 
to the index hospitalization. Finally, I will report the results from the respective statistical 
analyses for Aim One and Aim Two.  
 
Data Reduction 
 
One variable—combat flag status—was excluded from analysis since the amount of 
missing data affected more than 10% of the sample. Of the 690 patients in the preliminary sample 
(before excluding non-VA hospital admissions) 102 (15%) had missing data for this variable. As 
a result, this variable was not considered for analysis. Several categorical variables were further 
reduced for ease of description and analysis. In Table 4.1 I have described the original and 
reduced categories for the cohort that experienced a VA admission (N = 504), with descriptive 
statistics. Treatment types were divided into six categories: Mental Health, Substance Use, 
Suicide Prevention, Posttraumatic Stress Disorder (PTSD), Homeless Care, and Vocational. 
Within each treatment type category, the treatment delivery modalities “Individual”, “Group” and 
“Telephone” were identified. The treatment type categories and the corresponding clinic stop 
codes included in each category can be viewed in Appendix C.  ICD-9-CM codes were used to 
categorize the primary psychiatric diagnosis and medical comorbidities. Tables depicting the 
reduction of ICD-9-CM codes into VA-MH 12 and Elixhauser categories can be found in 
Appendices D & E.  
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Table 4.1 
 
Original and Reduced Variables for Patient Demographic Characteristics (N = 504) 
 
Original Categories Reduced Categories 
Demographic Characteristic n (%)  n (%) 
Race    
American Indian or Alaskan Native 1 (0.2) Non-White 75 (14.9) 
Black 65 (12.9) White 415 (82.3) 
Native Hawaiian or Other Pacific Islander 2 (0.4) Missing 16 (3.2) 
White 415 (82.3)   
Unknown 7 (1.4)   
Missing 16 (3.2)   
Marital Status    
Divorced 203 (40.3) Divorced/Separated 248 (49.2) 
Married 146 (28.9) Married 146 (29.0) 
Never Married 93 (18.5) Never Married 93 (18.5) 
Separated 45 (8.9) Widowed 18 (3.6) 
Unknown 1 (0.2) Unknown 1 (0.2) 
Widowed 18 (3.6)   
Service Period    
Air Force--Active Duty 1 (0.2) Persian Gulf War 205 (40.7) 
Army--Active Duty 1 (0.2) Post-Vietnam 125 (24.8) 
Korean 6 (1.2) Vietnam Era 153 (30.4) 
Other Non-Veterans 1 (0.2) WWII-Post Korea 14 (2.8) 
Other or None 6 (1.2) Other 9 (1.8) 
Persian Gulf War 205 (40.7)   
Post-Korean 4 (0.8)   
Post-Vietnam 125 (24.8)   
Pre-Korean 1 (0.2)   
Vietnam Era 153 (30.4)   
World War II 3 (0.6)   
Service Connected Disability SCD Rating (%)    
0 235 (46.6) No SCD 235 (46.6) 
10 30 (6.0) <50% 88 (17.5) 
20 16 (3.2) 50-100% 183 (36.3) 
30 26 (5.2)   
40 16 (3.2)   
50 16 (3.2)   
60 24 (4.8)   
70 37 (7.3)   
80 17 (3.4)   
90 12 (2.4)   
100 77 (15.3)   
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Participants 
 
In the following sections I will describe the cohort of patients who were excluded from 
analysis (n = 184), and compare the frequency of patient characteristics with those included in the 
analysis (N = 506). From this cohort, the sample that was included for analysis will be described, 
and comparisons between the group that experienced a suicide reattempt (n = 31) and the group 
that did not experience a suicide reattempt (n = 473) will be described.  
Approximately 27% of patients in the original sample were excluded because they did 
not experience a VA inpatient admission at the time of the index suicide attempt. The proportion 
of excluded cases was larger than anticipated. Potential differences in patient characteristics 
between the included and excluded cases will inform the generalizability of findings. Therefore, a 
descriptive analysis was conducted to determine if there were any statistically significant 
differences between veterans included in the analysis and veterans who were excluded because of 
a non-VA admission for the index hospitalization. I compared demographic characteristics and 
proxies for access in the group that experienced a VA inpatient admission (“VA admit group”) 
with those in the group that did not experience a VA admission (“non-VA admit group”).  Please 
refer to Table 4.2 for descriptive statistics of these two groups.  
There were no statistically significant differences between the two groups in the 
proportions of race, gender, marital status, services connection, and repetition of suicide attempt.  
Both groups were predominately male, white, and divorced or separated. Statistically significant 
differences between the two groups were identified in the variables of age, number of 
comorbidities, service period, and residence in a county with a VA facility. The VA admit group 
was slightly older, with a mean age of approximately 48 years, SD = 12.9, compared to the non-
VA admit group, with a mean age of approximately 43 years, SD = 14.9. At first glance it 
appeared that the non-VA admit group contained a greater proportion of cases who had zero 
 80 
observed comorbidities (82%) compared to the VA admit group (27%). A greater proportion of 
those in the VA admit group resided in a county with a VA facility (50%) compared with the 
proportion of those who were not admitted to a VA facility (38%). Among the five categories for 
service period, those who served in the Persian Gulf period represented the largest proportion of 
both VA and non-VA admit groups (41 % and 61% respectively), and this proportion was greater 
in the non-VA admit group.  
Table 4.2 
 
Description of Patient Characteristics for VA and Non-VA Hospital Admissions for a Suicide 
Attempt  
 
 
Total 
N = 690 
 Non-VA Admit 
n = 184 
VA-Admit 
n = 506 
  
Demographic Characteristic Mean (SD)  Mean (SD) Mean (SD) t p 
Age (years) 46.7 (13.6)  43.2 (14.9) 47.9 (12.9) -3.79 <.001 
 n (%)  n (%) n (%) χ2  p 
Gender (Male) 622 (90.1)  164 (89.1) 458 (90.5) 0.29 .59 
Race      3.33 .19 
White 573 (83.0)  158 (85.9) 415 (82.0)   
Non-White 93 (13.5)  18 (9.8) 75 (14.8)   
Missing Data 24 (3.5)  8 (4.3) 16 (3.2)   
Marital Status     0.98 .91 
Divorced/Separated 334 (48.4)  86 (46.7) 248 (49.0)   
Married 201 (29.1)  55 (29.9) 146 (28.9)   
Never Married 127 (18.4)  34 (18.5) 93 (18.4)   
Widowed 26 (3.8)  8 (4.3) 18 (3.6)   
Unknown 2 (0.3)  1 (0.5) 1 (0.2)   
Service Period     24.77 <.001 
Persian Gulf 317 (45.9)  112 (60.9) 205 (40.5)   
Post-Vietnam 154 (22.3)  29 (15.8) 125 (24.7)   
Vietnam Era 187 (27.1)  34 (18.5) 153 (30.2)   
WWII-Post Korea 21 (3.0)  7 (3.8) 14 (2.8)   
Other 11 (1.6)  2 (1.1) 9 (1.8)   
SCD Rating     4.38 .11 
50-100% 261 (37.8)  78 (42.4) 183 (36.2)   
<50% 125 (18.1)  37 (20.1) 88 (17.4)   
No SCD Rating 304 (44.1)  69 (37.5) 235 (46.4)   
Lives in County w VA 323 (46.8)  69 (37.5) 254 (50.2) 8.74 .003 
Number of Comorbidities     163.36 <.001 
Zero 288 (41.7)  150 (81.5) 138 (27.3)   
One 295 (42.8)  14 (7.6) 156 (32.8)   
Two 125 (18.1)  10 (5.4) 115 (22.7)   
Three or more 107 (15.5)  10 (5.4) 97 (19.2)   
Repeat Attempt (6 mo.) 2 38 (5.5)  7 (3.8) 31 (6.1) 1.40 .24 
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 Of the patients who were admitted to VA for the index hospitalization, patients were 
divided into two groups: those who reattempted suicide within six months of discharge from the 
index hospitalization—the “reattempt group—and those who did not experience a suicide attempt 
within six months: “no reattempt group”. Two patient deaths occurred in the no-reattempt group 
and two deaths occurred in the reattempt group. The two deaths in the no-reattempt group were 
due to natural causes. They occurred at 79 and 130 days after discharge from the index 
hospitalization. Because these two patients did not survive the entire 6-month observation period, 
they were excluded from the final analysis. The two patients in the reattempt group experienced 
deaths as a results of their suicide attempts at days 21 and 178 after discharge. For these patients, 
the observation period was truncated at the time of reattempt. Therefore, these two patients 
remained in the reattempt group for analysis.  
Tables 4.3 - 4.6 describe the demographics, clinical characteristics, index admission 
factors and past utilization patterns for the sample known to not reattempt (n = 473) and those 
who did reattempt (n = 31). Single Sample Chi-Square tests determined whether the proportion of 
nominal variables in the group that did not experience a suicide attempt was equivalent to the 
expected proportions. Expected proportions were derived from those in the no-reattempt cohort. 
Mann-Whitney tests were used to determine differences in continuous variables between the two 
groups.  
Demographic Characteristics 
Summaries of the demographic characteristics of the sample known to not reattempt (n = 
473) and those who did reattempt (n = 31) are displayed in Table 4.3. The sample (N = 504) was 
predominantly comprised of white (82%) males (91%), with a median age of approximately 50 
years at the time of the index suicide attempt, IQR = 38.2 - 57.6. A large proportion were 
divorced or separated (49%) and served in military during the Persian Gulf era (41%). Half of the 
sample resided in a county with a VA facility (50%). Service-connected disability ratings were 
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determined for 271 cases (54%); of these 183 (36% of the sample) had service-connected 
disability ratings of 50-100%. For 282 (56%) of the cases, the index attempt was the first 
recorded suicide attempt. There were no statistically significant differences between the no-
reattempt group and the 6-month reattempt group in terms of any of these characteristics.  
Table 4.3 
 
Description of Demographic Characteristics for Patients Hospitalized at VA for a Suicide 
Attempt 
 
 
All Patients 
N = 504 
 No Reattempt 
n = 473 
Six-Month 
Reattempt 
n = 31 
  
Demographic 
Characteristic 
Median 
(IQR, min, max)  
Median 
(IQR, min, max) 
Median 
(IQR, min, max) z p 
Age (years) 50.1 (38.1-56.0)  
50.1 
(38.8-56.9) 
50.4 
(34.6-56.0) -0.54 .590 
 n (%)  n (%) n (%) χ2  p 
Gender (male) 456 (90.5)  428 (90.5) 28 (90.3) 0.00 .976 
Race (white) 414 (82.1)  390 (82.5) 24 (77.4) 1.32 .517 
Marital Status     0.95 a .917 
Divorced/Separated 247 (49.0)  232 (49.0) 15 (48.4)   
Married 145 (28.8)  137 (29.0) 8 (25.8)   
Never Married 93 (18.4)  87 (18.3) 6 (19.4)   
Widowed 18 (3.6)  16 (3.4) 2 (6.5)   
Unknown 1 (0.2)  1 (0.2) 0 (0.0)   
Service Period     3.30 a .509 
Persian Gulf 205 (40.5)  188 (39.6) 17 (54.8)   
Post-Vietnam 125 (24.7)  119 (25.1) 6 (19.4)   
Vietnam Era 152 (30.2)  145 (30.7) 7 (22.6)   
WWII-Post Korea 13 (2.6)  12 (2.5) 1 (3.2)   
Other 9 (1.8)  9 (1.9) 0 (0.0)   
SCD Rating     0.25 b .882 
50-100% 183 (36.2)  173 (36.4) 10 (32.3)   
<50% 88 (17.4)  82 (17.3) 6 (19.4)   
No SCD Rating 233 (46.2)  218 (46.1) 15 (48.4)   
Lives in County w VA 253 (50.2)  234 (49.5) 19 (61.3) 1.63 .202 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum; SCD = Service Connected 
Disability.  
a df = 4 c df = 2 
 
Clinical Characteristics 
Summaries of various clinical characteristics are shown in table 4.4. Each patient in the 
cohort has one primary diagnosis that was determined during the index hospital admission. In 
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addition, some patients carried a secondary diagnosis of a substance use disorder or post-
traumatic stress disorder (PTSD), which was also determined during the index hospital admission. 
A primary diagnosis of major depressive disorder was identified during the index hospitalization 
in 29% of all patients. Depressive disorders other than major depressive disorder comprised 9% 
of the primary diagnoses in the cohort.  Primary alcohol disorders and drug disorders comprised 
the second and third most prevalent diagnoses in the cohort (17% and 14% respectively). A 
secondary diagnosis of a substance use disorder (in cases where the primary diagnosis was not an 
alcohol or drug disorder) was determined in 37% of the cohort. A primary diagnosis of post-
traumatic stress disorder (PTSD) was determined for 8% of the cohort. A secondary diagnosis of 
PTSD (in cases where the primary disorder was not PTSD) was determined for 22% of the 
cohort. Diagnoses associated with severe mental illnesses, such as bipolar disorder and 
schizophrenia, were determined in 10% and 5% (respectively) of the cases in this cohort.  
Psychotic disorders other than schizophrenia comprised 0.4% of the primary diagnoses in the 
cohort. Adjustment disorders, anxiety disorders, personality disorders and dementia comprised 
6%, 0.2%, 0.4% and 0.8% of the primary diagnoses in the cohort, respectively.   
Medical comorbidities were determined from ICD-9-CM codes listed during the index 
hospitalization and from VA hospitalizations that occurred in the two years prior to the index 
admission. Patients experienced a median of one medical comorbidity (IQR = 0-2). When 
described as a categorical variable, patients with zero medical comorbidities comprised 27% of 
the cohort. Patients with one medical comorbidity comprised 31% of the cohort. Patients with two 
medical comorbidities comprised 23% of the cohort. Patients with three or more comorbidities 
comprised 19% of the cohort.   
When comparing the reattempt cohort with the cohort that did not experience a suicide 
reattempt, there were statistically significant differences in proportions of four diagnostic 
categories. The proportion of personality disorder diagnosis in the reattempt group was larger, 
compared to the no-reattempt group (3% vs. 0.2% respectively). The proportions of other 
 84 
psychoses, dementia, and anxiety disorders were higher in the no-reattempt group (0.4%, 0.8% 
and 0.2% respectively), when compared to the group who experienced a suicide reattempt where 
no cases were detected with these diagnoses. There were no differences between the reattempt 
groups in the proportions of patients in each comorbidity category.  
Table 4.4 
 
Description of the Clinical Characteristics for Patients Hospitalized at VA for a Suicide Attempt 
 
 All Patients 
N = 504 
 No Reattempt 
n = 473 
Six-Month 
Reattempt 
n = 31 
  
Clinical Characteristic n (%)  n (%) n (%) χ2  p 
History of Attempts (yes) 223 (44.2)  208 (44.0) 15 (48.4) 0.23 .632 
Alcohol Disorder 85 (16.8)  79 (16.6) 6 (19.4) 0.17 .680 
Drug Disorder 72 (14.2)  66 (13.9) 6 (19.4) 0.77 .380 
PTSD 41 (8.1)  40 (8.4) 1 (3.2) 1.08 .299 
Adjustment Disorder 32 (6.3)  32 (6.7) 0 (0.0) 0.55 .458 
Bipolar Disorder 50 (9.9)  49 (10.3) 1 (3.2) 1.68 .195 
Major Depressive Disorder 147 (29.1)  138 (29.1) 9 (29.0) 0.00 .993 
Other Depressive Disorder 43 (8.5)  38 (8.0) 5 (16.1) 2.44 .171 
Personality Disorder 2 (0.4)  1 (0.2) 1 (3.2) 14.22 <.001 
Schizophrenia 25 (4.9)  23 (4.8) 2 (6.5) 0.19 .667 
Other Psychosis 2 (0.4)  2 (0.4) 0 (0.0) 5.69 .015 
Dementia 4 (0.8)  4 (0.8) 0 (0.0) 13.18 <.001 
Anxiety Disorder 1 (0.2)  1 (0.2) 0 (0.0) 13.72 <.001 
Secondary SUD 185 (36.7)  178 (37.6) 7 (22.6) 2.84 .092 
Secondary PTSD 110 (21.7)  103 (21.7) 7 (22.6) 0.01 .915 
Number of Comorbidities     5.38 a .146 
Zero 138 (27.3)  124 (26.1) 14 (45.2)   
One 155 (30.8)  147 (31.1) 8 (25.8)   
Two 115 (22.7)  110 (23.2) 5 (16.1)   
Three or more 96 (19.0)  92 (19.5) 4 (12.9)   
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum; PTSD = Post Traumatic Stress 
Disorder; SUD = Substance Use Disorder.  
a df = 3.  
 
Prior Utilization Patterns 
Summaries of past healthcare utilization are described in Table 4.5. Healthcare utilization 
prior to the index attempt was determined by measuring the days between the index hospital 
admission and the discharge date of the last VA inpatient hospitalization (medical and 
psychiatric), and the date of the last outpatient visit (behavioral health and primary care). There 
were no statistically significant differences, between the reattempt groups, in the days since last 
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outpatient behavioral health visit, outpatient primary care visit or discharge from a medical 
hospitalization. Veterans in the reattempt group experienced more recent psychiatric 
hospitalizations, when compared to the no-reattempt group (median days since discharge were 
234 days and 730 days, respectively). There were no statistically significant differences between 
the proportions of patients with a primary care or a behavioral health visits in the 30 days prior to 
the index hospital admission, between the no-reattempt and the reattempt groups.  
Table 4.5 
 
Description of Healthcare Utilization prior to the Index Hospitalization 
 
 
All Patients 
N = 504 
 No Reattempt 
n = 473 
Six-Month 
Reattempt 
n = 31 
  
Prior Health Care 
Utilization 
Median 
 (IQR, min, max) 
 Median  
(IQR, min, max) 
Median 
(IQR, min, max) 
z p 
BH Appointment a  44.5 (9-356, 0,730)  
45.0 
(10-362, 0,730) 
44.0 
(6.0-265.0, 0,730) -0.75 .456 
PCC Appointment a  147.0 (49-567, 0,730)  
144.0 
(51-534, 0,730) 
223.0 
(31.0-730.0, 6,730) -0.49 .624 
Psychiatric 
Admission b  
730.0 
(275-730, 0,730)  
730.0 
(327-730, 0,730) 
234.0 
(54-730, 2,730) -3.45 .001 
Medical Admission b 730.0 (730-730, 0,730)  
730.0 
(730-730, 0,730) 
730.0 
(672-730, 40,730) -0.27 .786 
 n (%)  
n 
(%) 
n 
(%) χ
2  p 
Thirty Days since last 
BH Appt c 
208 
(41.3)  
195 
(41.2) 
13 
(41.9) 1.57
a .667 
Thirty Days since last 
PCC appt c 
88 
(17.5)  
81 
(17.1) 
7 
(22.6) 2.34
a .504 
Note. Observation period for prior utilization = 730 days; IQR = Interquartile Range; Min = Minimum; 
Max = Maximum; BH = Behavioral Health; PCC = Primary Care Clinic 
a Days between last outpatient appointment and admission date of index hospitalization. b Days between 
discharge from prior hospitalization and admission date of index hospitalization. c Proportion of patients 
who attended an appointment in the thirty days prior to the admission date of the index hospitalization 
 
Index Hospitalization Factors 
Summaries of factors pertaining to the index admission are described in Table 4.6. 
During the index hospital admission, 70% of all of the patients were admitted to and discharged 
from a psychiatric unit, 8% were admitted to and discharged from a medical unit, and 23% 
experienced a transfer between a medical unit and psychiatric unit during their index hospital 
admission. Forty patients (8%) were transferred from their “home” VA site, to another VISN 9 
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VA facility for admission. The overall median inpatient length of stay was 6 days (IQR=3-9). 
Behavioral health consults were initiated for 25% of patients. The majority of patients (95%) had 
an active High Risk Flag upon discharge from the index hospital admission. There were no 
statistically significant differences between the no-reattempt group and the 6-month reattempt 
group related to these factors.  
Table 4.6  
 
Description of Factors Related to the Index Hospitalization 
 
 
All Patients 
N = 504 
 No Reattempt 
n = 473 
Six-Month 
Reattempt 
n = 31 
  
Index Admission 
Median 
 (IQR, min, max) 
 Median  
(IQR, min, max) 
Median 
(IQR, min, max) 
z p 
Length of Stay 
(days) 
5.5 
(3-9, 0,301)  
5.0 
(3-9, 0,301) 
6.0 
(4-11, 0,24) -0.72 .471 
 n (%) 
 n 
(%) 
n 
(%) 
χ2  p 
Site Transfer 40 (7.9)  
35 
(7.4) 
5 
(16.1) 3.03
a .082 
High Risk Flag 
Activation  
480 
(95.2)  
450 
(95.1) 
30 
(96.8) 0.17
a .678 
Consult Initiation 126 (25.0)  
118 
(24.9) 
8 
(25.8) 0.01
a .915 
Medical 
Admission 
38 
(7.5)  
37 
(7.8) 
1 
(3.2) 0.90
a .342 
Psychiatric 
Admission 
351 
(69.6)  
327 
(69.1) 
24 
(77.4) 0.95
a .331 
Med-Psych 
Transfer 
115 
(22.7)  
109 
(22.9) 
6 
(19.4) 0.22
a .639 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum.  
a df = 1  
 
 
Aim One Results 
 
Aim One of this study was to “describe the setting, provider, type, timing, duration and 
intensity of behavioral health care to veterans recently hospitalized for a suicide attempt”.  For the 
purpose of describing the post-discharge treatment delivered to patients hospitalized for a suicide 
attempt, I divided the sample into three groups: those who did not reattempt suicide in the 6 
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months after discharge (“no-reattempt group”, n = 467), those who reattempted between 8 and 30 
days after discharge (“8-30 day reattempt group”, n = 7) and those who reattempted between 31 
and 180 days after discharge (“31-180 day reattempt group”, n = 20).  
Of the patients who experienced a hospitalization for a suicide attempt (N = 504), seven 
patients did not attend any appointments during the six-month post-discharge observation period. 
Six of these patients were in the group that did not experience a suicide reattempt. One patient 
who experienced a suicide reattempt between days 8-30 did not attend any post-discharge 
appointments.  The reported results from Aim One included only those patients who attended any 
treatment in the six months after hospital discharge.  
In order to conduct accurate comparisons between patients who did not reattempt suicide, 
and patients who reattempted suicide in the six months after discharge, analysis was limited to the 
behavioral health treatments delivered during two time intervals: seven days post-discharge and 
thirty days post discharge. This adjustment accommodated the varying observation periods 
experienced by the patients who reattempted suicide after discharge and allowed for comparison 
during the interval that all patients had an equal opportunity to attend appointments. In light of 
this adjustment, patients who reattempted between zero and seven days after discharge (n = 3) 
were not included in the description of post-discharge treatment. 
The three patient groups described in Aim One experienced equal opportunities to participate 
in treatment during the first seven days of the observation period. Therefore, descriptions related 
to the first seven days of the observation period were conducted between the no-reattempt group 
and the 8-30 day reattempt group, as well as the no-reattempt group and the 31-180 day reattempt 
group. Statistical comparisons related to the first thirty days of treatment will be limited to the no-
reattempt group and the 31-180 day reattempt group. The 8-30 day reattempt group will not be 
included in the thirty-day comparisons, since the observation period for this group is truncated 
when the reattempt occurs. As a result, patients in this group experienced unequal opportunity for 
participation in care and cannot be accurately compared to the no-reattempt group. Due to the 
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relatively small size of the 8-30 day reattempt group (n = 7), no statistical comparisons with this 
group were generated as part of this analysis.  
Duration, Timing, and Intensity of Behavioral Health Appointments 
 
Descriptions of timing and intensity are limited to the first seven and first thirty days of the 
six-month interval after hospital discharge. Timing is described as the median number of days to 
the first appointment in each treatment category. Intensity is described as (1) the proportion of 
those who participated in any behavioral health appointment, in the first seven days and in the 
first thirty days post discharge from the index hospitalization and (2) as the median number of 
appointments attended in the first seven and the first thirty days after discharge. Descriptions of 
settings, modalities, and providers of treatment were limited to the appointments attended in the 
first seven and first thirty days after discharge.  
  Duration. The duration of behavioral health care is described by the number of days 
between the first and last behavioral health appointments during the observation period. Patients 
in the no-reattempt cohort participated in behavioral health care for a median of 137 days during 
the 180-day observation period, IQR = 95-161. Duration was only described for the no-reattempt 
group since all patients in this group were observed for six months after discharge.   
Timing. Timing of the initial behavioral health appointment after discharge for the index 
suicide attempt was described as the number of days between the index hospital discharge and the 
first outpatient behavioral health appointment.  The median number of days between discharge 
and the first behavioral health appointment for patients in the 31-180 day reattempt group was 
zero days, IQR = 0-2, Min = 0, Max = 9. This was two days less than that for patients in the no-
reattempt group, z = 2.85, p = .004, for whom the median time to the first appointment was two 
days, IQR = 0-6, Min = 0, Max = 136. Appointments reported on day zero reflect an appointment 
attended less than 24 hours of hospital discharge. The median time to the first behavioral health 
appointment, for patients in the 8-30 day reattempt group, was five days, IQR = 0-8, Min = 0, 
Max = 20.  
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  Intensity. One approach to describing the intensity of care is the median number of 
appointments completed during a fixed time interval, such as the first seven days and first thirty 
days after discharge. As seen in table 4.7, the median number of appointments attended by 
patients who did not reattempt suicide was 2 appointments in the first week of discharge and 6 
appointments in the first 30 days after discharge. A statistically significant difference in the 
median number of appointments attended in the first thirty days after hospital discharge was 
noted between patients in the no-reattempt group and the 31-180 day reattempt group.  There 
were no statistically significant differences found in the median number of appointments attended 
in the first 7 days after discharge between these groups. The median number of appointments 
attended in the first seven days after discharge, by patients in the 8-30 day reattempt group, was 
one appointment, IQR = 1-3, Min = 1, Max = 4. Due to the relatively small size of this group 
(N=7), no comparisons were generated as part of this analysis.  
Table 4.7 
 
Comparison of Appointments Attended in the First Seven and the First Thirty Days after Hospital 
Discharge 
 
 
No-Reattempt 
n = 467 
31-180 day Reattempt 
n = 20   
Number of Appointments Median (IQR, min, max) Median (IQR, min, max) z p 
First Seven Days  2 (1-3, 1,46) 3 (2-5, 1,7) -1.83 .067 
First Thirty Days 6 (4-9, 1,197) 8 (5-13, 1,86) -2.18 .029 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum. 
 
Table 4.8 
  
Proportion of Patients who Attended Behavioral Health Appointments in the First Seven and 
First Thirty Days after Hospital Discharge 
 
  No-Reattempt 
N=467 
 8-30 day Reattempt 
N=7 
 31-180 day Reattempt  
N=20 
  n (%)  n (%)  n (%) 
Any Seven-Day Appointment  396 (84.8)  5 (71.4)  19 (95.0) 
Any Thirty Day Appointment  449 (96.1)  --  20 (100.0) 
Four or More Appointments  
in Thirty Days 
 341 (73.0)  --  18 (90.0) 
Note. Proportions for thirty-day appointment attendance were not calculated for the 8-30 day reattempt 
group.  
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 Table 4.8 describes the proportion of patients who attended behavioral health 
appointments during specific intervals after discharge from the index hospitalization. These 
intervals reflect VA recommendations for clinical care of veterans recently hospitalized for a 
suicide attempt.  
Providers of Behavioral Health Treatments 
Table 4.9 describes the median number of providers delivering behavioral health 
appointments to two patient groups: those who did not reattempt suicide (n = 473), and those who 
reattempted in days 31-180 (n = 20). These results reflect only the patients who participated in 
treatment during the seven-day and thirty-day interval after hospital discharge. There were no 
statistically significant differences found in the median number of providers delivering treatment 
between the no-reattempt group and the 31-180 reattempt group.  
Patients who reattempted suicide in 8-30 days after discharge, and received treatment in 
the first seven days (n = 7), were treated by a median of one provider during this interval, IQR = 
1-2, Min = 1, Max = 2.  
Table 4.9 
 
Comparison of the Number of Treating Providers, per Patient, in the First Seven and First Thirty 
Days after Discharge 
 
 
No-Reattempt 
n = 467 
31-180 day Reattempt 
n = 20   
Provider Count Median (IQR, min, max) Median (IQR, min, max) z p 
Seven Day 2 (1-3, 1,11) 2 (2-3, 1,5) -1.54 .123 
Thirty Day 3 (2-5, 1,16) 3 (3-5, 1,9) -0.19 .851 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum. 
 
Timing and Intensity of Treatment by Type, Modality, and Setting 
In the following sections, I will describe the timing and intensity of care according to the 
type, the modality, and the setting of treatment. As in the previous sections, these descriptions 
will be limited to the first seven and first thirty days after discharge, for the no-reattempt, the 8-30 
day reattempt, and the 31-180 day reattempt groups. Statistical comparisons were limited to the 
no-reattempt group and the 31-180 day reattempt group.  
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Treatment Type. This section will describe the timing and intensity of care delivered to 
three patient groups: those who did not experience a suicide reattempt, those who reattempted in 
8-30 days and those who reattempted in 31-180 days. In this section, the type of treatment is the 
focus of description. In the present study, treatment is categorized into seven types: Mental 
Health, Suicide Prevention, Substance Use, Psychology, PTSD, Homeless Care, and Vocational 
Treatment. Treatment type categories are informed by VA clinic stop codes, which are assigned 
to clinics based upon the procedures performed in the clinics or the clinical population that is the 
focus of treatment (e.g. PTSD or Substance Use Treatments). Treatment category assignments are 
mutually exclusive.  
Table 4.10 describes the number of median days to first appointment, by treatment type, 
for the no-reattempt group and the 31-180 day reattempt group. Any appointment that occurs in 
zero days reflects an appointment that occurred on the day of hospital discharge. For patients in 
the 8-30 day reattempt group, the median time to the first Mental Health appointment was five 
days, IQR = 2-13, Min = 0, Max = 20. Suicide Prevention appointments were completed by two 
patients in the 8-30 day reattempt group, on day seven and on day eight, respectively. One patient 
in this group attended a Substance Use appointment one day after discharge, and one patient 
attended a Homeless Care appointment on the day of hospital discharge. There are no results to 
report for Psychology, PTSD, or Vocational treatment types in the 8-30 day reattempt group, 
because no patient in this group participated in these treatments. Due to the small number of 
patients in the 8-30 day reattempt group I did not provide conclusions about statistically 
significant differences between these two groups.  
As shown in Table 4.10, statistically significant differences in the number of median days 
to the first Mental Health and Suicide Prevention appointments were found between the no-
reattempt group and the 31-180 day reattempt group. For Mental Health appointments, median 
time from discharge to first appointment was one day for the 31-180 day reattempt group, 
compared to five days for the no-reattempt group. Median time to the first Suicide Prevention 
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appointment was approximately six days for the 31-180 day reattempt group, and eight days for 
the no-reattempt group. In both of these treatment types, patients in the 31-180 reattempt group 
are participating in Mental Health and Suicide Prevention care sooner, when compared to the no-
reattempt group. There were no statistically significant differences in the median days to 
Substance Use, Psychology, PTSD, Homeless Care or Vocational treatments, when comparing 
the no-reattempt group with the 31-180 day reattempt group.  
Table 4.10 
Comparison of Time to First Appointment, by Treatment Type 
 
 
No-Reattempt 
n = 467 
31-180 day Reattempt 
n = 20   
Treatment Type Median (IQR, min, max) Median (IQR, min, max) z p 
Mental Health 5.0 (1-12, 0,154)  1.0 (0-4, 0,80) -2.24 .025 
Suicide Prevention 8.0 (4-55, 0,167) 5.5 (0-15, 0,84) -2.04 .041 
Substance Use 10.0 (3-37, 0,162) 9.5 (1-14, 0,23) -0.92 .356b 
Psychology 20.0 (11-55, 0,142) 46.5 (21,72)a -0.92 .357b 
PTSD 19.0 (6-69, 0,159) 15.5 (3,28)a -0.65 .516b 
Homeless Care 27.0 (3-64, 0,162) 8.0 (1-128, 0-153) -0.12 .908b 
Vocational 44.5 (12-112, 0,149) 45.0 (45,45)a 0.00 1.000b 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum; PTSD = Post Traumatic Stress 
Disorder. 
a Median (Min, Max) reported due to too few cases to generate IQR. b 31-180 Reattempt group contained 
fewer than 10 cases for these comparisons.  
 
Tables 4.11 and 4.12 describe the number of patients who attended appointments, by 
treatment type, in the first 7 and first 30 days after hospital discharge.  In each table, I provided 
the number of patients who attended appointments in the 7-day or 30-day interval, as well as the 
180-day interval. This allows for proportion calculations by column, or by row.  Direct 
comparisons between patient groups were not conducted.   
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Table 4.11 
 
Frequency of Patients who Attended a Behavioral Health Appointment within Seven and 180 
Days of Discharge, by Treatment Type 
 
  No-Reattempt 
n = 467 
 8-30 day Reattempt 
n = 7 
 31-180 day Reattempt  
n = 20 
Treatment Type   7 Days 180 Days   7 Days 180 Days   7 Days 180 Days 
Mental Health  291 439  4 5  16 19 
Suicide Prevention  195 407  1 2  10 16 
Substance Use  58 137  1 1  6 6 
Psychology  11 73  0 0  2 2 
PTSD  18 57  0 0  2 2 
Homeless Care  4 91  0 1  5 5 
Vocational  6 32  0 0  1 1 
Note. PTSD = Post Traumatic Stress Disorder 
 
Table 4.12 
 
Frequency of Patients who Attended a Behavioral Health Appointment within Thirty and 180 
Days of Discharge, by Treatment Type 
 
  No-Reattempt 
n = 467 
 31-180 day Reattempt  
n = 20 
Treatment Type   30 Days 180 Days   30 Days 180 Days 
Mental Health  403 439  18 19 
Suicide Prevention  283 407  14 16 
Substance Use  96 137  6 6 
Psychology  47 73  1 2 
PTSD  34 57  2 2 
Homeless Care  39 91  3 5 
Vocational  11 32  0 1 
Note. PTSD = Post Traumatic Stress Disorder 
 
 Tables 4.13 through 4.15 describe the median number of appointments completed, by 
treatment type, in the first 7 and first 30 days of the six-month observation period. Due to the 
small number of patients in the 8-30 day reattempt group who participated in treatment (n = 7), I 
did not compare the median number of appointments completed during the seven-day post-
discharge period. The number of thirty-day appointments completed by patients in the 8-30 day 
reattempt group was not described, since these patients did not have an equal opportunity to 
complete these appointments. Comparisons related to the median number of seven-day and thirty-
day appointments between the no-reattempt group and the 31-180 day reattempt group are 
reported in tables 4.14 and 4.15.  When comparing the no-reattempt group and the 31-180 day 
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reattempt group, there were no statistically significant differences in the median number of 
appointments attended, by treatment type, in the first seven and first thirty days after hospital 
discharge.  
Table 4.13 
 
Description of the Number of Appointments Completed in the First Seven days after Hospital 
Discharge, by Treatment Type 
 
 
No-Reattempt 
n = 467 
8-30 day Reattempt 
n = 7 
Treatment Type Median (IQR, min, max) Median (IQR, min, max) 
Mental Health 1.0 (0-2, 0,13) 1.0 (1-2, 0,2) 
Suicide Prevention 0.0 (0-1, 0,6) 0.5 (0,1)a 
Substance Use 0.0 (0-1,0,46) 1.0 (1,1)a 
Psychology 0.0 (0-0, 0,1) -- 
PTSD 0.0 (0-1, 0,12) -- 
Homeless Care 0.0 (0-0, 0,1) 0.0 (0,0)a 
Vocational 0.0 (0-0, 0,2) -- 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum; PTSD = Post Traumatic Stress 
Disorder. 
a Median (Min, Max) reported due to too few cases to generate IQR. 
 
Table 4.14 
 
Comparison of the Number of Appointments Completed in the First Seven Days after Hospital 
Discharge, by Treatment Type 
 
 
No-Reattempt 
n = 467 
31-180 day Reattempt 
n = 20   
Treatment Type Median (IQR, min, max) Median (IQR, min, max) z p 
Mental Health 1.0 (0-2, 0,13) 1.0 (1-3, 0,4) -1.80 .072 
Suicide Prevention 0.0 (0-1, 0,6) 1.0 (0-3, 0,4) -1.55 .122 
Substance Use 0.0 (0-1,0,46) 0.0 (0-2, 0,6) -0.42 .676b 
Psychology 0.0 (0-0, 0,1) 0.0a (0,0) -0.59 .555b 
PTSD 0.0 (0-1, 0,12) 0.5a (0,1) -0.49 .625b 
Homeless Care 0.0 (0-0, 0,1) 0.0a (0,0) -0.48 .634b 
Vocational 0.0 (0-0, 0,2) 0.0a (0,0) -0.47 .639b 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum; PTSD = Post Traumatic Stress 
Disorder. 
a Median (Min, Max) reported due to too few cases to generate IQR. b 31-180 Reattempt group contained 
fewer than 10 cases for these comparisons.  
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Table 4.15 
 
Comparison of the Number of Appointments Completed in the First Thirty Days after Hospital 
Discharge, by Treatment Type 
 
 
No-Reattempt 
n = 467 
31-180 day Reattempt 
n = 20   
Treatment Type Median (IQR, min, max) Median (IQR, min, max) z p 
Mental Health 3.0 (1-4, 0,26) 3.0 (1-5, 0,7) -0.55 .583 
Suicide Prevention 1.0 (0-4, 0,11) 2.5 (1-6, 0,10) -1.87 .061 
Substance Use 1.0 (0-4, 0,196) 8.5 (1-39, 1,84) -1.58 .114b 
Psychology 1.0 (0-1, 0,6) 0.5 (0,1)a  -0.64 .525b 
PTSD 1.0 (0-3, 0,25)  2.0 (1,3)a  -0.67 .500b 
Homeless Care 0.0 (0-2, 0,6) 2.0 (0-3, 0,3) -1.02 .306b 
Vocational 0.0 (0-1, 0,4) 0.0 (0,0)a -0.69 .489b 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum; PTSD = Post Traumatic Stress 
Disorder. 
a Median (Min, Max) reported due to too few cases to generate IQR. b 31-180 Reattempt group contained 
fewer than 10 cases for these comparisons.  
 
Modality. This section will describe the timing and intensity of care delivered to three 
patient groups: those who did not experience a suicide reattempt, those who reattempted in 8-30 
days and those who reattempted in 31-180 days. In this section, the modality of treatment is the 
focus of description. The treatment modality describes the format of the interaction during the 
clinical appointment and is categorized as either “individual”, “group”, or “phone”. Modality 
category assignments are mutually exclusive.  
Table 4.16 describes the number of median days to first appointment, by modality in the 
no-reattempt group and the 31-180 day reattempt group. Any appointment that occurs in zero 
days reflects an appointment that occurred on the day of discharge. Patients in the 31-180 day 
reattempt group experienced individual appointments and telephone appointments earlier than 
patients in the no-reattempt group. The median time to the first individual appointment, in the 8-
30 day reattempt group, was five days, IQR = 0-8, Min = 0, Max = 20. Group appointments were 
attended by one patient in the 8-30 day reattempt group; this appointment occurred one day after 
hospital discharge. The interval between the date of hospital discharge and the first phone 
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appointment could not be described in the 8-30 day reattempt group, because no patients in the 8-
30 day reattempt group participated in any phone appointments.  
Table 4.16 
Comparison of Time to First Appointment, by Treatment Modality 
 
 
No-Reattempt 
n = 467 
31-180 day Reattempt 
n = 20   
Treatment Modality Median (IQR, min, max) Median (IQR, min, max) z p 
Individual 5.0 (1-8, 0,36) 1.0 (0-5, 0,9) -2.72 .006 
Group 11.0 (5-43, 0,177) 6.5 (1-12, 0,23) -1.85 .051 
Telephone 6.0 (1-27, 0-154) 1.5 (0-7, 0,111) -1.95 .064 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum.  
 
As shown in Table 4.18, statistically significant differences in the number of median days 
to the first individual and first group appointments were found between the no-reattempt group 
and the 31-180 day reattempt group. For individual appointments, median time from discharge to 
first appointment was one day for the 31-180 day reattempt group and five days for the no-
reattempt group. Median time to an initial phone appointment was also approximately 4 days 
sooner for the 31-180 day reattempt group than for the no-reattempt group. There were no 
statistically significant differences between the no-reattempt group and the 30-180 day reattempt 
group in the median days to the first phone appointment. 
Tables 4.17 and 4.18 describe the number of patients who received care, by modality, in 
the first 7 and first 30 days after hospital discharge.  In each table, I provided the number of 
patients who attended appointments in the 7-day or 30-day interval, as well as the 180-day 
interval. This allows for proportion calculations by column, or by row.  Direct comparisons 
between patient groups were not conducted.   
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Table 4.17 
 
Frequency of Patients who Attended a Behavioral Health Appointment within Seven and 180 
Days of Discharge, by Treatment Modality 
 
  No-Reattempt 
n = 467 
 8-30 day Reattempt 
n = 7 
 31-180 day Reattempt  
n = 20 
Treatment Modality   7 Days 180 Days   7 Days 180 Days   7 Days 180 Days 
Individual  335 459  5 7  19 20 
Group  67 169  1 1  10 16 
Telephone  200 369  0 0  13 16 
 
Table 4.18 
 
Frequency of Patients who Attended a Behavioral Health Appointment within Thirty and 180 
Days of Discharge, by Treatment Modality 
 
  No-Reattempt 
n = 467 
 31-180 day Reattempt  
n = 20 
Treatment Modality   30 Days 180 Days   30 Days 180 Days 
Individual  429 459  20 20 
Group  117 169  10 16 
Telephone  284 369  14 16 
 
Tables 4.19 and 4.20 describe the number of appointments attended by patient groups in 
the first seven days after hospital discharge. As seen in Table 4.21, comparison between patients 
in the no-reattempt group and the 31-180 day reattempt group did not result in statistically 
significant differences in the median number of individual appointments or the median number of 
group appointments completed in the first seven days after discharge. The difference in the 
median number of phone appointments completed in the first seven days was found to be 
statistically significant. It was noted that the median value is equal when comparing the no-
reattempt group with the 31-180 day reattempt group, and the interquartile ranges did not overlap.   
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Table 4.19 
 
Description of the Number of Appointments Completed in the First Seven days after Hospital 
Discharge, by Treatment Modality 
 
 
No-Reattempt 
n = 467 
8-30 day Reattempt 
n = 7 
Treatment Modality Median (IQR, min, max) Median (IQR, min, max) 
Individual 1 (0-2, 0,17) 1 (0-1, 0,4) 
Group 0 (0-1, 0, 40) 1 (1, 1)a 
Telephone 1 (0-1, 0, 5) 0 (0,0)a 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum.  
a Median (Min, Max) reported due to too few cases to generate IQR. 
 
Table 4.20 
Comparison of the Number of Appointments Completed in the First Seven Days after Hospital 
Discharge, by Treatment Modality 
 
 
No-Reattempt 
n = 467 
31-180 day Reattempt 
n = 20   
Treatment Modality Median (IQR, min, max) Median (IQR, min, max) z p 
Individual 1.0 (0-2, 0,17) 1.5 (1-2, 0,4) -1.29 .198 
Group 0.0 (0-1, 0, 40) 0.5 (0-1, 0,6) -0.29 .773 
Telephone 1.0 (0-1, 0, 5) 1.0 (1-2, 0,4) -2.07 .039 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum. 
 
The difference between the no-reattempt group and the 31-180 day reattempt group, in 
the number of phone appointments completed in the first 30 days, was found to be statistically 
significant (Table 4.21). Patients in the 31-180 day reattempt group experienced approximately 
three median phone appointments in the first 30 days, IQR = 1-6, and the no-reattempt group 
experienced one phone appointment, IQR = 1-2. There were no statistically significant 
differences between the two groups in the median individual appointments and median group 
appointments in the first thirty days after discharge.  
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Table 4.21 
 
Comparison of the Number of Appointments Completed in the First Thirty Days after Hospital 
Discharge, by Treatment Modality 
 
 
No-Reattempt 
n = 467 
31-180 day Reattempt 
n = 20   
Treatment Modality Median (IQR, min, max) Median (IQR, min, max) z p 
Individual 4.0 (2-6, 0, 56) 4.0 (3-6, 1,10) -0.71 .481 
Group 2.0 (0-4, 0,150) 2.5 (1-17, 1,75) -1.39 .166 
Telephone 1.0 (1-2, 0-10) 2.5 (1-6, 0,7) -2.33 .020 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum.  
 
 Setting. This section will describe the timing and intensity of care delivered to three 
patient groups: those who did not experience a suicide reattempt, those who reattempted in 8-30 
days and those who reattempted in 31-180 days.  In this section, the setting of treatment is the 
focus of description. In the present study, setting is categorized into three types: VA Medical 
Center, Community-Based Outpatient Clinic (CBOC), and Residential. Setting category 
assignments are mutually exclusive.  
Table 4.22 compares the number of median days to appointment, by setting, for the no-
reattempt group and the 31-180 day reattempt group. Any appointment that occurs in zero days 
reflects an appointment that occurred on the day of hospital discharge. The median time to the 
first appointment in a medical center, for patients in the 8-30 day reattempt group, was five days, 
IQR = 0-14, Min = 0, Max = 20. One patient in the 8-30 day reattempt group attended an 
appointment in a CBOC, eight days after discharge. No patient in the 8-30 day appointment group 
attended any appointment in a residential setting.   
As shown in Table 4.22, a statistically significant difference in the number of median 
days to the first appointment attended in a medical center was found between the no-reattempt 
group and the 31-180 day reattempt group. For appointments attended in a medical center, 
median time from discharge to the first appointment was zero days for the 31-180 day reattempt 
group and three days for the no reattempt group. There were no statistically significant 
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differences between the no-reattempt and the 31-180 day reattempt group in the median days to 
the first appointments attended in a CBOC or Residential setting.  
Table 4.22 
 
Comparison of Time to First Appointment, by Treatment Setting 
 
 
No-Reattempt 
n = 467 
31-180 day Reattempt 
n =20   
Treatment Setting Median (IQR, min, max) Median (IQR, min, max) z p 
Medical Center 3 (0-7, 0,167) 0 (0-3, 0,10) -2.81 .005 
CBOC 7 (4-19, 0,177) 5 (4-30, 1,124) -0.24 .808 
Residential 27 (2-85, 0,169) 17 (0,28)a -0.91 .396b 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum; CBOC = Community-Based 
Outpatient Clinic.  
a Median (Min, Max) reported due to too few cases to generate IQR. b 31-180 Reattempt group contained 
fewer than 10 cases for these comparisons.  
 
 
Tables 4.23 and 4.24 describe the number of patients who received care, by setting, in the 
first seven and first thirty days after hospital discharge.  In each table, I provided the number of 
patients who attended appointments in the seven-day or thirty-day interval, as well as the 180-day 
interval. This allows for proportion calculations by column, or by row.  Direct comparisons 
between patient groups were not conducted.   
Table 4.23 
 
Frequency of Patients who Attended a Behavioral Health Appointment within Seven and 180 
Days of Discharge, by Treatment Setting 
 
  No-Reattempt 
n = 467 
 8-30 day Reattempt 
n = 7 
 31-180 day Reattempt  
n = 20 
Treatment Setting   7 Days 180 Days   7 Days 180 Days   7 Days 180 Days 
Medical Center   348 443  5 7  18 20 
CBOC  96  175  0 1  6 10 
Residential  17 57  0 0  1  3 
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Table 4.24 
 
Frequency of Patients who Attended a Behavioral Health Appointment within Thirty and 180 
Days of Discharge, by Treatment Setting 
 
  No-Reattempt 
n = 467 
 31-180 day Reattempt  
n = 20 
Treatment Setting   30 Days 180 Days   30 Days 180 Days 
Medical Center   407 443  20 20 
CBOC  144 175  8 10 
Residential  30 57  3 3 
 
Tables 4.25 through 4.27 describe the median number of appointments completed, by 
treatment setting, in the first seven and first thirty days of the six-month post-discharge 
observation period. As seen in Table 4.26, no statistically significant differences were found 
between the no-reattempt group and the 31-180 day reattempt group in the median number of 
appointments attended in each setting within seven days after discharge. There were no 
statistically significant differences in the number of thirty-day appointments attended in a medical 
center, CBOC or residential setting between the no-reattempt group and the 31-180 reattempt 
group.  
Table 4.25 
 
Description of the Number of Appointments Completed in the First Seven days after Hospital 
Discharge, by Treatment Setting 
 
 
No-Reattempt 
n = 467 
8-30 day Reattempt 
n = 7 
Treatment Setting Median (IQR, min, max) Median (IQR, min, max) 
Medical Center 2 (1-3, 0,26) 1 (0-2, 0,4) 
CBOC 1 (0-1, 0,4) 0 (0,0) a 
Residential 0 (0-1, 0,45) -- 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum; CBOC = Community-Based 
Outpatient Clinic.  
a Median (Min, Max) reported due to too few cases to generate IQR. 
 
 102 
 
Table 4.26 
 
Comparison of the Number of Appointments Completed in the First Seven Days after Hospital 
Discharge, by Treatment Setting 
 
 
No-Reattempt 
n = 467 
31-180 day Reattempt 
n = 20   
Treatment Setting Median (IQR, min, max) Median (IQR, min, max) z p 
Medical Center 2 (1-3, 0,26) 2 (1-4, 0,7) -1.20 .230 
CBOC 1 (0-1, 0,4) 1 (0-1, 0,3) -0.24 .812 
Residential 0 (0-1, 0,45) 0 (0,0)b -0.15 a .883a 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum; CBOC = Community-Based 
Outpatient Clinic.  
a 31-180 Reattempt group contained fewer than 10 cases for these comparisons. b Median (Min, Max) 
reported due to too few cases to generate IQR. 
 
Table 4.27 
 
Comparison of the Number of Appointments Completed in the First Thirty Days after Hospital 
Discharge, by Treatment Setting 
 
 
No-Reattempt 
n = 467 
31-180 day Reattempt 
n = 20   
Treatment Setting Median (IQR, min, max) Median (IQR, min, max) z p 
Medical Center 4 (2-8, 0,54) 5.5 (2-9, 1,20) -0.81 .420 
CBOC 2 (1-4, 0,10) 2.0 (1-5, 0,8) -0.04 .971 
Residential 1 (0-4, 0,195) 22.0 (3,79)b -2.00a .056a 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum; CBOC = Community-Based 
Outpatient Clinic.  
a 31-180 Reattempt group contained fewer than 10 cases for these comparisons. b Median (Min, Max) 
reported due to too few cases to generate IQR. 
 
In summary, statistically significant differences were found between the no-reattempt 
group and the 31-180 day reattempt group in the timing and intensity of behavioral health 
treatment. The interval between hospital discharge and the first behavioral health appointment 
was shorter for patients in the 31-180 day reattempt group, when compared to the no-reattempt 
group. The intensity of treatment in the first thirty days after hospital discharge was greater for 
patients in 31-180 day reattempt group, as evidenced by attending a greater number of 
appointments during this interval, compared to patients in the no-reattempt group. When 
specifying the setting, modality or type of treatment, patients in the 31-180 day reattempt group 
attended medical center, group, individual, mental health and suicide prevention appointments 
earlier than patients in the no-reattempt group. When examining the first thirty days after 
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discharge, the median number of telephone appointments in the 31-180 day reattempt group, 
compared to the no-reattempt group.  
 
Aim Two Results 
 
Aim Two of this study was to “describe associations between factors related to patient 
characteristics, prior health utilization, index admission and the timing of post-discharge 
behavioral health care”.  The analysis for Aim Two determined whether patient demographics, 
clinical characteristics, prior health utilization, and factors relevant to the inpatient hospitalization 
were associated with the number of days between inpatient discharge and attendance of the first 
behavioral health appointment. These analyses included only patients who participated in 
treatment after discharge (n = 496).  
The completion of the first specialty mental health appointment was measured in days, 
from the date of discharge, to the date of the first completed behavioral health appointment.  The 
number of days to the first behavioral health appointment was not evenly distributed. Therefore, a 
Mann-Whitney test was used to determine differences between dichotomous groups. In 
comparing categorical variables, a Kruskal-Wallis test was used to determine if there are 
differences in days to appointment among categories in the variable. Finally, to compare 
continuous variables to the number of days until the first appointment, a Spearman’s rank 
correlation was used.  
Tables 4.28 and 4.29 summarize the number of days to first behavioral health 
appointment and patient demographic and clinical characteristics. The variable for race contains a 
category of 16 missing values. The statistics shown in the table reflect a comparison among all 
three groups via Kruskal-Wallis test. I also conducted a Mann-Whitney test, omitting the 
“missing” cases. There was no statistically significant difference in the number of days to first 
behavioral health appointment between white and non-white patients (z = -1.77, p = .077).  
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Table 4.28 
Associations Between Patient Demographic Characteristics and the Time to First Completed 
Post-Discharge Behavioral Health Appointment (N=496) 
 
Patient Demographic Characteristic  Time to First Behavioral Health Appointment (Days) 
   rs df p 
Age    0.02  .704 
 n (%)  Median (IQR, min, max) χ2   p 
Gender    1.68 1 .195 
Male 449 (90.5)  2.0 (0-6, 0,136)    
Female 47 (9.5)  3.0 (1-6, 0,65)    
Race     3.10 2 .212 
White 408 (82.3)  2.0 (0-6, 0,136)    
Non-white 72 (14.5)  1.0 (0-5, 0,99)    
Missing 16 (3.2)  2.0 (0-11, 0,38)    
Marital Status    3.11 4 .539 
Divorced/Separated 243 (49.0)  2.0 (0-6, 0,136)    
Married 142 (28.6)  2.5 (0-5, 0,97)    
Never Married 92 (18.5)  2.0 (0-6, 0,98)    
Widowed 18 (3.6)  1.0 (0-4, 0,61)    
Unknown 1 (0.2)  6.0 (6,6)a    
Service Period    4.25 4 .373 
Persian Gulf 201 (40.5)  2.0 (0-6, 0,136)    
Post-Vietnam 122 (24.6)  1.0 (0-5, 0,199)    
Vietnam Era 152 (30.6)  3.0 (0-6, 0,135)    
WWII-Post Korea 13 (2.6)  2.0 (0-8, 0,91)    
Other 8 (1.6)  4.5 (0-11, 0,11)    
SCD Rating    0.98 2 .614 
50-100% 180 (36.3)  2.0 (0-5, 0,65)    
<50% 86 (17.3)  2.0 (0-5, 0,100)    
No SCD Rating 230 (46.4)  2.0 (0-6, 0,136)    
    z  p 
Lives in County w VA    -0.31  .756 
Yes 249 (49.8)  2.0 (0-6, 0,99)    
No 247 (50.2)  2.0 (0-6, 0,136)    
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum; SCD = Service Connected 
Disability.  
a Median (Min, Max) reported due to too few cases to generate IQR. 
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Table 4.29 
 
Associations Between Patient Clinical Characteristics and the Time to First Completed Post-
Discharge Behavioral Health Appointment (N=496) 
 
    Time to First Behavioral Health Appointment (Days) 
  n (%)  Median (IQR, Min,Max) z  p 
History of Attempts      -1.16  .247 
Yes  219 (44.2)  3.0 (0-6, 0,99)    
No  277 (55.8)  2.0 (0-6, 0,136)    
Secondary SUD     -0.93  .351 
Yes  181 (36.5)  3.0 (0-5, 0,136)    
No  315 (63.5)  2.0 (0-6, 0,135)    
Secondary PTSD     -0.98  .328 
Yes  105 (21.2)  2.0 (0-5, 0,99)    
No  391 (78.8)  2.0 (0-6, 0,136)    
     χ2  df p 
Primary Diagnosis     10.47  11 .488 
Alcohol Disorder  84 (16.9)  1.0 (0-6, 0,135)    
Drug Disorder  71 (14.3)  2.0 (0-7, 0,62)    
PTSD  41 (8.3)  2.0 (0-7, 0,136)    
Adjustment Disorder  32 (6.5)  1.0 (0-5, 0,100)    
Bipolar Disorder  50 (10.1)  4.0(0-6, 0,98)    
Major Depressive Disorder  144 (29.0)  3.0 (0-6, 0,99)    
Other Depressive Disorder  41 (8.3)  2.0 (0-6, 0,91)    
Personality Disorder  2 (0.4)  0.5 (0,1)    
Schizophrenia  24 (4.8)  1.5 (0-5, 0,15)    
Other Psychosis  2 (0.4)  3.0 (2,4)    
Dementia  4 (0.8)  3.5 (1-7, 0,8)    
Anxiety Disorder  1 (0.2)  0.0 (0,0)a    
Number of Comorbidities     2.38 3 .497 
Zero  135 (27.2)  2.0 (0-5, 0,97)    
One  152 (30.6)  3.0 (0-6, 0,136)    
Two  113 (22.8)  2.0 (0-6, 0,135)    
Three or more  96 (19.4)  2.0 (0-6, 0,99)    
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum; SUD = Substance Use Disorder; 
PTSD = Post-Traumatic Stress Disorder. 
a Median (Min, Max) reported due to too few cases to generate IQR. 
 
As seen in Table 4.30, a statistically significant correlation was determined between the 
number of days since the last behavioral health appointment, prior to the index admission, and the 
number of days to the first post-discharge appointment. The direction of the coefficient indicates 
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a positive correlation between these two variables. However, the strength of the coefficient is 
weak (0.13).  
Table 4.30 
 
Associations Between Prior Healthcare Utilization and the Time to First Completed Post-
Discharge Behavioral Health Appointment (N = 496) 
 
 Time to First Behavioral Health Appointment (Days) 
Interval between index hospital admission and last:  Median (IQR, min,max) rs p 
Behavioral Health Appointment 44 (8-343, 0,730) 0.13 .004 
Primary Care Appointment 143 (48-512, 0-730) 0.09 .087 
Psychiatric Hospitalization 730 (275-730, 0,730) 0.06 .169 
Medical Hospitalization 730 (730-730, 0,730) -0.04 .405 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum. 
Table 4.31  
 
Associations between Factors Related to Hospitalization and the Median Time to First  
Completed Post-Discharge Behavioral Health Appointment (N = 496) 
 
  Time to First Behavioral Health Appointment (Days) 
  Yes  No    
Hospitalization 
Factors   
n 
(%) 
Median 
(IQR, min, max)  
n 
(%) 
Median 
(IQR, min, max) 
 
 
 z p 
Site Transfer   39  (7.9) 
1.0  
(0-3, 0,8) 
 457  
(92.1) 
2.0  
(0-6, 0,136) 
 -2.17 .030 
Consult Initiation   125 (25.2) 
2.0  
(0-7, 0,135) 
 371  
(74.8) 
2.0  
(0-6, 0,136) 
 -1.21 .226 
High Risk Flag 
Activation  
 475 
(95.8) 
2.0   
(0-6, 0,136) 
 21  
(4.2) 
1.0   
(0-5, 0,13) 
 -1.01 .311 
Psychiatric 
Admission 
 346 
(69.8) 
2.0  
(0-6, 0,136) 
 150  
(30.2) 
3.0  
(0-6, 0,98) 
 -0.93 .354a 
Medical 
Admission 
 37  
(7.5) 
6.0  
(1-10, 0,98) 
 459  
(92.5) 
2.0  
(0-6, 0,136) 
 -2.67 .008a 
Med-Psych 
Transfer 
 113 
(22.8) 
2.0  
(0-5, 0,91) 
 383  
(77.2) 
2.0  
(0-6, 0,136) 
 -0.66 .511a 
Note. IQR = Interquartile Range; Min = Minimum; Max = Maximum.  
a Adjusted α = .017 for post-hoc comparisons among admit types Χ2(2) = 7.19, p = .027. 
 
As seen in Table 4.31, the two statistically significant associations related to factors 
relevant to the inpatient hospitalization were associated with the location of inpatient admission. 
First, the median time to first behavioral health appointment for patients hospitalized at a 
different inpatient site than the patients “home” site was shorter compared to those who did not 
experience a facility transfer.  For the 457 patients who did not experience a facility transfer, the 
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median number of days was two (IQR = 0-6); for those who did experience a facility change (n = 
39), the median number of days to first appointment was one (IQR = 0-3). Second, patients who 
experienced the entirety of their inpatient admission on a medical unit demonstrated a longer 
median time to the first post-discharge appointment.  For patients with a medical admissions (n = 
37), the median time to the first post-discharge appointment was 6 days (IQR = 1-10). Those who 
experienced a psychiatric admission (n = 348) and those who experienced a transfer between a 
medical and psychiatric unit (n = 113) attended the first behavioral health appointment in a 
median time of two days after discharge.  
To compare median days to first appointment among admit types, I first conducted a 
Kruskal-Wallis analysis with all three admit groups. This analysis revealed statistically significant 
differences among the three groups, X2 (2) = 7.19, p = .027. I dummy coded each admit type and 
ran a post-hoc Mann-Whitney on each dummy coded admit variable. These results are reflected 
in Table 4.31. The difference in median days to first post-discharge appointment between those 
who were medically admitted compared to those who were not was statistically significant, even 
after adjusting the alpha (.017) to accommodate three post-hoc comparisons, z = -2.65, p = .008.  
The median length of inpatient stay for patients who received outpatient treatment (n = 
496) was five days, IQR = 3-9. Length of stay was not associated with the number of days 
between discharge and the first behavioral health appointment, rs = -0.20, p = .660.  
In summary, statistically significant associations with the timing of the first post-
discharge behavioral health appointment were related to prior health care utilization and factors 
related to the hospital admission. Although I determined a statistically significant association 
between prior behavioral health utilization and the days to the first post-discharge appointment, 
this association was very weak. Factors related to site transfer and medical admissions were 
associated with the timing of post-discharge care.   
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CHAPTER V 
 
DISCUSSION 
 
In the following sections I have related the findings of the present study to results from 
prior research on suicide behavior and behavioral health treatment delivery to high-risk 
populations. In some cases comparisons cannot be made since there is no existing literature on the 
topic. This study used previously unexplored data sources that had not been used to describe 
treatment delivered to patients who have recently attempted suicide. Implications and 
recommendations for methods related to the use of these data sources will be discussed. Potential 
areas for improvement in clinical care are also discussed. Limitations included the relatively rare 
occurrence of suicide behavior, which precluded an adjusted analysis of associations between 
treatment delivery and suicide reattempt. Limitations related to the inconsistent availability of VA 
data elements and how they inform future research in this area will conclude this chapter.  
 
Participants 
 
Sample Characteristics 
A substantial proportion (27%) of veterans were not admitted to VA at time of index 
suicide attempt (N = 690). Veterans who were not admitted to VA were younger (mean 43 years 
vs. 48 years old), healthier (82% with zero medical comorbidities vs. 27%), less likely to reside in 
a county with a VA facility (38% live in county with VA vs. 50%), and more likely to have 
served during the Persian Gulf engagements (61% served in Persian Gulf vs. 41%). There was no 
difference in the proportion of veterans who experienced a suicide reattempt within six months 
between the non-VA admit group and the group that was admitted to VA (4% vs. 6%, 
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respectively). It was beyond the scope of this study to determine whether the non-VA admissions 
were reported to VA for continuity or reimbursement purposes.  
 The demographic characteristics of age, gender, and service connected disability rating of 
the cohort under study (N = 504) were compared to VISN 9 reports of these characteristics in 
verified VA enrollees, for FY2011.  Frequencies for these patient characteristics are compared in 
Table 5.1. Proportions of male patients and of service connected disability ratings are comparable 
between the VISN 9 Enrollees and the cohort of patients who experienced a VA hospitalization 
for a suicide attempt. Differences were noted in age categories. Notably, there appears to be 
larger proportions of veterans in the age categories for under 60 years in the cohort under study 
(2010-2012) when compared to the VISN 9 Enrollee group. Veterans aged 60 and older are 
represented as larger proportions in the VISN 9 Enrollee group, when compared to the cohort 
under study.  
 When describing the VISN 9 hospitalized attempt cohort and FY 2011 VA statistics on 
nationwide reported suicide attempts, the distribution of cases across age groups appears similar. 
For example, the greatest proportion of patients, in both groups, is in the 50-59 age group. In both 
groups, the majority of patients were male. There were no data available on service connected 
disability ratings from the VA suicide data report.  
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Table 5.1 
 
Percentages of VA Patient Characteristics  
 
 VISN 9  All VISNsa  
 
Verified Enrollees 
FY 2011 
N=245,124 
Suicide Attempts 
(2010-2012) 
N=504 
Suicide Attempts 
FY 2011 
N=12,309 
Characteristic n (%) n (%) n (%) 
Male Gender 232482 (94.8) 456 (90.5) 10796 (87.7) 
Age Category    
≤29 8662 (3.5) 61 (12.1) 1804 (14.7) 
30-39 12630 (5.2) 74 (14.7) 1664 (13.5) 
40-49 23653 (9.6) 106 (21.0) 2337 (19.0) 
50-59 41287 (16.8) 174 (34.5) 3643 (29.6) 
60-69 86763 (35.4) 73 (14.5) 2137 (17.4) 
70-79 40675 (16.6) 12 (2.4) 3333 (2.7) 
80-89 31454 (12.8) 4 (0.8) b 
No SC 133613 (54.5) 233 (46.2) -- 
<50% SC 50973 (20.8) 88 (17.5) -- 
50%-100% SC 60538 (24.7) 183 (36.3) -- 
Note. VA = Veterans Affairs; VISN = Veterans Integrated Service Network; FY = Fiscal Year.  
aAdapted from “Suicide Data Report”, by J. Kemp and R. Bossarte, 2012, Department of Veterans Affairs, 
Mental Health Services, Suicide Prevention Program, p. 58.  b Categories with fewer than 20 cases were 
suppressed. 
 
The rate of six-month suicide reattempt in this cohort was approximately 6%. It is 
difficult to compare this finding to other studies since the present study only examined patients 
who were hospitalized for a suicide attempt. Furthermore, most studies report much longer 
observation periods to detect repeat suicide events. VA investigators Kemp and Bossarte (2012) 
used the same data source (SPAN) to conduct a non-research based analysis to detect 12-month 
non-fatal reattempt rates from 2009 to 2011. Of this nationwide veteran sample, 15% of patients 
reattempted suicide in 12 months. In other studies of the prevalence of suicide reattempt over a 
12-month period, rates of 14-16% have been reported (Kapur, et al., 2006; D. Owens, et al., 2002) 
There were few differences between the group that did not experience a suicide reattempt 
and the group that did experience a suicide reattempt. While the differences were very small, they 
were statistically significant. The proportion of personality disorders was slightly higher in 
reattempt group, consistent with literature reporting that patients with personality disorders 
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demonstrate elevated risk for repetition of suicide behavior (Haw, et al., 2007). The proportion of 
other psychoses, dementia, and anxiety disorders were slightly higher in the group that did not 
experience a suicide reattempt. Although statistically significant, these differences are likely due 
to the lack of any cases with these diagnoses in the reattempt group. This precludes meaningful 
comparison between the two groups. The absence of a difference in the proportion of cases with 
depressive symptoms, alcohol use disorders is inconsistent with reports that cases with these 
diagnoses are associated repetition of suicide behavior (Kapur, et al., 2006).  
The present study demonstrated that the interval between the index suicide attempt and 
the most recent past psychiatric hospitalization was shorter for patients who reattempted suicide, 
compared to those who did not. The association between recent psychiatric hospitalization and 
suicide reattempt or suicide completion is well established in the literature (Appleby, et al., 1999; 
Desai, et al., 2005; Hunt, et al., 2009; Valenstein, et al., 2009). Although every patient in the 
present study experienced a psychiatric hospitalization, those who had a history of recent 
psychiatric hospitalization prior to the index attempt were more likely to experience a suicide 
reattempt in the six months after the index attempt. Frequent psychiatric hospitalization may be 
associated with an unmeasured risk factor that both increased the likelihood of hospitalization and 
increased the risk for suicide reattempt.  
 
Aim One Findings 
 
Aim One described, for patients who did and did not experience a suicide re-attempt in 
six months after the index attempt, the setting, provider, type, timing, duration and intensity of 
behavioral health care to veterans recently hospitalized for a suicide attempt. 
Comparison with Other Studies 
 In the following paragraphs, I will compare the findings related to Aim One of this study, 
to those of other published works.  
 112 
Interval between last healthcare contact and suicide attempt. The present study 
evaluated the interval between the most recent behavioral health and primary care contacts and 
the index suicide attempt. In the thirty days prior to the index suicide attempt, 41% of patients 
experienced a behavioral health encounter and 18% experienced a primary care encounter.  
Of patients who reattempted suicide (n = 31), 28 participated in outpatient behavioral 
health care during the interval between the index hospital discharge and the suicide reattempt. Of 
these 28 patients, 15 (54%) experienced a behavioral health appointment in the seven days prior 
to the reattempt. An additional eight patients (29%) experienced a behavioral health appointment 
within 30 days of the reattempt. Overall, 82% of patients who experienced a suicide reattempt 
participated in behavioral healthcare within 30 days of the repeat attempt. The greater proportion 
of patients who participated in behavioral health care prior to the repeat attempt, compared to the 
proportion of those patients who participated in behavioral health care prior to the index attempt 
(82% vs. 41%, respectively) is likely a reflection of the assertive treatment delivered to these 
veterans after the index attempt, by way of the suicide prevention program.  
Three studies set in VA have investigated the interval between a suicide event and the 
most recent clinical contact prior to the suicide event. In the only study examining the nationwide 
prevalence of suicide attempts in Veterans, 80% of suicide attempts occurred within four weeks 
of any contact with VA (Kemp & Bossarte, 2012). Furthermore, 50% of those seen within a year 
of their suicide attempt were seen in primary care, and another 40% were seen in a behavioral 
health clinic in the year prior to the suicide attempt. A study of suicides in veterans with a 
substance use disorder reported that the majority of the nation-wide sample (95%) had some 
contact with VA in the year prior to death, and 55% had VA contact in the month before death 
(Ilgen, et al., 2012). A smaller study, set in Oregon, examined the last VA clinical contact of 112 
veterans who completed suicide. In the year prior to death, 63% had one or more primary care 
contacts, and 48% had one or more behavioral health contacts (Denneson, et al., 2010). 
Consistent with these findings, the present study found that a large proportion of suicide attempts 
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(index and repeat) were preceded by a clinical contact in mental health or primary care in the 30 
days prior to the index attempt and the repeat attempt.  
Timing and intensity of behavioral health treatment after psychiatric discharge. The 
present study determined that 84% of patients completed a behavioral health follow-up visit 
within seven days, surpassing the proportion of seven-day behavioral health follow up in other 
studies. Pfeiffer and colleagues found that only 39% of VA patients hospitalized for depression 
received behavioral health within seven days (Pfeiffer, et al., 2012). In the present study, 
completion of a behavioral health encounter within 30 days was determined for 95% of the cohort 
that did not experience a suicide reattempt. Other studies have investigated 30-day behavioral 
health follow up after VA psychiatric hospitalization in specific clinical populations. For 
example, in patients diagnosed with depression, the proportion of patients completing 30-day 
appointments was 76% (Pfeiffer, et al., 2012). In VA patients with comorbid psychiatric and 
substance use disorder, 71% received psychiatric treatment, SUD treatment, or both within 30 
days of discharge (Ilgen, Hu, Moos, & McKellar, 2008). 
  In its evaluation of follow-up delivered to VA patients hospitalized for a psychiatric 
condition, RAND investigators determined seven-day and 30-day post-discharge behavioral 
health follow-up attendance for all diagnostic groups (Watkins & Pincus, 2011). The VHA 
national average for seven-day appointment attendance was 48%, ranging from 38% to 61% 
among VISNs. The proportion of patients who attended a behavioral health follow-up 
appointment in 30 days was 78% for all of VHA, ranging from 71% to 84% among VISNs. The 
proportions of those in the present study who completed a seven-day appointment (84%) 
exceeded the national average and meet the upper end of the range among VISNs. The proportion 
of those in the present study who completed any 30-day behavioral health appointment was 95%, 
far exceeding the national VHA average and the range of proportions among VISNs.  
 The present study found that for reattempt and no-reattempt groups, the median time to 
any behavioral health follow-up was one and two days, respectively. This interval is much shorter 
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than that reported by the RAND evaluation, which determined that for those with any follow-up, 
the mean number of days to the first visit was approximately 27 days. Among the VISNs, this 
interval ranged from 20 days to 35 days (Watkins & Pincus, 2011). 
 The present study was the only one to examine whether patients completed four 
behavioral health appointments in the 30 days after discharge from psychiatric hospitalization. 
With the implementation of its suicide prevention program, VA required this intensity of 
behavioral health care when veterans were identified as a “High Risk of Suicide”. Of those 
without a suicide reattempt and who completed any behavioral health encounters in the first 30 
days (n = 449), 73% of patients completed 4 or more encounters. Currently, there is no clinical 
standard of care to determine the acceptable proportion of patients who should complete four or 
more behavioral health encounters in the month after discharge. However, VA performance 
measurement standards mandate that 85% of patients identified as a high risk of suicide receive 
this intensity of behavioral health care in the month after discharge. Therefore, those who did not 
reattempt did not meet this standard.  
A relatively greater proportion of patients in the 31-180 day reattempt cohort exceeded 
the performance of the no-reattempt cohort on the two VA post-discharge follow-up 
requirements. Of the twenty patients in this reattempt cohort, 19 (95%) competed the requirement 
for a behavioral health contact with one week of discharge. The requirement for the High Risk of 
Suicide patients, to complete four behavioral health appointments in the first 30 days after 
discharge, was fulfilled by 18 (90%) of the 20 patients in the 31-180 day reattempt cohort. In 
comparison, of the patients in the no-reattempt cohort, 84% completed a seven-day appointment 
and 72% completed four appointments in the first 30 days after discharge.  
 The present study determined that the proportion of patients who received timely and 
intense post-discharge behavioral health follow-up met or exceeded proportions reported in other 
studies of VA psychiatric populations. It should be noted that the sample in the present study was 
the only one to be exposed to the VA suicide prevention program. The efforts of the suicide 
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prevention program to facilitate behavioral health appointment scheduling and patient 
engagement likely contributed to the robust performance on the quality indicators for post-
discharge follow-up in this sample.  
The present study determined that, compared to the group that did not experience a 
reattempt, patients who experienced a suicide reattempt in days 31-180 after discharge 
experienced more timely and more intense behavioral health care. Specifically, greater 
proportions of patients who reattempted suicide in days 31-180 received care in the seven-day 
(95% vs. 85%) and 30-day (100% vs. 96%) post discharge period. A greater proportion of 
patients in the reattempt group completed 4 behavioral health appointments in the 30 days after 
discharge (90% vs. 73%). When comparing the total number of completed behavioral health 
appointments in the immediate post-discharge interval, patients who reattempted suicide in days 
31-180, experienced more appointments in the first seven days and the first 30 days after hospital 
discharge than patients who did not reattempt suicide. These results suggest that patients, who 
experienced a reattempt within six months of discharge, not only received more behavioral health 
appointments but also received them sooner and with greater intensity, compared to the group 
that did not experience a reattempt.  These findings are counterintuitive to the recommendations 
of suicide prevention strategies, which promote timely and intense care for psychiatric patients 
after hospital discharge.  
The notion that “more care is better” for high-risk psychiatric patients has been 
challenged in prior research. A 2000 study examined the number and types of appointments 
delivered to Medicaid recipients in Massachusetts after psychiatric discharge and the risk for 
psychiatric readmission. The investigator concluded that patients who received any behavioral 
health care were less likely to experience a 30-day psychiatric readmission, compared to those 
who received no behavioral health care. However, patients who received above the median 
number of appointments were more likely to experience a readmission in 30-days. Findings were 
significant even when adjusting for severity of illness and functional status (Huff, 2000). This 
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lends support to the recommendation for determining additional confounding risk factors that 
may be contributing to the delivery of behavioral health treatment and the risk for a new episode 
of acute psychiatric symptoms or suicide reattempt.  
Provider of treatment. In the present study, all behavioral health treatments in the first 
thirty days after discharge were delivered by a median of three providers to the no-reattempt 
group, IQR = 2-5, and by a median of three providers to the 31-180 day reattempt group, IQR = 
3-5. A study of Medicaid recipients in Massachusetts reported that 38% of patients discharged 
from a psychiatric hospitalization contacted four to nine providers in the 30 days after discharge 
(Huff, 2000).  
Setting and modality of treatment. A review of the literature did not yield any works 
describing variation in the setting of behavioral health treatment in the post-discharge period and 
risk for suicide attempt. When examining the modality of appointments in the first 30 days after 
discharge, patients in the 31-180 reattempt group attended more phone appointments than the no-
reattempt group (median 2.5 appointments vs. one appointment, respectively). In a case-control 
study of suicides that occurred within two weeks of hospital discharge, patients who completed 
suicide were less likely to experience the last clinical encounter by face-to-face appointment than 
telephone, O.R. = 0.18, p = .030. Investigators concluded that a face-to-face visit was slightly 
protective against suicide, when compared to telephone visits (Bickley, et al., 2013)   
Type of treatment. The present study determined no differences in the intensity of care, 
by treatment type, when comparing the no-reattempt group, and the 31-180 day reattempt group. 
As it relates to the timing of care, by treatment type, patients who reattempted suicide attended 
mental health and suicide prevention appointments sooner, when compared to the no-reattempt 
group.  
It was noted that there was a difference in the number of patients with a primary or 
secondary substance use disorder or post-traumatic stress disorder, and the number of patients 
who participated in Substance Use or PTSD care. In the sample of patients who were admitted to 
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a VA inpatient unit at the time of the index suicide attempt (N = 504), 342 patients had a primary 
or secondary diagnosis of a substance use disorder, and 144 patients attended any Substance Use 
appointment during the six-month observation period. In other words, approximately 40% of 
those with a diagnosed substance use disorder received specified treatment. A similar trend was 
identified among patient with PTSD. Of the 151 patients with a primary or secondary diagnosis of 
PTSD, 59 attended any PTSD appointment in the post-discharge period (39%). These results 
suggest that much of the treatment delivered in the most immediate post discharge period does 
not target the disorder under treatment during the index hospitalization.  
Prior studies have suggested that there is variation in the receipt of evidence-based 
treatment for PTSD.  Evaluations of VA mental health services determined that evidence-based 
psychotherapy for PTSD was inadequately delivered to veterans with the disorder (Rosen, et al., 
2004). As a result, VA has made changes to increase the availability of evidence-based PTSD 
treatment. For example, since 2006 VA has increased its mental health workforce capacity, and 
provided ongoing systematic training of clinicians in evidence-based psychotherapies for PTSD 
(Karlin, et al., 2010). In a recent RAND evaluation of VHA mental health services, investigators 
reported that evidence based treatments for PTSD were implemented in 98% of facilities.  
However, in spite of these efforts to increase access to evidence-based psychotherapies for PTSD, 
only 20% of PTSD patients received evidence-based psychotherapy for these conditions (Watkins 
& Pincus, 2011).  
 Similar differences in the delivery of SUD treatments in VA have also been reported. In 
the aforementioned RAND investigation of VHA mental health care delivery, treatments such as 
intensive outpatient treatment and psychosocial interventions, were implemented at more than 
90% of VA facilities; approximately 80% of facilities had implemented opiate agonist therapy 
and integrated dual diagnosis therapy by 2009. However, the capacity of VHA facilities to 
provide these services had not translated into patient-level receipt of targeted care for SUD. Only 
22% of SUD patients identified in this evaluation received the indicated treatment (Watkins & 
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Pincus, 2011). The present study echoes the finding that veterans with these psychiatric disorders 
may not be receiving targeted treatment, and that this is not related to the organizational capacity 
to provide such treatments.  
Approximately 15% of patients who participated in treatment (N=496) attended 
psychology appointments. At first glance, it appears that relatively few patients attended 
psychology appointments in the six months after discharge. It is possible that more than the 15% 
of patients who attended psychology appointments were exposed to psychotherapeutic 
interventions, during other types of behavioral health appointments.  Without CPT codes, it was 
not possible to determine whether patients were exposed to psychotherapeutic procedures in other 
behavioral health clinics outside of the psychology stop codes. Therefore, the proportion of 
appointments categorized in the present study as psychology treatments likely underestimate the 
extent of psychotherapy procedures delivered to this population, by non-psychologist healthcare 
providers. 
 
Aim Two Findings 
 
Aim Two set out to describe associations between factors related to patient 
characteristics, prior health utilization, index admission and the timing of post-discharge 
behavioral health care.  
Comparison with other Studies 
Transitions of care and timing of the first post-discharge appointment. The analysis 
for Aim Two determined whether factors relevant to the inpatient hospitalization were associated 
with the number of days between inpatient discharge and completion of the first behavioral health 
appointment. One statistically significant association was between the number of days to first 
behavioral health appointment and whether the patient was hospitalized at a different inpatient 
site than the patients “home” site. For the 457 patients who did not experience a facility change, 
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the median time to the first appointment was two days, IQR = 0-6.  For patients who experienced 
a facility change (n = 39), the median time to the first appointment was one day, IQR=0-3. This 
finding was surprising, since it was expected that patients who experienced a facility change 
would be exposed to more opportunities for disruptions in continuity of care during the transition 
from inpatient to outpatient care. However, this did not appear to be the case. It is possible that 
knowledge of the patient’s facility change generated heightened scrutiny of the discharge plan 
and greater vigilance in communicating the discharge plan to the staff at the “home” site. 
Additionally, the difference of one day is not clinically insignificant since many suicide events 
can occur within one day of contact with a healthcare provider (Hunt, et al., 2009). 
A second finding related to this aim was the relationship between experiencing a medical 
admission for the index hospitalization and the number of days to the first post-discharge 
appointment. Although the number of patients that experienced a medical admission to manage 
the sequelae of the suicide attempt was relatively small (n = 37), this group attended the first 
post-discharge appointment a median of four days later than those who did not. A potential 
explanation for this finding may be the lack of specialized knowledge of medical unit staff 
regarding the recommendations for post-discharge care for “High Risk of Suicide” patients. Since 
these staff may not typically schedule behavioral health post-discharge care, there is likely more 
variation in these processes compared to the discharge planning that occurs on a psychiatric unit. 
This aspect of care was not measured in the present study and will likely inform future research.   
Few studies have examined transitions of patients with psychiatric disorders from non-
psychiatric units, into outpatient mental health treatment. One multi-site study, conducted at VA 
facilities, examined the effect of a care coordination intervention for patients during a medical or 
surgical admission, with comorbid symptoms of depression, anxiety and/or alcohol abuse. Efforts 
to proactively manage the discharge of these patients and to coordinate post-discharge mental 
health treatment resulted in reduced costs (associated with fewer inpatient bed days) for the group 
who received the intervention. Patients who were exposed to the care management intervention 
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also attended more outpatient appointments in the 12 months post discharge, compared to patients 
who received usual care (Kominski, et al., 2001). These results underscore the need to address 
challenges associated with transitions of care for patients with psychiatric conditions who 
experience medical admissions.  
 
Recommendations for Future Research 
 
Leveraging Health Information Technology 
 Future research should leverage information technology to enhance surveillance of at-
risk populations and to capture the effects of dual use of VA and non-VA services.  The 
development of health information exchanges between VA and non-VA healthcare facilities is 
currently underway (Weiner & Haggstrom, 2013). Exchanges should be designed with 
consideration for suicide behavior surveillance, which will allow for the study of non-VA care 
and its impact on risk for future suicide behavior.  The development of health information 
exchanges between VA and DoD is also in development has the potential to provide longitudinal 
data for observation of the onset of risk factors and the impact of healthcare services on these 
factors.  These enhancements will be crucial to the study of suicide prevention in active duty and 
veteran populations. A priori consideration for suicide surveillance should be included in the 
development of these VA initiatives.  
VISN-Level Comparisons of Healthcare Delivery and Suicide Behavior Outcomes 
The present study found that variation of suicide attempt outcomes, within one VISN, 
was not sufficient to conduct robust analyses for describing the association between patient-level 
risk factors and the repetition of a suicide attempt. Future study will require multi-VISN or 
national samples of cases in order to conduct multivariate analyses towards determining the 
association between healthcare delivery and future suicide behavior.  
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The majority of patients in the present study received some sort of behavioral health 
treatment after hospitalization for a suicide attempt and most of these met seven-day and 30-day 
performance standards set by VA. Sources of variation that can be linked to suicide behavior 
outcomes require evaluation beyond merely the occurrence of an appointment, but on the 
procedures that took place during the appointment, the quality of those procedures, or the extent 
to which the appointment specifically addressed the recent suicide behavior.  
Investigate Potential Differences in Healthcare Delivery to PTSD and SUD Patients  
Treatment of an underlying mental health condition is a necessary component of caring 
for a patient after a suicide attempt. The scope of the present study did not include an examination 
of PTSD and SUD treatments delivered to patients with PTSD and SUD diagnoses. It was noted, 
however, that the numbers of patients who did receive these treatments were not equivalent to 
those who were diagnosed with PTSD or SUD during their index hospitalization. Further study 
should determine whether veterans with these disorders are receiving the evidence-based care 
indicated for these conditions.  
 Populations with PTSD and SUD are of particular interest to VA due to the prevalence of 
these disorders in VA and the associated risk for suicide behaviors. Enhanced access to evidence-
based PTSD and SUD treatment has recently been emphasized in light of rising rates of veteran 
suicides. Contemporary perspectives in suicide prevention assert that identifying and treating 
underlying psychiatric conditions, such as PTSD or SUD, will reduce the risk of future suicide 
(US Department of Health and Human Services (HHS) Office of the Surgeon General and 
National Action Alliance for Suicide Prevention).  
Establish Methods for Evaluating Quality of Behavioral Health Appointments 
Simply counting the number of attended appointments does not provide the depth of 
variation required to target areas for intervention. Additionally, counting the number of 
appointments only reinforces the potential fallacy that more appointments are directly associated 
with a risk for future reattempt. Indeed, at first glance, it appears that patients in this study who 
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reattempted suicide received more behavioral health appointments, than those that did not 
reattempt suicide. Further risk adjustment is required to determine if more appointments are 
completed in patients who reattempt suicide because of an underlying clinical or interpersonal 
need for care (as indicated by a measure of illness severity, or other psychosocial characteristic) 
and not because clinical appointments in and of themselves contribute to suicide reattempt risk.  
 
Clinical Recommendations 
 
This study found an unexpected relationship between the frequency and intensity of 
behavioral health appointments and suicide reattempt in days 31-180 after psychiatric discharge 
for a suicide attempt. The finding that patients who reattempted also experienced more frequent 
and intense care contradicts a commonly held view that quality of behavioral health care can be 
measured through appointment attendance. This contradiction challenges health policy initiatives 
that emphasize accountability for appointment attendance. Without accurate quality measures, 
health care providers cannot begin to improve their clinical practice. For example, the delivery of 
evidence-base treatments, especially to patients with PTSD or substance use disorder, may 
improve the quality of care delivered during behavioral health appointments.    
Behavioral health appointment attendance is necessary but not sufficient for a 
comprehensive systems-based suicide prevention strategy. Systems of care should be developed 
around a bundle of services that can readily accommodate fluctuations in acuity for clinical 
populations at high risk of suicide (e.g. patients with depression). Some examples of this are: 24-
hour crisis intervention, advanced access clinic schedules, and consultation with support for non-
mental health providers who encounter suicidal patients. These efforts have been adopted by 
healthcare systems that have subsequently demonstrated reductions in suicide rates (Coffey, 
2007). Patient sub-populations, defined by clinical characteristics such as a diagnosis of PTSD or 
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a substance use disorder, should be readily identified and targeted for specialized, evidence-based 
treatment. 
The broader use of phone or group-based care to maximizes efficient use of resources, 
acknowledges patient preference for modality, and encourages peer support from group 
encounters. The delivery of psychotherapeutic interventions via phone or videoconferencing has 
been validated in clinical settings (Mohr, Burns, Schueller, Clarke, & Klinkman, 2013). Such 
interventions have not been studied in a veteran population determined to be at high risk of 
suicide. However, the systematic implementation and evaluation of interventions to improve 
access to care are supported by national suicide prevention strategies (US Department of Health 
and Human Services (HHS) Office of the Surgeon General and National Action Alliance for 
Suicide Prevention). 
It was found that multiple providers were involved in an individual’s behavioral health 
treatment. It was not possible to determine if providers functioned as a team in caring for this 
high-risk population. Emphasis on team-based clinical care can potentially minimize disruptions 
to continuity of care. High functioning clinic teams are another component of a clinical culture 
that supports effective suicide management strategies.   
 
Implications for Research Methods and Tools 
 
 This is the first known study to combine SPAN and VA administrative data for 
investigation of behavioral health treatment delivery to veterans who have experienced a suicide-
related event. Access to these data sources has created opportunities for observational study of a 
notoriously elusive study population. Due to the nascence of the SPAN data source, and the lack 
of published works using SPAN data, many of the implications of using SPAN data for 
observational study were discovered during the present study.  
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 At this time, there is no single source of VA data to describe the delivery of any health 
treatment to a cohort of patients who have recently attempted suicide. SPAN data must be 
combined with VA administrative data in order to glean accurate demographic and utilization 
information. Even with successful merging of these two data sources, there is not an established 
method for combining these data with information from community providers, in the event that 
the veteran received care in the community.   
 Although the ability to study suicide behavior in VHA surpasses that of other healthcare 
systems, there are limitations in methods when studying the effect of treatments on suicide 
behavior in any population. These limitations are related to the scarcity of ethical methods and 
study designs that would allow for comparison between treatment and control groups, precluding 
the use of randomized controlled trials. The state of the science in suicide behavior surveillance 
and prevention is characterized by the observation and measurement of variation in treatment and 
risk exposure. To further compound these challenges, the delivery of treatment to this population 
is informed by mandated frequency of appointments. As a result there is little variation to study, 
as was the case in the present study.  
To capture a more comprehensive representation of care experienced by veterans, it will 
be necessary to establish linkages to community data sources in order to determine behavioral 
health delivery to veterans who do not receive care at VHA.  Such initiatives are in pilot stages at 
some VA facilities.  
SPAN is currently designed to provide information for clinical quality improvement 
activities, not research. Efforts to improve the quality of data entered into SPAN and validation of 
SPAN data elements will enhance the reliability of this data source for research. Evaluation of 
data entry training to suicide prevention coordinators should be part of this improvement effort. 
Access to real-time data collection for observational study of treatment delivery will resolve some 
limitations of the current study, specifically those that related to data elements that could not be 
captured retrospectively.  
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One immediate improvement to the SPAN data source could be the identification of 
hospitalization in VA or non-VA facility. This modification will potentially streamline case 
finding for future studies. If this option had been available in the present study, it would have 
reduced the number of patients included in the original data request, thus reducing the risk of a 
breach of confidentiality through exposure to unneeded protected health information.  
Finally, data that accurately reflects the care that was delivered during the clinical 
encounter will enhance future investigations of behavioral health treatment delivery to this 
vulnerable population. The development and use of procedural coding for specific evidence based 
therapies would allow for detection of these therapies in administrative data, eliminating the need 
for chart abstractions.  
 
Limitations 
 
Findings related to the timing and intensity of care, by treatment type, setting or provider, 
should be interpreted with caution due to limitations related to the sample. Specifically, the 
outcome of interest for aim one—suicide reattempt—was a rare event. This sample was not large 
enough to capture enough events to conduct the planned regression analysis.  
The observation period (six months after discharge from a psychiatric unit) was shorter 
than many other studies investigating repetition of suicide behavior. Other studies cite reattempt 
rates in twelve or more months. In the present study, extending the observation period to one year 
or more would have reduced the number of cases to include in the sample. Studies examining 
changes in the rate of suicide over time, after a psychiatric discharge, found that the highest rate 
of suicide occurs within the six months after discharge. Therefore, it is unlikely that a higher rate 
of reattempted suicide would have occurred during the unobserved period between six and twelve 
months. The rate of reattempt in the present study was approximately 6% in six months, whereas 
other studies report reattempt rates between 14% and 16% in 12 months after discharge.  
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A substantial proportion of veterans in this cohort were not hospitalized at VA for the 
index admission. These could not be included for analysis, since many data elements relied on 
discharge date for variable creation. As a result, these cases could not be included in analysis, 
reducing sample size. Because veterans who were not hospitalized at a VA medical center were 
excluded, the results of the present study can only be generalized to veterans who experienced a 
VA medical center admission for a suicide attempt.  
There were several limitations associated with the availability of certain data elements in 
the VA administrative data. For example, some data elements related to demographic information 
could not be captured retrospectively. Variables such as “residing in county with VA facility”, 
“Service Connected Disability %”, and “Marital Status” reflect the veteran’s status at the time of 
the data request (February, 2013) and not at the time of the index suicide attempt.  
Data related to encounter information was also limited. In the present study, only 
completed encounters were captured. As a result, I was unable to describe the extent of no-show 
or cancelled appointments. This detracts from generating conclusions about the efforts made by 
the healthcare organization versus patients towards participation in behavioral healthcare.  
Limitations in describing treatments that occurred during encounters were due to the inability to 
obtain CPT codes for this investigation. As a result, the procedures conducted during the patient 
encounter are not part of the description of “treatment”. Only VA stop codes were used to inform 
“treatment”, which limits assumptions regarding the therapeutic value of the encounters included 
in the study. This also limits comparison with other studies, which have used CPT codes to 
differentiate among services delivered within the clinic types.  
Finally, there was little variation in treatment exposure. Almost all of the veterans in the 
present study received some sort of behavioral health treatment during the observation period. 
The majority received the recommended standard of care mandated by VA policies. There may 
be unmeasured variation in the quality of care that is contributing to the difference in reattempt 
rates between the two groups.  
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Conclusion 
 
The study of post-discharge healthcare utilization for veterans who have recently 
attempted suicide is relatively nascent. The ability to study large cohorts of patients who have 
recently attempted suicide is possible due to the surveillance and data collection efforts of VHA.  
Future study in this area will be enhanced through ongoing efforts to improve the quality of data 
included in these surveillance tools.  
In describing the care delivered to patients after a suicide attempt, Kane’s treatment 
essentials (timing, duration, intensity, provider, and setting), contributed some explanation for 
variation in the outcome of interest (suicide reattempt). Some of these explanations were 
surprising; trends that would typically be associated with more ideal treatment delivery were 
more prevalent in the group with the undesirable outcome: suicide reattempt.  However, Kane’s 
treatment factors, as operationalized in the present study, were not able to capture aspects of 
quality care specific to treating a veteran after a suicide attempt.  Future work should attempt to 
determine other sources of variation in quality in order to glean potential associations with suicide 
behavior outcomes.  
Future study of suicide prevention and healthcare utilization will rely on continued 
surveillance of suicide behaviors in large patient cohorts. The VHA, as the largest integrated 
health system in the US, will be a key player in this research. As VHA continues to work towards 
extending its reach into the community, its surveillance and prevention strategies will include 
larger and potentially more diverse veteran groups.  
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APPENDIX A 
 
 
DOCUMENTATION OF ACTIVATING THE CATEGORY II PATIENT RECORD FLAG: HIGH RISK OF SUICIDE 
  
 
 
Flag Name: HIGH RISK OF SUICIDE 
 
Assignment Narrative:    
Problem: This veteran has been determined to be at high risk for suicide. 
If you are the primary Mental Health provider for this veteran the following procedure must be followed: 
**Over the next 30 days this veteran needs to be monitored weekly by appointment or phone. 
**After 30 days the veteran needs to be monitored at least monthly for the next 2 months.  All   contacts 
need to be documented.  
**Assure that patient's diagnoses and care plan are reviewed in light of this identified risk.               
**Develop a safety plan that is documented in CPRS with a copy given to the veteran. The safety plan should 
assist the veteran in identifying times when he/she is at increased risk and specific steps to take to 
preserve his or her own life. 
  
Make sure this veteran has the National Suicide Hotline: 1-800-273-TALK (8255). 
**Include SPCs (Lesley Murray and Paul Fisher) as additional signers to ALL weekly/monthly MH provider 
progress notes and no-show phone calls. 
             
Flag Type: CLINICAL 
Flag Category: II (LOCAL) 
Assignment Status: Active 
Initial Assigned Date: OCT 18, 2011@13:40:55 
Approved by: MURRAY, LESLEY D 
Next Review Date: DEC 04, 2012 
Owner Site: TENNESSEE VALLEY HCS  (TENNESSEE VALLEY HCS) 
Originating Site: TENNESSEE VALLEY HCS  (TENNESSEE VALLEY HCS) 
Figure A1. Sample alert for the Category II Patient Record Flag: High Risk of Suicide. This alert, in the form of a pop-up box, is made visible to the viewer of 
the medical record when the electronic health record is accessed. When the flag is deactivated, this pop-up box no longer appears.  
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Figure A2. Sample narrative that accompanies activation of the Category II Patient Record Flag: High Risk of Suicide. This documentation is a permanent entry 
in the patient’s electronic medical record.  
 
 
PRF HIGH RISK FOR SUICIDE PLACED ON CHART 
  Veteran has been placed on the facility's high risk for suicide list, and a Category II Patient Record 
Flag, High Risk for Suicide has been placed on Veteran's chart.  The status of the PRF will be reviewed at 
least every 90 days, with documentation associated with that review to be posted in the medical record. 
    Comment: Admitted with worsening SI with plan to stab self.  Reported 
    that 1 week prior to admission, he ingested rat poison in an attempt 
    to kill himself.  High Risk Flag has been reactivated. 
  
ALL MEDICAL PROVIDERS:  Please be alert to veteran making any threats of harm to self, seeking access to 
means to harm self such as extra medications or firearms, or talking or writing about death, dying or 
suicide.  Contact veteran's principal mental health provider, the facility suicide prevention coordinator, 
or the psychiatrist on duty if you notice any of these signs. 
  Principal MH Provider: PACs 
  Suicide Prevention Coordinator: Lesley Murray 
  
TO ALL STAFF:  Please be attentive, friendly, supportive and respectful of veteran's privacy.  If veteran 
is exhibiting any of the warning signs for suicide, or if you have concerns for any reason, please contact 
a provider. 
 
THE PRINCIPAL MENTAL HEALTH PROVIDER or case manager for veteran should initiate the following procedures: 
Please ensure Suicide Safety Plan has been completed. 
For the first 30 days after placement on the high risk list suicide risk needs to be evaluated weekly.  
After 30 days, suicide risk status needs to be evaluated at least monthly. Placement on high risk list must 
be evaluated at least every 90 days, and status updated/documented. 
  
MISSED OR CANCELLED APPOINTMENTS should be followed by designated outreach procedures and appropriately 
documented. 
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APPENDIX B 
  
 
VARIABLE DEFINITIONS 
 	  
Case Identification 
Variable Description Purpose Output Source Level of 
Measurement 
Limitations 
Suicide Event 
Type 
Suicide attempt since 
1/1/2009 
Case-finding Attempt 
Completion 
Ideations 
Undetermined 
SPAN: Event 
Type  
nominal  suicide completions are underreported and are 
not verified by medical examiner, therefore, 
these data will not be gathered from SPAN 
 
documented suicide attempts only represent 
those that are treated by or reported to the 
healthcare organization 
 
In general, suicide completions and ideations 
are likely underrepresented in SPAN data.  
Event Outcome Disposition resulting from 
suicide event; this item will 
be used to discern suicide 
attempts that resulted in 
hospitalization, from attempts 
that did not result in this 
outcome.  
Case-Finding 
 
Patients who are hospitalized for a 
suicide attempt are exposed to a 
similar standard of care, post-
discharge.  
Hospitalization 
Outpatient Treatment 
No Treatment 
Sought 
Other 
SPAN: 
Outcome 
nominal Hospitalization may have been non-VA, and 
therefore may not be captured by 
administrative data. Non-VA admissions will 
be described but will not be included in 
analysis, since the date of discharge cannot be 
accurately ascertained  
Study ID randomly generated 4 digit 
number, assigned to case for 
identification purposes. 
Case identification 1000-9999 SPSS nominal  
Demographics 
Variable Description Purpose Output Source Level of 
Measurement 
Limitations 
Date of Birth patient's date of birth; can be 
used to determine age at time 
of event.  
Case Identification 
 
to calculate age at time of suicide 
attempt 
mm/dd/yyyy VHA Medical 
SAS Dataset: 
PTF 
date  
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Age age in years, at the time of 
the suicide event 
Demographic Description 
 
to adjust for utilization behaviors 
(i.e. older patients more likely to 
be hospitalized) and for risk of 
suicide behavior (i.e. higher risk 
associated with certain age 
groups) 
age in years SPAN 
VHA Medical  
SAS Dataset: 
PTF 
continuous calculated from event date (SPAN) and date of 
birth (SAS) 
Sex Sex identified during index 
hospital admission 
Case identification 
 
Demographic Description 
 
to adjust for gender differences in 
suicide behavior.  
male 
female 
VHA Medical 
SAS Dataset: 
PTF 
nominal transgendered individuals are labeled as male 
or female according to their preference, 
however this change in the medical record is 
initiated in collaboration with the patient's 
physician.  
Race & 
Ethnicity 
race and ethnicity identified 
at time of index hospital 
admission 
Demographic Description 
 
to adjust for racial differences in 
suicide behavior.  
Hispanic, White 
Hispanic, Black 
American Indian 
Black 
Asian 
White 
Unknown 
VHA Medical 
SAS Dataset: 
PTF 
nominal "unknown" race less than 1% of all VA data 
 
% of usable race values increases with 
inpatient data 
 
% of usable race values increases with multiple 
time frames 
 
% of usable race values increases with multiple 
data sources 
Marital Status patient's marital status 
identified during index 
hospital admission 
Demographic Description 
 
to adjust for marital status 
differences in suicide behavior.  
Never married 
Married 
Separated 
Divorced 
Widowed 
Unknown 
VHA Medical 
SAS Dataset: 
PTF 
nominal  
Psychiatric 
Diagnosis 
the primary ICD-9-CM listed 
in "discharge diagnosis" from 
index hospital admission. In 
the event that the primary 
diagnosis is not a psychiatric 
condition, i.e. If the ICD-9-
CM instead reflects the injury 
sustained secondary to the 
suicide event, the first listed 
psychiatric condition will be 
used.  
Demographic Description 
 
to adjust for differences in suicide 
behavior and utilization.  
One primary and up 
to nine secondary 
ICD-9-CM codes per 
discharge.  
 
Accepted Psychiatric 
ICD-9-CM codes per 
VAMH-12 index.  
VHA Medical 
SAS Dataset: 
PTF 
nominal Reliability of ICD-9-CM data is affected by 
multiple factors: failure to correctly list 
diagnoses, omitting procedures (especially OR 
procedures), coding variation, and keypunch 
errors (Lloyd, 1999).   
 
Diagnoses for suicidal behavior determined 
from (vancott, 2010) 
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Medical 
Comorbidities 
number of medical conditions 
treated in VHA, as evidenced 
by presence of diagnosis code 
in encounter information of 2 
outpatient medical encounters 
>30 days apart, or one 
inpatient hospitalization for 
the diagnosis.  
Risk adjustment: Elixhauser + 
high risk of suicide comorbidities 
will be used to guide 
identification of medical 
comorbidities 
One primary and up 
to nine secondary 
ICD-9-CM codes per 
discharge/encounter 
VHA Medical 
SAS Dataset: 
OPC 
  
Service 
Connected 
Rating 
determination of disability 
that is attributable to medical 
or psychiatric conditions that 
arose during military service 
Demographic Description 
 
to adjust for differences in 
utilization patterns by service 
connectedness 
Not Service 
Connected 
 
0-100% in 10% 
increments 
VHA Medical 
SAS Dataset: 
PTF 
continuous "Not service connected" is different than 0% 
service connected; the former indicates the 
patient does not have a condition that arose 
during military service, or has not sought a 
disability determination rating. The latter 
indicates that the patient may have a condition 
that is attributable to military service, but this 
condition does not result in a disability.  
 
As a result, a veteran described as "not service 
connected" may have a condition that has not 
yet been identified by the VA disability 
determination process. This does not affect the 
purpose of this variable, since it will only be 
used to adjust for enhanced access to 
healthcare services 
Combat Veteran A combat veteran is a veteran 
who served on active duty in 
a theater of combat 
operations during a period of 
war after the Persian Gulf 
War or in combat against a 
hostile force during a period 
of hostilities after November 
11, 1998. 
 
 
Demographic Description 
 
 
to adjust for differences in 
utilization patterns by combat 
status 
yes/no VHA Medical 
SAS Dataset: 
PTF 
binary Combat veteran status imparts additional 
benefits for 5 years after discharge from 
military service, including waiver of copays for 
inpatient care, outpatient care, outpatient 
medications and extended care services. 
Combat status will be used in this study to 
adjust for enhanced access to care as a result of 
increased level of benefits for this population.  
Address County will be used to 
determine proximity to care, 
i.e. whether veteran lives in 
same county as VA facility.  
 
Demographic Description 
 
 
to adjust for differences in 
utilization patterns by proximity 
to care 
Street address or PO 
BOX 
City 
State 
ZIP code 
County 
Country 
VHA Medical 
SAS Dataset: 
PTF 
nominal Address data cannot be accessed 
retrospectively at the time of the event. 
Address information corresponds with the 
patient’s status at the time of the data request, 
and not the time of the event.  
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Proximity to 
treating 
outpatient 
facility 
Whether veteran lives in the 
same county as a VA facility 
or CBOC 
This will be determined by 
ascertaining whether there is a VA 
facility in the same county of 
residence, by using county 
information from the veteran’s 
listed address (see above).  
 
 
VA facility in county 
of residence? Yes/no 
CBOC county 
data: TVHS 
Public 
Relations 
binary Proximity to VA services as measured by 
determining the presence of any VA facility in 
the county of residence, has demonstrated 
predictive power for mental health service 
utilization, even when controlling for distance 
to the nearest VA facility (Weissman, 
Rosenheck, & Essock, 2002).   
Episode of Care: Prior to Index Attempt 
Variable Description Purpose Output Source Level of 
Measurement 
Limitations 
Prior Attempts Number of prior suicide 
attempts 
 
Presence of prior attempts 
 0-99 
 
 
yes/no 
SPAN continuous 
 
 
binary 
Subject to recall bias and variability in SPC 
chart review to determine number of previous 
attempts 
 
This variable will be compressed into 
dichotomous variable: "prior suicide attempt-
yes/no" 
Prior outpatient 
mental health 
treatment 
mental health treatments in 
the two years prior to index 
admission as evidenced by an 
encounter in a mental health 
stop code for a psychiatric 
diagnosis listed in VAMH-
12, and psychiatric procedure 
code.  
 days since last 
treatment 
VHA Medical 
SAS Dataset: 
Outpatient 
Care Files 
(OPC) 
  
continuous reliability of administrative data in capturing 
care delivery is enhanced (up to 92% in SUD 
population) when using mental health stop 
code or bed section, mental health diagnosis 
code, and mental health procedure code to 
identify outpatient encounters.  
 
does not capture non-VA treatment 
Prior outpatient 
primary care 
treatment 
primary care encounters in 
the two years prior to 
admission 
 
Ascertain utilization of medical 
services prior to index attempt.  
 
Determine presence of medical 
comorbidities treated at VHA 
days since last 
treatment 
VHA Medical 
SAS Dataset: 
Outpatient 
Care Files 
(OPC) 
  
continuous does not capture non-VA treatment 
Prior psychiatric 
hospitalizations 
psychiatric hospitalization as 
indicated by inpatient 
admission characterized by a 
primary discharge diagnosis 
of a psychiatric condition 
(VAMH-12) or ICD-9-CM 
code reflecting self-injurious 
behavior (E950-E958, E980-
E989) and psychiatry bed 
section in the two years prior 
to attempt 
Ascertain prior healthcare 
utilization 
days since last 
psychiatric 
admission 
VHA Medical 
SAS Dataset 
(PTF) 
continuous does not capture non-VA treatment 
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Prior medical 
hospitalizations 
medical hospitalization as 
indicated by inpatient 
admission characterized by a 
primary discharge diagnosis 
other than a psychiatric 
condition (VAMH-12) or 
ICD-9-CM code reflecting 
self-injurious behavior 
(E950-E958, E980-E989) and 
non-psychiatry bed section in 
the two years prior to attempt 
Ascertain prior healthcare 
utilization 
 
Determine medical comorbidities 
by discharge diagnoses 
days since last 
medical admission 
  does not capture non-VA treatment 
Location code, 
to cboc level 
this will indicate the location 
where outpatient mental 
health treatment was 
delivered.  
 64 possible locations VHA Medical 
SAS Dataset: 
OPC 
nominal  
Episode of Care: Inpatient Index Admission 
Variable Description Purpose Output Source Level of 
Measurement 
Limitations 
Index Event 
date 
Date that suicide event 
occurred 
Case-finding 
 
mm/dd/yyyy SPAN: Event 
Date 
date  
Index Admit 
date 
Date of hospital admission 
that was a result of suicide 
event 
Case-finding 
 
Calculate LOS 
mm/dd/yyyy VHA Medical 
SAS Dataset: 
Patient 
Treatment File 
(PTF) 
date  
Index Discharge 
date 
Date of hospital discharge, 
precipitated by suicide 
attempt 
Case-finding 
 
This date will be used to calculate, 
LOS,  the six month post-
discharge observation period, as 
well as factors related to timing, 
duration and intensity of treatment  
mm/dd/yyyy VHA Medical 
SAS Dataset: 
PTF 
date  
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Facility of index 
admission 
The VA facility where the 
index admission occurred 
To determine where inpatient care 
occurred; this may not be the 
same facility where veteran will 
receive outpatient treatment.  
581-Huntington 
596-Lexington 
603-Louisville 
614-Memphis 
621-Mountain Home 
626-Tennessee 
Valley HCS 
VHA Medical 
SAS Dataset 
(PTF) 
nominal  
Index 
Admission LOS 
Length of stay for index 
admission, calculated as the 
number of days between the 
admission date and the date 
of discharge from the 
psychiatric unit.  
 number of days VHA Medical 
SAS Dataset 
continuous  
Facility Change is the inpatient facility 
affiliated with the medical 
center where Veteran 
receives treatment/will 
receive treatment upon 
discharge?  
 yes/no VHA Medical 
SAS 
Dataset/SPAN 
binary  
Bed Section The bed section is the 
specialty code of the 
physician who manages the 
patient's care during all or a 
portion of the inpatient stay 
 
bed sections used during 
inpatient stay. Will be used to 
determine whether any bed 
section, other than psychiatry, 
was used during the index 
admission.  
 number of bed 
sections utilized 
during inpatient 
admission 
 
or, was a bed section 
utilized that was not 
psychiatry?  
VHA Medical 
SAS Dataset 
(PTF) 
continuous 
 
 
 
binary 
Reliability of bed section information is 
variable, depending on the bedsection; 
agreement between administrative bedsection 
data (citing 20 most commonly recorded bed 
sections) and the medical record were best for 
orthopedics (kappa=0.852), medical ICU 
(kappa=0.846), and Neurology (kappa = 
0.820); worst for Hematology/oncology (kappa 
= 0.009), Intermediate Medicine 
(kappa=0.248), Substance Abuse 
(kappa=0.259) and Ear, Nose, Throat 
(kappa=0.290). ( Kashner, 1998) 
Consult 
Initiation 
whether inpatient provider 
initiated consult for PTSD, 
SUD or mental health 
treatment.   
Will be used in analysis to 
determine if consult initiation is 
associated with the length of time 
(in days) until first PTSD, SUD or 
mental health treatment.  
yes/no VHA Medical 
SAS Dataset: 
PTF 
binary  
Episode of Care: Post-Discharge Aftercare 
Variable Description Purpose Output Source Level of 
Measurement 
Limitations 
Suicide 
Prevention Staff 
Name of suicide prevention 
staff member at VISN 9 
facility.  
Will be used to identify care that 
was delivered by suicide 
prevention staff, distinct from 
other types of mental health 
treatment 
name VISN 9 Lead 
SPC 
nominal  
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time to first 
outpatient 
behavioral 
health 
appointment 
number of days between 
index discharge and first 
qualifying mental health 
encounter 
this will inform management plan 
continuity measure, and the 
treatment factor of timing 
number of days VHA Medical 
SAS Dataset: 
OPC 
continuous non-VA treatment information is not available  
Patient Record 
Flag Activation 
was a PRF: High Risk of 
Suicide completed after the 
suicide event date? This will 
be used to determine if the 
recommendations for post-
discharge aftercare were 
available to the inpatient 
treatment team.  
this will inform information 
continuity measure 
yes/no VHA Medical 
SAS Dataset: 
OPC 
binary this is a measure of continuity that can be 
determined without any input from the patient.  
Concentration 
of Care 
Number of providers with 
whom the patient had contact 
during first 7 and first 30 
days after discharge 
 
Measure based on the 
assumption that a greater 
concentration of care with 
one provider (or care site) 
signifies stronger 
relationships, more consistent 
care plans, and/or smoother 
transfers of information. 
this will inform measure of 
concentration of care, as it 
pertains to the involvement of 
mental health providers in the 
patient's treatment.  
Range 0 to ∞ VHA Medical 
SAS Dataset: 
OPC 
continuous non-VA treatment information is not available  
Treatment: Type type of outpatient behavioral 
health treatment 
 Mental Health 
Suicide Prevention 
Psychology 
Substance Use 
Treatment 
PTSD 
Homeless Care 
Vocational 
Treatment 
VHA Medical 
SAS Dataset: 
OPC 
nominal determined by VA Clinic Stop Code 
non-VA treatment information is not available 
  
Timing # of days between discharge 
and first MH treatment 
 Range 0 to 180 VHA Medical 
SAS Dataset: 
OPC 
continuous non-VA treatment information is not available  
Duration # days between first and last 
observed behavioral health 
appointment 
 Range 0 to 180 VHA Medical 
SAS Dataset: 
OPC 
continuous non-VA treatment information is not available  
Intensity # any mental health 
treatments in first 7 and first 
30 days 
 Range 0 to ∞ VHA Medical 
SAS Dataset: 
OPC 
continuous non-VA treatment information is not available  
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Setting of 
outpatient 
treatment 
name of setting where 
outpatient behavioral health 
treatment occurred 
 Medical Center 
CBOC 
Residential 
VHA Medical 
SAS Dataset: 
OPC 
nominal non-VA treatment information is not available  
Modality of 
outpatient 
treatment 
name of modality by which 
outpatient behavioral health 
treatment occurred 
 Face-to-Face 
(Individual) 
Group 
Telephone 
VHA Medical 
SAS Dataset: 
OPC 
nominal non-VA treatment information is not available  
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APPENDIX C 
 
 
BEHAVIORAL HEALTH ENCOUNTER STOP CODES AND CORRESPONDING VARIABLE CATEGORIES 
 
 
 TREATMENT TYPE CATEGORIES (ALL 
APPTS) 
13785 (% OF ALL 
APPTS) 
TREATMENT TYPE 
CATEGORIES (ALL APPTS) 
13785 (% OF ALL 
APPTS) 
 HOMELESS CARE TOTAL 511 3.71% HOMELESS CARE TOTAL 511 3.71% 
511 GRANT & PER DIEM-IND 40 0.29% 
511 GRANT & PER DIEM 42 0.30% 
522 HUD-VASH 75 0.54% 
522 HUD-VASH-IND 54 0.39% 
529 HCHV/HCMI 85 0.62% 
529 HCHV/HCMI-IND 115 0.83% 
Homeless Care Individual 411 2.98% 
507 HUD/VASH-GRP 2 0.01% 
508 HCHV/HCMI-GRP 10 0.07% 
Homeless Care Group 12 0.09% 
528 TELEPHONE HCMI 28 0.20% 
530 TELEPHONE/HUD-VASH 60 0.44% 
Homeless Care Telephone 88 0.64% 
       
 MENTAL HEALTH TOTAL 4418 32.05% MENTAL HEALTH TOTAL 4418 32.05% 
502 MENTAL HEALTH-IND 1700 12.33% 
503 MEN HLTH RESID CARE-IND 57 0.41% 
509 PSYCHIATRY-IND 748 5.43% 
512 PSYCHIATRY CONSULTATION 91 0.66% 
571 SERV-MH IND 72 0.52% 
573 MH INCEN THER-FACE TO FACE 8 0.06% 
582 PRRC IND 2 0.01% 
576 PSYCHOGERIA CLIN/INDV 247 1.79% 
588 RRTP AFTERCARE IND 1 0.01% 
591 INCARCERATED VETS REENTRY 7 0.05% 
534 MH INTGRTD CARE IND 63 0.46% 
Mental Health Individual 3522 25.55% 
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552 MHICM INDIVIDUAL 492 3.57% 
564 MH TEAM CASE MGT 19 0.14% 
596 RRTP ADMISSION SCREENING SRVCS 15 0.11% 
   
550 MENTAL HEALTH-GRP 250 1.81% 
553 DAY TRMT-GRP 5 0.04% 
566 MH RISK FAC RED EDU GRP 7 0.05% 
572 SERV-MH GRP 2 0.01% 
583 PRRC GRP 15 0.11% 
595 RRTP AFTERCARE GRP 58 0.42% 
Mental Health Group 337 2.44% 
546 TELEPHONE/MHICM 39 0.28% 
527 TELEPHONE/GENERAL PSYCHIATRY 513 3.72% 
597 TELEPHONE RRTP 7 0.05% 
Mental Health Telephone 559 4.06% 
       
 PSYCHOLOGY TOTAL 286 2.07% PSYCHOLOGY TOTAL 286 2.07% 
510 PSYCHOLOGY-IND 176 1.28% 
524 ACT DUTY SEX TRAUMA 30 0.22% 
538 PSYCHOLOGICAL TESTING 4 0.03% 
Psychology Individual 210 1.52% 
558 PSYCHOLOGY-GRP 76 0.55% Psychology Group 76 0.55% 
       
 PTSD TOTAL 625 4.53% PTSD TOTAL 625 4.53% 
519 SUBST USE DIS/PTSD TEAMS 11 0.08% 
540 PTSD CLINICAL TEAM PTS IND 234 1.70% 
580 PTSD DAY HOSP 101 0.73% 
562 PTSD-IND 50 0.36% 
PTSD Individual 396 2.87% 
516 PTSD GROUP 107 0.78% 
561 PCT PTSD-GRP 107 0.78% 
PTSD Group 214 1.55% 
542 TELEPHONE/PTSD 15 0.11% PTSD Telephone 15 0.11% 
       
 SUBSTANCE USE TOTAL 5516 40.01% SUBSTANCE USE TOTAL 5516 40.01% 
513 SUBST USE DISORDR IND 1417 10.28% 
514 SUBST USE DISORDR HOME VST 17 0.12% 
Substance Use Individual 1643 11.92% 
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523 OPIOID SUBSTITUTION 12 0.09% 
548 INTNSE SUB USE DSRDER IND 197 1.43% 
   
547 INTNSE SUB USE DSRDER GRP 596 4.32% 
560 SUBST USE DISORDR GRP 3145 22.81% 
Substance Use Group 3741 27.14% 
545 PHONE SUBSTANCE USE DSORDR 132 0.96% Substance Use Telephone 132 0.96% 
       
 VOCATIONAL TOTAL 133 0.96% VOCATIONAL TOTAL 133 0.96% 
535 MH VOCAT ASSIST-IND 1 0.01% 
568 MH CWT/SE FACE TO FACE 63 0.46% 
569 MH CWT/SE NON-F TO F (MASNONCT) 1 0.01% 
574 MH CWT/TWE FACE TO FACE 64 0.46% 
Vocational Individual 129 0.94% 
575 MH VOCAT ASSIST-GRP 1 0.01% Vocational Group 1 0.01% 
536 TELEPHONE/MH VOC ASSIST 2 0.01% 
537 TELEPHONE PSYC/SOC REHAB 1 0.01% 
Vocational Telephone 3 0.02% 
       
 SUICIDE PREVENTION (CLINIC + SPC) 
TOTAL 
2296 16.66% SUICIDE PREVENTION 
(CLINIC + SPC) TOTAL 
2296 16.66% 
502 MENTAL HEALTH-IND 1206 8.75% 
509 PSYCHIATRY-IND 3 0.02% 
510 PSYCHOLOGY-IND 1 0.01% 
571 SERV-MH IND 1 0.01% 
591 INCARCERATED VETS REENTRY 1 0.01% 
Suicide Prevention Individual 1212 8.79% 
550 MENTAL HEALTH-GRP 190 1.38% 
558 PSYCHOLOGY-GRP 4 0.03% 
560 SUBST USE DISORDR GRP 1 0.01% 
Suicide Prevention Group 195 1.41% 
527 TELEPHONE/GENERAL PSYCHIATRY 889 6.45% Suicide Prevention Telephone 889 6.45% 
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APPENDIX D:  
 
 
ELIXHAUSER COMORBIDITY DIAGNOSES AND CATEGORIES (N = 791) 
 
 
ICD-9-CM 
Code Description N (%) 
Elixhauser Category 
n (%) 
ALL ALL Diagnoses 
791 
(100.0)  
250.00 
Diabetes Mellitus without Mention of Complication, Type II, or Unspecified Type, not Stated as 
Uncontrolled 
80 
(10.1) 
250.02 Diabetes Mellitus without Mention of Complication, Type II, or Unspecified Type, Uncontrolled 1 (0.1) 
250.22 Diabetes with Hyperosmolarity, Type II or Unspecified Type, Uncontrolled 1 (0.1) 
Diabetes, uncomplicated 
82 (10.4) 
250.60 Diabetes with Neurological Manifestations, Type II or Unspecified, not Stated as Uncontrolled 5 (0.6) 
250.62 Diabetes with Neurological Manifestations, Type II or Unspecified, Uncontrolled 1 (0.1) 
250.50 Diabetes with Opthalmic Manifestations, Type II or Unspecified, not Stated as Uncontrolled 2 (0.3) 
Diabetes, complicated 
8 (1.0) 
531.70 Chronic Gastric Ulcer without mention of Hemorrhage or Perforation, without mention of Obstruction 1 (0.1) 
532.90 
Duodenal Ulcer, Unspecified as Acute or Chronic, without mention of Hemorrhage or Perforation, without 
mention of Obstruction 1 (0.1) 
533.90 
Peptic Ulcer of Unspecified Site, Unspecified as Acute or Chronic, without mention of Hemorrhage or 
Perforation 5 (0.6) 
V12.71 Personal History of Peptic Ulcer Disease 1 (0.1) 
Peptic ulcer disease 
8 (1.0) 
493.90 Asthma, Unspecified 
10 
(1.3) 
490.00 Bronchitis, not Specified as Acute or Chronic 4 (0.5) 
496.00 Chronic Airway Obstruction, not Elsewhere Classified 
43 
(5.4) 
493.20 Chronic Obstructive Asthma, Unspecified 4 (0.5) 
493.00 Extrinsic Asthma, Unspecified 1 (0.1) 
491.21 Obstructive Chronic Bronchitis, with (Acute) Exacerbation 5 (0.6) 
491.20 Obstructive Chronic Bronchitis, without Exacerbation 2 (0.3) 
492.80 Other Emphysema 3 (0.4) 
491.90 Unspecified Chronic Bronchitis 1 (0.1) 
Chronic pulmonary 
disease 
73 (9.1) 
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344.90 Paralysis Unspecified 2 (0.3) 
344.10 Paraplegia 3 (0.4) 
342.90 Unspecified Hemiplegia& Hemiparesis affecting Unspecified Side 2 (0.3) 
Paralysis 
7 (0.9) 
42.00 Human Immunodeficiency Virus (HIV) Disease 5 (0.6) 
AIDS/HIV 
5 (0.6) 
201.90 Hodgkin's Disease, Unspecified Type, Unspecified Site, Extranodal, and Solid Organ Sites 1 (0.1) 
202.30 Malignant Histiocytosis, Unspecified Site, Extranodal and Solid Organ Sites 1 (0.1) 
203.00 Multiple Myeloma with mention of Remission 1 (0.1) 
202.11 Mycosis Fungoides Involving Lymph Nodes of Head, Face and Neck 1 (0.1) 
202.80 Other Malignant Lymphomas, Unspecified Site, Extranodal and Solid Organ Sites 1 (0.1) 
Lymphoma 
5 (0.6) 
571.00 Alcoholic Fatty Liver 1 (0.1) 
70.54 Chronic Hepatitis C without mention of Hepatic Coma 
35 
(4.4) 
70.32 Chronic Viral Hepatitis B without mention of Hepatic Coma, without mention of Hepatitis Delta 1 (0.1) 
456.00 Esophageal Varices with Bleeding 1 (0.1) 
456.10 Esophageal Varices without mention of Bleeding 1 (0.1) 
572.80 Other Sequelae of Chronic Liver Disease 1 (0.1) 
572.30 Portal Hypertension 2 (0.3) 
Liver disease 
42 (5.3) 
278.00 Obesity, Unspecified 
41 
(5.2) 
Obesity 
41 (5.2) 
276.20 Acidosis 8 (1.0) 
276.30 Alkalosis 1 (0.1) 
276.51 Dehydration 6 (0.8) 
276.00 Hyperosmolality and/or Hypernatremia 2 (0.3) 
276.80 Hypopotassemia 8 (1.0) 
276.10 Hyposmolality and/or hyponatremia 9 (1.1) 
276.52 Hypovolemia 1 (0.1) 
276.40 Mixed Acid-Base Balance Disorder 2 (0.3) 
276.50 Volume Depletion, Unspecified 2 (0.3) 
Fluid and electrolyte 
disorders 
39 (4.9) 
424.10 Aortic Valve Disorders 2 (0.3) 
397.00 Diseases of Tricuspid Valve 1 (0.1) 
V43.3 Heart Valve Replaced by other Means 1 (0.1) 
Valvular disease 
4 (0.5) 
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263.10 Malnutrition of Mild Degree 1 (0.1) 
261.00 Nutritional Marasmus 1 (0.1) 
263.90 Unspecified Protein-Calorie Malnutrition 2 (0.3) 
Weight loss 
4 (0.5) 
426.70 Anomalous Atrioventricular Excitation 3 (0.4) 
427.31 Atrial Fibrillation 8 (1.0) 
V45.02 Automatic Implantable Cardiac Defibrillator in Situ 1 (0.1) 
V45.01 Cardiac Pacemaker in Situ 2 (0.3) 
426.11 First Degree Atrioventricular Block 1 (0.1) 
427.00 Paroxysmal Supraventricular Tachycardia 1 (0.1) 
426.40 Right Bundle Branch Block 1 (0.1) 
785.00 Tachycardia Unspecified 
12 
(1.5) 
Cardiac arrhythmias 
29 (3.7) 
331.90 Cerebral Degeneration, unspecified 1 (0.1) 
348.30 Encephalopathy, unspecified 1 (0.1) 
345.90 Epilepsy, unspecified, without mention of Intractable Epilepsy 
19 
(2.4) 
345.10 Generalized Convulsive Epilepsy, without mention of Intractable Epilepsy 2 (0.3) 
345.40 
Localization-Related (focal) (partial) Epilepsy Syndromes with Complex Partial Seizures, without mention 
of Intractable Epilepsy 
1 (0.1) 
345.50 
Localization-Related (focal) (partial) Epilepsy Syndromes with Simple Partial Seizures, without mention of 
Intractable Epilepsy 
1 (0.1) 
340.00 Multiple Sclerosis 1 (0.1) 
332.00 Paralysis Agitans 4 (0.5) 
Other neurological 
disorders 
30 (3.8) 
280.00 Iron Deficiency Anemia Secondary to Blood Loss (Chronic) 3 (0.4) 
Blood loss anemia 
3 (0.4) 
285.90 Anemia, Unspecified 
22 
(2.8) 
280.90 Iron Deficiency Anemia, Unspecified 5 (0.6) 
281.90 Unspecified Deficiency Anemia 1 (0.1) 
Deficiency Anemia 
28 (3.5) 
 
346.90 Migraine Unspecified without mention of Intractable Migraine 
28 
(3.5) 
Migraine 
28 (3.5) 
401.10 Benign Essential Hypertension 3 (0.4) 
401.90 Unspecified Essential Hypertension 
255 
(32.2) 
Hypertension, 
uncomplicated 
258 (32.6) 
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720.00 Ankylosing Spondylitis 1 (0.1) 
720.20 Sacroilitis, not elsewhere classified 
1 (0.1) 
Rheumatoid arthritis and 
collagen vascular 
disease 
2 (0.3) 
244.90 Unspecified Acquired Hypothyroidism 
19 
(2.4) 
Hypothyroidism 
19 (2.4) 
428.32 Chronic Diastolic Heart Failure 2 (0.3) 
428.22 Chronic Systolic Heart Failure 1 (0.1) 
428.00 Congestive Heart Failure Unspecified 
12 
(1.5) 
428.30 Unspecified Diastolic Heart Failure 1 (0.1) 
Congestive heart failure 
16 (2.0) 
155.20 Malignant Neoplasm of Liver, not Specified as Primary or Secondary 1 (0.1) 
162.90 Malignant Neoplasm of Bronchus and Lung, Unspecified 1 (0.1) 
162.20 Malignant Neoplasm of Main Bronchus 1 (0.1) 
185.00 Malignant Neoplasm of Prostate 3 (0.4) 
172.90 Melanoma of Skin, Site Unspecified 1 (0.1) 
V10.82 Personal History of Malignant Melanoma of the Skin 2 (0.3) 
V10.3 Personal History of Malignant Neoplasm of Breast 1 (0.1) 
V10.11 Personal History of Malignant Neoplasm of Bronchus and Lung 1 (0.1) 
V10.52 Personal History of Malignant Neoplasm of Kidney 1 (0.1) 
V10.53 Personal History of Malignant Neoplasm of Renal Pelvis 1 (0.1) 
V10.83 Personal History of Other Malignant Neoplasm of Skin 1 (0.1) 
Solid tumors w/o 
metastasis 
14 (1.8) 
441.40 Abdominal Aneurysm without mention of Rupture 1 (0.1) 
441.90 Aortic Aneurysm of Unspecified Site without mention of Rupture 1 (0.1) 
440.10 Atherosclerosis of Renal Artery 1 (0.1) 
443.90 Peripheral Vascular Disease Unspecified 8 (1.0) 
557.90 Unspecified Vascular Insufficiency of Intestine 2 (0.3) 
Peripheral vascular 
disorders 
13 (1.6) 
286.30 Congenital Deficiency of Other Clotting Factors 1 (0.1) 
296.90 Other an Unspecified Coagulation Defects 2 (0.3) 
287.50 Thrombocytopenia, Unspecified 8 (1.0) 
Coagulopathy 
11 (1.4) 
585.30 Chronic Kidney Disease, Stage III (Moderate) 1 (0.1) 
585.90 Chronic Kidney Disease, Unspecified 8 (1.0) 
403.91 Hypertensive Chronic Kidney Disease, Unspecified, with Chronic Kidney Disease Stage V or End Stage 1 (0.1) 
Renal failure 
10 (1.3) 
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Renal Disease  
438.20 Late Effect of Cerebrovascular Disease, Hemiplegia Affecting Unspecified Side 2 (0.3) 
438.13 Late Effects of Cerebrovascular Disease, Dysarthria 1 (0.1) 
433.10 Occlusion & Stenosis of Carotid Artery, without Cerebral Infarction 2 (0.3) 
437.90 Unspecified Cerebrovascular Disease 1 (0.1) 
432.90 Unspecified Intercranial Hemorrhage 1 (0.1) 
435.90 Unspecified Transient Cerebral Ischemia 3 (0.4) 
Cerebrovascular disease 
10 (1.3) 
416.80 Other Chronic Pulmonary Heart Diseases 1 (0.1) 
Pulmonary circulation 
disorders 
1 (0.1) 
851.80 
Other and Unspecified Cerebral Laceration and Contusion, without mention of Open Intercranial Wound, 
with state of… 1 (0.1) 
Traumatic brain injury 
(TBI) 
1 (0.1) 
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APPENDIX E 
 
 
VA MH-12 PRIMARY PSYCHIATRIC DIAGNOSES AND CATEGORIES (N = 506) 
 
 
ICD-9 Description N (%) Category N (%) 
309.24 Adjustment Disorder with Anxiety 1 (0.2) 
309.00 Adjustment Disorder with Depressed Mood 20 (4.0) 
309.28 Adjustment Disorder with Mixed Anxiety and Depressed Mood 7 (1.4) 
309.40 Adjustment Disorder with Mixed Disturbance of Emotions and Conduct 2 (0.4) 
309.90 Unspecified Adjustment Reaction 2 (0.4) Adjustment Disorder 32 (6.3) 
303.01 Acute Alcoholic Intoxication in Alcoholism, Continuous Drinking Behavior 11 (2.2) 
303.00 Acute Alcoholic Intoxication in Alcoholism, Unspecified Drinking Behavior 3 (0.6) 
305.01 Alcohol Abuse, Continuous Drinking Behavior 6 (1.2) 
305.02 Alcohol Abuse, Episodic Drinking Behavior 1 (0.2) 
305.00 Alcohol Abuse, Unspecified Drinking Behavior 7 (1.4) 
291.81 Alcohol Withdrawal 12 (2.4) 
291.00 Alcohol Withdrawal Delirium 3 (0.6) 
303.91 Other and Unspecified Alcohol Dependence, Continuous Drinking Behavior 20 (4.0) 
303.92 Other and Unspecified Alcohol Dependence, Episodic Drinking Behavior 2 (0.4) 
303.90 Other and Unspecified Alcohol Dependence, Unspecified Drinking Behavior 7 (1.4) 
291.89 Other Specified Alcohol-Induced Mental Disorders 13 (2.6) Alcohol Disorder 85 (16.8) 
304.41 Amphetamine and Other Psychostimulant Dependence, Continuous 1 (0.2) 
305.21 Cannabis Abuse, Continuous Use 1 (0.2) 
304.31 Cannabis Dependence, Continuous Use 1 (0.2) 
305.60 Cocaine Abuse, Unspecified 1 (0.2) 
305.61 Cocaine Abuse, Continuous Use 2 (0.4) 
304.21 Cocaine Dependence, Continuous Use 4 (0.8) 
304.80 Combinations of Drug Dependence Excluding Opioid Type Drug, Unspecified Use 1 (0.2) 
292.00 Drug Withdrawal 2 (0.4) 
292.81 Drug-Induced Delirium 1 (0.2) 
Drug Disorder 72 (14.2) 
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292.84 Drug-Induced Mood Disorder 38 (7.5) 
305.51 Opioid Abuse Continuous 2 (0.4) 
305.50 Opioid Abuse Unspecified 1 (0.2) 
304.01 Opioid Type Dependence Continuous 6 (1.2) 
304.00 Opioid Type Dependence Unspecified 4 (0.8) 
304.61 Other Specified Drug Dependence, Continuous Use 1 (0.2) 
305.91 Other, Mixed, or Unspecified Drug Abuse, Continuous Use 1 (0.2) 
305.40 Sedative, Hypnotic or Anxiolytic Abuse, Unspecified 1 (0.2) 
304.11 Sedative, Hypnotic or Anxiolytic Abuse, Continuous 2 (0.4) 
304.10 Sedative, Hypnotic or Anxiolytic Dependence, Unspecified 2 (0.4) 
  
300.01 Panic Disorder without Agoraphobia 1 (0.2) Anxiety Disorder 1 (0.2) 
296.80 Bipolar Disorder, Unspecified 7 (1.4) 
296.54 
Bipolar I Disorder, Most Recent Episode (Or Current) Depressed, Severe, Specified as with 
Psychotic Behavior 1 (0.2) 
296.53 
Bipolar I Disorder, Most Recent Episode (Or Current) Depressed, Severe, Without Mention 
of Psychotic Behavior 5 (1.0) 
296.50 Bipolar I Disorder, Most Recent Episode (Or Current) Depressed, Unspecified 9 (1.8) 
296.44 
Bipolar I Disorder, Most Recent Episode (Or Current) Manic, Severe, Specified as with 
Psychotic Behavior 2 (0.4) 
296.43 
Bipolar I Disorder, Most Recent Episode (Or Current) Manic, Severe, Without Mention of 
Psychotic Behavior 1 (0.2) 
296.40 Bipolar I Disorder, Most Recent Episode (Or Current) Manic, Unspecified 2 (0.4) 
296.63 
Bipolar I Disorder, Most Recent Episode (Or Current) Mixed, Severe, Without Mention of 
Psychotic Behavior 
2 (0.4) 
296.70 Bipolar I Disorder, Most Recent Episode (Or Current) Unspecified 3 (0.6) 
296.89 Other and Unspecified Bipolar Disorders, Other 2 (0.4) 
296.90 Unspecified Episodic Mood Disorder 16 (3.2) Bipolar Disorder 50 (9.9) 
294.11 Dementia in Conditions Classified Elsewhere with Behavioral Disturbance 1 (0.2) 
294.80 Other Persistent Mental Disorders due to Conditions Classified Elsewhere 1 (0.2) 
294.90 Unspecified Persistent Mental Disorders due to Conditions Classified Elsewhere 2 (0.4) Dementia 4 (0.8) 
296.31 Major Depressive Affective Disorder, Recurrent Episode, Mild Degree 1 (0.2) 
296.32 Major Depressive Affective Disorder, Recurrent Episode, Moderate Degree 5 (1.0) 
296.34 Major Depressive Affective Disorder, Recurrent Episode, Severe Degree, Specified as with 19 (3.8) 
MDD 147 (29.1) 
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Psychotic Behavior 
296.33 
Major Depressive Affective Disorder, Recurrent Episode, Severe Degree, Without Mention 
of Psychotic Behavior 60 (11.9) 
296.30 Major Depressive Affective Disorder, Recurrent Episode, Unspecified Degree 27 (5.3) 
296.22 Major Depressive Affective Disorder, Single Episode, Moderate Degree 2 (0.4) 
296.24 
Major Depressive Affective Disorder, Single Episode, Severe Degree, Specified as with 
Psychotic Behavior 
2 (0.4) 
296.23 
Major Depressive Affective Disorder, Single Episode, Severe Degree, Without Mention of 
Psychotic Behavior 6 (1.2) 
296.20 Major Depressive Affective Disorder, Single Episode, Unspecified Degree 25 (4.9) 
  
296.82 Atypical Depressive Disorder 1 (0.2) 
311.00 Depressive Disorder, Not Elsewhere Classified 37 (7.3) 
300.40 Dysthymic Disorder 7 (1.4) Other Depressive Disorder 45 (8.9) 
298.90 Unspecified Psychosis 2 (0.4) Other Psychoses 2 (0.4) 
301.83 Borderline Personality Disorder 1 (0.2) 
301.89 Other Personality Disorders 1 (0.2) Personality Disorders 2 (0.4) 
309.81 Post Traumatic Stress Disorder 41 (8.1) PTSD 41 (8.1) 
295.32 Paranoid Schizophrenia, Chronic State 1 (0.2) 
295.30 Paranoid Schizophrenia, Unspecified State 3 (0.6) 
295.72 Schizoaffective Disorder, Chronic 1 (0.2) 
295.74 Schizoaffective Disorder, Chronic with Acute Exacerbation 1 (0.2) 
295.73 Schizoaffective Disorder, Subchronic with Acute Exacerbation 1 (0.2) 
295.70 Schizoaffective Disorder, Unspecified 14 (2.8) 
295.63 Schizophrenic Disorders, Residual Type, Subchronic with Acute Exacerbation 1 (0.2) 
295.92 Unspecified Type Schizophrenia, Chronic State 1 (0.2) 
295.90 Unspecified Type Schizophrenia, Unspecified State 2 (0.4) Schizophrenia 25 (4.9) 
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